Background  ||| S:24 E:43 ||| NN
Traditionally ||| S:43 E:56 ||| RB
,  ||| S:56 E:58 ||| ,
techniques  ||| S:58 E:69 ||| NNS
for  ||| S:69 E:73 ||| IN
the  ||| S:73 E:77 ||| DT
study  ||| S:77 E:83 ||| NN
of  ||| S:83 E:86 ||| IN
gene  ||| S:86 E:99 ||| NN
expression  ||| S:99 E:110 ||| NN
were  ||| S:110 E:115 ||| VBD
significantly  ||| S:115 E:129 ||| RB
limited  ||| S:129 E:137 ||| VBN
in  ||| S:137 E:140 ||| IN
both  ||| S:140 E:145 ||| DT
breadth  ||| S:145 E:153 ||| NN
and  ||| S:153 E:165 ||| CC
efficiency  ||| S:165 E:176 ||| NN
since  ||| S:176 E:182 ||| IN
these  ||| S:182 E:188 ||| DT
studies  ||| S:188 E:196 ||| NNS
typically  ||| S:196 E:206 ||| RB
allowed  ||| S:206 E:222 ||| VBN
investigators  ||| S:222 E:236 ||| NNS
to  ||| S:236 E:239 ||| TO
study  ||| S:239 E:245 ||| VB
only  ||| S:245 E:250 ||| RB
one  ||| S:250 E:254 ||| CD
or  ||| S:254 E:257 ||| CC
a  ||| S:257 E:259 ||| DT
few  ||| S:259 E:263 ||| JJ
genes  ||| S:263 E:269 ||| NNS
at  ||| S:269 E:272 ||| IN
a  ||| S:272 E:274 ||| DT
time ||| S:274 E:278 ||| NN
.  ||| S:278 E:288 ||| .
However ||| S:288 E:295 ||| RB
,  ||| S:295 E:297 ||| ,
the  ||| S:297 E:301 ||| DT
recently  ||| S:301 E:310 ||| RB
developed  ||| S:310 E:320 ||| VBN
DNA  ||| S:320 E:324 ||| NN
microarray  ||| S:324 E:335 ||| NN
technique  ||| S:335 E:345 ||| NN
is  ||| S:345 E:356 ||| VBZ
a  ||| S:356 E:358 ||| DT
powerful  ||| S:358 E:367 ||| JJ
method  ||| S:367 E:374 ||| NN
that  ||| S:374 E:379 ||| WDT
provides  ||| S:379 E:388 ||| VBZ
researchers  ||| S:388 E:400 ||| NNS
with  ||| S:400 E:405 ||| IN
the  ||| S:405 E:417 ||| DT
opportunity  ||| S:417 E:429 ||| NN
to  ||| S:429 E:432 ||| TO
analyze  ||| S:432 E:440 ||| VB
the  ||| S:440 E:444 ||| DT
expression  ||| S:444 E:455 ||| NN
patterns  ||| S:455 E:464 ||| NNS
of  ||| S:464 E:467 ||| IN
tens  ||| S:467 E:472 ||| NNS
of  ||| S:472 E:483 ||| IN
thousands  ||| S:483 E:493 ||| NNS
of  ||| S:493 E:496 ||| IN
genes  ||| S:496 E:502 ||| NNS
in  ||| S:502 E:505 ||| IN
a  ||| S:505 E:507 ||| DT
short  ||| S:507 E:513 ||| JJ
time  ||| S:513 E:518 ||| NN
[  ||| S:518 E:520 ||| -LRB-
1  ||| S:520 E:522 ||| LS
]  ||| S:522 E:524 ||| -RRB-
.  ||| S:524 E:526 ||| .
Presently ||| S:526 E:535 ||| RB
,  ||| S:535 E:545 ||| ,
several  ||| S:545 E:553 ||| JJ
vendors  ||| S:553 E:561 ||| NNS
offer  ||| S:561 E:567 ||| VBP
these  ||| S:567 E:573 ||| DT
microarray  ||| S:573 E:584 ||| JJ
systems ||| S:584 E:591 ||| NNS
,  ||| S:591 E:593 ||| ,
also  ||| S:593 E:598 ||| RB
known  ||| S:598 E:612 ||| VBN
as  ||| S:612 E:615 ||| IN
chips ||| S:615 E:620 ||| NNS
,  ||| S:620 E:622 ||| ,
with  ||| S:622 E:627 ||| IN
a  ||| S:627 E:629 ||| DT
variety  ||| S:629 E:637 ||| NN
of  ||| S:637 E:640 ||| IN
technologies  ||| S:640 E:653 ||| NNS
available ||| S:653 E:662 ||| JJ
.  ||| S:662 E:672 ||| .
Currently ||| S:672 E:681 ||| RB
,  ||| S:681 E:683 ||| ,
DNA  ||| S:683 E:687 ||| NNP
microarrays  ||| S:687 E:699 ||| NNS
are  ||| S:699 E:703 ||| VBP
manufactured  ||| S:703 E:716 ||| VBN
using  ||| S:716 E:722 ||| VBG
either  ||| S:722 E:737 ||| DT
cDNA  ||| S:737 E:742 ||| JJ
or  ||| S:742 E:745 ||| CC
oligonucleotides  ||| S:745 E:762 ||| NN
as  ||| S:762 E:765 ||| IN
gene  ||| S:765 E:770 ||| NN
probes.  ||| S:770 E:778 ||| CD
cDNA  ||| S:778 E:783 ||| JJ
microarrays  ||| S:783 E:803 ||| NNS
are  ||| S:803 E:807 ||| VBP
created  ||| S:807 E:815 ||| VBN
by  ||| S:815 E:818 ||| IN
spotting  ||| S:818 E:827 ||| VBG
amplified  ||| S:827 E:837 ||| VBN
cDNA  ||| S:837 E:842 ||| JJ
fragments  ||| S:842 E:852 ||| NNS
in  ||| S:852 E:855 ||| IN
a  ||| S:855 E:857 ||| DT
high  ||| S:857 E:870 ||| JJ
density  ||| S:870 E:878 ||| JJ
pattern  ||| S:878 E:886 ||| NN
onto  ||| S:886 E:891 ||| IN
a  ||| S:891 E:893 ||| DT
solid  ||| S:893 E:899 ||| JJ
substrate  ||| S:899 E:909 ||| JJ
such  ||| S:909 E:914 ||| JJ
as  ||| S:914 E:917 ||| IN
a  ||| S:917 E:919 ||| DT
glass  ||| S:919 E:933 ||| NN
slide  ||| S:933 E:939 ||| NN
[  ||| S:939 E:941 ||| -LRB-
1  ||| S:941 E:943 ||| CD
2  ||| S:943 E:945 ||| CD
]  ||| S:945 E:947 ||| -RRB-
.  ||| S:947 E:949 ||| .
Oligonucleotide  ||| S:949 E:965 ||| JJ
arrays  ||| S:965 E:972 ||| NNS
are  ||| S:972 E:976 ||| VBP
either  ||| S:976 E:983 ||| RB
spotted  ||| S:983 E:999 ||| VBN
or  ||| S:999 E:1002 ||| CC
constructed  ||| S:1002 E:1014 ||| VBN
by  ||| S:1014 E:1017 ||| IN
chemically  ||| S:1017 E:1028 ||| JJ
synthesizing  ||| S:1028 E:1041 ||| NNS
approximately  ||| S:1041 E:1063 ||| RB
25-mer  ||| S:1063 E:1070 ||| CD
oligonucleotide  ||| S:1070 E:1086 ||| CD
probes  ||| S:1086 E:1093 ||| NNS
directly  ||| S:1093 E:1102 ||| RB
onto  ||| S:1102 E:1107 ||| IN
a  ||| S:1107 E:1109 ||| DT
glass  ||| S:1109 E:1115 ||| NN
or  ||| S:1115 E:1126 ||| CC
silicon  ||| S:1126 E:1134 ||| JJ
surface  ||| S:1134 E:1142 ||| NN
using  ||| S:1142 E:1148 ||| VBG
photolithographic  ||| S:1148 E:1166 ||| JJ
technology  ||| S:1166 E:1177 ||| NN
[  ||| S:1177 E:1179 ||| -LRB-
3  ||| S:1179 E:1181 ||| LS
]  ||| S:1181 E:1191 ||| -RRB-
.  ||| S:1191 E:1201 ||| .
Due  ||| S:1201 E:1205 ||| JJ
to  ||| S:1205 E:1208 ||| TO
the  ||| S:1208 E:1212 ||| DT
powerful  ||| S:1212 E:1221 ||| JJ
nature  ||| S:1221 E:1228 ||| NN
of  ||| S:1228 E:1231 ||| IN
microarrays ||| S:1231 E:1242 ||| NN
,  ||| S:1242 E:1244 ||| ,
the  ||| S:1244 E:1248 ||| DT
number  ||| S:1248 E:1255 ||| NN
of  ||| S:1255 E:1266 ||| IN
relevant  ||| S:1266 E:1275 ||| JJ
publications  ||| S:1275 E:1288 ||| NNS
in  ||| S:1288 E:1291 ||| IN
this  ||| S:1291 E:1296 ||| DT
burgeoning  ||| S:1296 E:1307 ||| JJ
field  ||| S:1307 E:1313 ||| NN
is  ||| S:1313 E:1324 ||| VBZ
increasing  ||| S:1324 E:1335 ||| VBG
exponentially ||| S:1335 E:1348 ||| NNS
.  ||| S:1348 E:1350 ||| .
During  ||| S:1350 E:1357 ||| IN
the  ||| S:1357 E:1361 ||| DT
years  ||| S:1361 E:1367 ||| NNS
1995-1997 ||| S:1367 E:1376 ||| RB
,  ||| S:1376 E:1378 ||| ,
the  ||| S:1378 E:1390 ||| DT
number  ||| S:1390 E:1397 ||| NN
of  ||| S:1397 E:1400 ||| IN
reports  ||| S:1400 E:1408 ||| NNS
featuring  ||| S:1408 E:1418 ||| VBG
microarray  ||| S:1418 E:1429 ||| JJ
data  ||| S:1429 E:1434 ||| NNS
was  ||| S:1434 E:1438 ||| VBD
less  ||| S:1438 E:1443 ||| JJR
than  ||| S:1443 E:1456 ||| IN
ten ||| S:1456 E:1459 ||| NN
.  ||| S:1459 E:1461 ||| .
However ||| S:1461 E:1468 ||| RB
,  ||| S:1468 E:1470 ||| ,
in  ||| S:1470 E:1473 ||| IN
2001  ||| S:1473 E:1478 ||| CD
alone  ||| S:1478 E:1484 ||| RB
approximately  ||| S:1484 E:1498 ||| RB
800  ||| S:1498 E:1502 ||| CD
publications  ||| S:1502 E:1523 ||| NNS
featured  ||| S:1523 E:1532 ||| VBD
data  ||| S:1532 E:1537 ||| NNS
generated  ||| S:1537 E:1547 ||| VBN
by  ||| S:1547 E:1550 ||| IN
microarray  ||| S:1550 E:1561 ||| JJ
studies  ||| S:1561 E:1569 ||| NNS
( ||| S:1569 E:1570 ||| -LRB-
according  ||| S:1570 E:1580 ||| VBG
to  ||| S:1580 E:1591 ||| TO
a  ||| S:1591 E:1593 ||| DT
PubMed  ||| S:1593 E:1600 ||| JJ
search ||| S:1600 E:1606 ||| NN
) ||| S:1606 E:1607 ||| -RRB-
.  ||| S:1607 E:1617 ||| .
Microarray  ||| S:1617 E:1628 ||| JJ
technology  ||| S:1628 E:1639 ||| NN
certainly  ||| S:1639 E:1649 ||| RB
has  ||| S:1649 E:1653 ||| VBZ
the  ||| S:1653 E:1657 ||| DT
potential  ||| S:1657 E:1667 ||| JJ
to  ||| S:1667 E:1678 ||| TO
greatly  ||| S:1678 E:1686 ||| RB
enhance  ||| S:1686 E:1694 ||| VB
our  ||| S:1694 E:1698 ||| PRP$
knowledge  ||| S:1698 E:1708 ||| NN
about  ||| S:1708 E:1714 ||| IN
gene  ||| S:1714 E:1719 ||| NN
expression ||| S:1719 E:1729 ||| NN
,  ||| S:1729 E:1731 ||| ,
but  ||| S:1731 E:1743 ||| CC
there  ||| S:1743 E:1749 ||| EX
are  ||| S:1749 E:1753 ||| VBP
drawbacks  ||| S:1753 E:1763 ||| NNS
that  ||| S:1763 E:1768 ||| WDT
need  ||| S:1768 E:1773 ||| VBP
to  ||| S:1773 E:1776 ||| TO
be  ||| S:1776 E:1779 ||| VB
considered ||| S:1779 E:1789 ||| VBN
.  ||| S:1789 E:1791 ||| .
As  ||| S:1791 E:1794 ||| IN
Knight  ||| S:1794 E:1801 ||| NNP
[  ||| S:1801 E:1811 ||| -LRB-
4  ||| S:1811 E:1813 ||| LS
]  ||| S:1813 E:1815 ||| -RRB-
cautioned ||| S:1815 E:1824 ||| VBD
,  ||| S:1824 E:1826 ||| ,
it  ||| S:1826 E:1829 ||| PRP
is  ||| S:1829 E:1832 ||| VBZ
possible  ||| S:1832 E:1841 ||| JJ
that  ||| S:1841 E:1846 ||| IN
errors  ||| S:1846 E:1853 ||| NNS
could  ||| S:1853 E:1859 ||| MD
be  ||| S:1859 E:1870 ||| VB
incorporated  ||| S:1870 E:1883 ||| VBN
during  ||| S:1883 E:1890 ||| IN
the  ||| S:1890 E:1894 ||| DT
manufacture  ||| S:1894 E:1906 ||| NN
of  ||| S:1906 E:1909 ||| IN
the  ||| S:1909 E:1913 ||| DT
chips ||| S:1913 E:1918 ||| NNS
.  ||| S:1918 E:1928 ||| .
Consequently ||| S:1928 E:1940 ||| RB
,  ||| S:1940 E:1942 ||| ,
the  ||| S:1942 E:1946 ||| DT
fidelity  ||| S:1946 E:1955 ||| NN
of  ||| S:1955 E:1958 ||| IN
the  ||| S:1958 E:1962 ||| DT
DNA  ||| S:1962 E:1966 ||| NN
fragments  ||| S:1966 E:1976 ||| VBZ
immobilized  ||| S:1976 E:1996 ||| VBN
to  ||| S:1996 E:1999 ||| TO
the  ||| S:1999 E:2003 ||| DT
microarray  ||| S:2003 E:2014 ||| JJ
surface  ||| S:2014 E:2022 ||| NN
may  ||| S:2022 E:2026 ||| MD
be  ||| S:2026 E:2029 ||| VB
compromised ||| S:2029 E:2040 ||| VBN
.  ||| S:2040 E:2042 ||| .
However ||| S:2042 E:2049 ||| RB
,  ||| S:2049 E:2059 ||| ,
there  ||| S:2059 E:2065 ||| EX
are  ||| S:2065 E:2069 ||| VBP
few  ||| S:2069 E:2073 ||| JJ
studies  ||| S:2073 E:2081 ||| NNS
where  ||| S:2081 E:2087 ||| WRB
the  ||| S:2087 E:2091 ||| DT
majority  ||| S:2091 E:2100 ||| NN
of  ||| S:2100 E:2103 ||| IN
the  ||| S:2103 E:2107 ||| DT
gene  ||| S:2107 E:2120 ||| NN
sequences  ||| S:2120 E:2130 ||| VBZ
spotted  ||| S:2130 E:2138 ||| VBN
on  ||| S:2138 E:2141 ||| IN
the  ||| S:2141 E:2145 ||| DT
microarrays  ||| S:2145 E:2157 ||| NN
were  ||| S:2157 E:2162 ||| VBD
verified  ||| S:2162 E:2171 ||| VBN
[  ||| S:2171 E:2173 ||| -LRB-
5  ||| S:2173 E:2175 ||| LS
]  ||| S:2175 E:2177 ||| -RRB-
.  ||| S:2177 E:2187 ||| .
Kuo  ||| S:2187 E:2200 ||| FW
et  ||| S:2200 E:2203 ||| FW
al  ||| S:2203 E:2206 ||| FW
( ||| S:2206 E:2207 ||| -LRB-
2002 ||| S:2207 E:2211 ||| CD
)  ||| S:2211 E:2213 ||| -RRB-
compared  ||| S:2213 E:2222 ||| VBN
the  ||| S:2222 E:2226 ||| DT
data  ||| S:2226 E:2231 ||| NNS
from  ||| S:2231 E:2244 ||| IN
two  ||| S:2244 E:2248 ||| CD
high-throughput  ||| S:2248 E:2264 ||| JJ
DNA  ||| S:2264 E:2268 ||| NN
microarray  ||| S:2268 E:2279 ||| NN
technologies ||| S:2279 E:2291 ||| NNS
,  ||| S:2291 E:2293 ||| ,
cDNA  ||| S:2293 E:2306 ||| JJ
microarray  ||| S:2306 E:2317 ||| NNS
( ||| S:2317 E:2318 ||| -LRB-
Stanford  ||| S:2318 E:2327 ||| NNP
type ||| S:2327 E:2331 ||| NN
)  ||| S:2331 E:2333 ||| -RRB-
and  ||| S:2333 E:2337 ||| CC
oligonucleotide  ||| S:2337 E:2353 ||| JJ
microarray  ||| S:2353 E:2372 ||| NNS
( ||| S:2372 E:2373 ||| -LRB-
from  ||| S:2373 E:2378 ||| IN
Affymetrix ||| S:2378 E:2388 ||| NNP
)  ||| S:2388 E:2390 ||| -RRB-
and  ||| S:2390 E:2394 ||| CC
found  ||| S:2394 E:2400 ||| VBD
very  ||| S:2400 E:2405 ||| RB
little  ||| S:2405 E:2412 ||| JJ
correlation  ||| S:2412 E:2424 ||| NN
between  ||| S:2424 E:2440 ||| IN
these  ||| S:2440 E:2446 ||| DT
two  ||| S:2446 E:2450 ||| CD
platforms  ||| S:2450 E:2460 ||| NNS
[  ||| S:2460 E:2462 ||| -LRB-
6  ||| S:2462 E:2464 ||| CD
]  ||| S:2464 E:2466 ||| -RRB-
.  ||| S:2466 E:2468 ||| .
Unfortunately ||| S:2468 E:2481 ||| RB
,  ||| S:2481 E:2483 ||| ,
many  ||| S:2483 E:2496 ||| JJ
investigators  ||| S:2496 E:2510 ||| NNS
are  ||| S:2510 E:2514 ||| VBP
reporting  ||| S:2514 E:2524 ||| VBG
microarray  ||| S:2524 E:2535 ||| JJ
data  ||| S:2535 E:2540 ||| NNS
without  ||| S:2540 E:2556 ||| IN
confirming  ||| S:2556 E:2567 ||| VBG
their  ||| S:2567 E:2573 ||| PRP$
results  ||| S:2573 E:2581 ||| NNS
by  ||| S:2581 E:2584 ||| IN
other  ||| S:2584 E:2590 ||| JJ
traditional  ||| S:2590 E:2602 ||| JJ
gene  ||| S:2602 E:2615 ||| NN
expression  ||| S:2615 E:2626 ||| NN
techniques  ||| S:2626 E:2637 ||| NNS
such  ||| S:2637 E:2642 ||| JJ
as  ||| S:2642 E:2645 ||| IN
PCR ||| S:2645 E:2648 ||| NNP
,  ||| S:2648 E:2650 ||| ,
Northern  ||| S:2650 E:2659 ||| JJ
blot  ||| S:2659 E:2664 ||| JJ
analysis  ||| S:2664 E:2681 ||| NN
and  ||| S:2681 E:2685 ||| CC
RNase  ||| S:2685 E:2691 ||| JJ
protection  ||| S:2691 E:2702 ||| NN
assay ||| S:2702 E:2707 ||| NN
.  ||| S:2707 E:2709 ||| .
Raw  ||| S:2709 E:2713 ||| JJ
microarray  ||| S:2713 E:2724 ||| JJ
data  ||| S:2724 E:2729 ||| NNS
obtained  ||| S:2729 E:2746 ||| VBN
from  ||| S:2746 E:2751 ||| IN
questionable  ||| S:2751 E:2764 ||| JJ
nucleotide  ||| S:2764 E:2775 ||| JJ
sequences  ||| S:2775 E:2785 ||| NNS
are  ||| S:2785 E:2789 ||| VBP
then  ||| S:2789 E:2794 ||| RB
often  ||| S:2794 E:2808 ||| RB
manipulated  ||| S:2808 E:2820 ||| VBN
using  ||| S:2820 E:2826 ||| VBG
cluster  ||| S:2826 E:2834 ||| NN
and  ||| S:2834 E:2838 ||| CC
statistical  ||| S:2838 E:2850 ||| JJ
analysis  ||| S:2850 E:2859 ||| NN
software  ||| S:2859 E:2876 ||| NN
and  ||| S:2876 E:2880 ||| CC
subsequently  ||| S:2880 E:2893 ||| RB
reported  ||| S:2893 E:2902 ||| VBN
in  ||| S:2902 E:2905 ||| IN
scientific  ||| S:2905 E:2916 ||| JJ
journals ||| S:2916 E:2924 ||| NNS
.  ||| S:2924 E:2926 ||| .
In  ||| S:2926 E:2937 ||| IN
addition  ||| S:2937 E:2946 ||| NN
the  ||| S:2946 E:2950 ||| DT
quality  ||| S:2950 E:2958 ||| NN
of  ||| S:2958 E:2961 ||| IN
the  ||| S:2961 E:2965 ||| DT
probe  ||| S:2965 E:2971 ||| NN
sequences  ||| S:2971 E:2981 ||| NNS
and  ||| S:2981 E:2985 ||| CC
the  ||| S:2985 E:2997 ||| DT
location  ||| S:2997 E:3006 ||| NN
of  ||| S:3006 E:3009 ||| IN
the  ||| S:3009 E:3013 ||| DT
probes  ||| S:3013 E:3020 ||| NNS
selected  ||| S:3020 E:3029 ||| VBN
for  ||| S:3029 E:3033 ||| IN
incorporation  ||| S:3033 E:3047 ||| NN
into  ||| S:3047 E:3052 ||| IN
the  ||| S:3052 E:3064 ||| DT
array  ||| S:3064 E:3070 ||| NN
are  ||| S:3070 E:3074 ||| VBP
also  ||| S:3074 E:3079 ||| RB
very  ||| S:3079 E:3084 ||| RB
important ||| S:3084 E:3093 ||| JJ
.  ||| S:3093 E:3095 ||| .
For  ||| S:3095 E:3099 ||| IN
example ||| S:3099 E:3106 ||| NN
,  ||| S:3106 E:3108 ||| ,
if  ||| S:3108 E:3111 ||| IN
probes  ||| S:3111 E:3118 ||| NNS
are  ||| S:3118 E:3130 ||| VBP
selected  ||| S:3130 E:3139 ||| VBN
only  ||| S:3139 E:3144 ||| RB
from  ||| S:3144 E:3149 ||| IN
the  ||| S:3149 E:3153 ||| DT
3 ||| S:3153 E:3154 ||| CD
'  ||| S:3154 E:3156 ||| POS
end  ||| S:3156 E:3160 ||| NN
of  ||| S:3160 E:3163 ||| IN
a  ||| S:3163 E:3165 ||| DT
given  ||| S:3165 E:3171 ||| VBN
gene ||| S:3171 E:3175 ||| NN
,  ||| S:3175 E:3177 ||| ,
then  ||| S:3177 E:3182 ||| RB
there  ||| S:3182 E:3196 ||| EX
is  ||| S:3196 E:3199 ||| VBZ
a  ||| S:3199 E:3201 ||| DT
strong  ||| S:3201 E:3208 ||| JJ
possibility  ||| S:3208 E:3220 ||| NN
that  ||| S:3220 E:3225 ||| IN
different  ||| S:3225 E:3235 ||| JJ
splice  ||| S:3235 E:3242 ||| JJ
variants  ||| S:3242 E:3251 ||| NN
of  ||| S:3251 E:3262 ||| IN
that  ||| S:3262 E:3267 ||| DT
gene  ||| S:3267 E:3272 ||| NN
will  ||| S:3272 E:3277 ||| MD
not  ||| S:3277 E:3281 ||| RB
be  ||| S:3281 E:3284 ||| VB
identified  ||| S:3284 E:3295 ||| VBN
if  ||| S:3295 E:3298 ||| IN
the  ||| S:3298 E:3302 ||| DT
alternative  ||| S:3302 E:3322 ||| JJ
splicing  ||| S:3322 E:3331 ||| NN
occurs  ||| S:3331 E:3338 ||| VBZ
at  ||| S:3338 E:3341 ||| IN
the  ||| S:3341 E:3345 ||| DT
5 ||| S:3345 E:3346 ||| CD
'  ||| S:3346 E:3348 ||| POS
region  ||| S:3348 E:3355 ||| NN
of  ||| S:3355 E:3358 ||| IN
the  ||| S:3358 E:3362 ||| DT
gene ||| S:3362 E:3366 ||| NN
.  ||| S:3366 E:3376 ||| .
The  ||| S:3376 E:3380 ||| DT
development  ||| S:3380 E:3392 ||| NN
of  ||| S:3392 E:3395 ||| IN
a  ||| S:3395 E:3397 ||| DT
single  ||| S:3397 E:3404 ||| JJ
chip  ||| S:3404 E:3409 ||| NN
containing  ||| S:3409 E:3420 ||| VBG
the  ||| S:3420 E:3424 ||| DT
complete  ||| S:3424 E:3441 ||| JJ
gene  ||| S:3441 E:3446 ||| NN
set  ||| S:3446 E:3450 ||| VBN
for  ||| S:3450 E:3454 ||| IN
a  ||| S:3454 E:3456 ||| DT
given  ||| S:3456 E:3462 ||| VBN
tissue  ||| S:3462 E:3469 ||| NN
or  ||| S:3469 E:3472 ||| CC
for  ||| S:3472 E:3476 ||| IN
a  ||| S:3476 E:3478 ||| DT
complex  ||| S:3478 E:3486 ||| JJ
organism  ||| S:3486 E:3503 ||| NNS
( ||| S:3503 E:3504 ||| -LRB-
30,000  ||| S:3504 E:3511 ||| CD
to  ||| S:3511 E:3514 ||| TO
60,000  ||| S:3514 E:3521 ||| CD
genes ||| S:3521 E:3526 ||| NNS
)  ||| S:3526 E:3528 ||| -RRB-
is  ||| S:3528 E:3531 ||| VBZ
likely  ||| S:3531 E:3538 ||| RB
in  ||| S:3538 E:3541 ||| IN
the  ||| S:3541 E:3545 ||| DT
near  ||| S:3545 E:3550 ||| JJ
future ||| S:3550 E:3556 ||| NN
,  ||| S:3556 E:3558 ||| ,
so  ||| S:3558 E:3569 ||| RB
it  ||| S:3569 E:3572 ||| PRP
is  ||| S:3572 E:3575 ||| VBZ
paramount  ||| S:3575 E:3585 ||| VBN
that  ||| S:3585 E:3590 ||| IN
chip  ||| S:3590 E:3595 ||| NN
manufacturers  ||| S:3595 E:3609 ||| NNS
avoid  ||| S:3609 E:3615 ||| VBP
these  ||| S:3615 E:3629 ||| DT
problems  ||| S:3629 E:3638 ||| NNS
[  ||| S:3638 E:3640 ||| -LRB-
7  ||| S:3640 E:3642 ||| CD
]  ||| S:3642 E:3644 ||| -RRB-
.  ||| S:3644 E:3646 ||| .
In  ||| S:3646 E:3649 ||| IN
this  ||| S:3649 E:3654 ||| DT
report ||| S:3654 E:3660 ||| NN
,  ||| S:3660 E:3662 ||| ,
we  ||| S:3662 E:3665 ||| PRP
demonstrate  ||| S:3665 E:3677 ||| VBP
that  ||| S:3677 E:3690 ||| IN
microarray  ||| S:3690 E:3701 ||| JJ
technology  ||| S:3701 E:3712 ||| NN
continues  ||| S:3712 E:3722 ||| VBZ
to  ||| S:3722 E:3725 ||| TO
be  ||| S:3725 E:3728 ||| VB
a  ||| S:3728 E:3730 ||| DT
dynamic  ||| S:3730 E:3738 ||| JJ
and  ||| S:3738 E:3750 ||| CC
developing  ||| S:3750 E:3761 ||| VBG
process  ||| S:3761 E:3769 ||| NN
and  ||| S:3769 E:3773 ||| CC
highlight  ||| S:3773 E:3783 ||| VB
potential  ||| S:3783 E:3793 ||| JJ
pitfalls  ||| S:3793 E:3802 ||| NNS
that  ||| S:3802 E:3815 ||| WDT
must  ||| S:3815 E:3820 ||| MD
be  ||| S:3820 E:3823 ||| VB
addressed  ||| S:3823 E:3833 ||| VBN
when  ||| S:3833 E:3838 ||| WRB
interpreting  ||| S:3838 E:3851 ||| JJ
data ||| S:3851 E:3855 ||| NNS
.  ||| S:3855 E:3879 ||| .
Results  ||| S:3879 E:3906 ||| NNS
Inconsistent  ||| S:3906 E:3919 ||| JJ
sequence  ||| S:3919 E:3928 ||| NN
fidelity  ||| S:3928 E:3937 ||| NN
of  ||| S:3937 E:3940 ||| IN
spotted  ||| S:3940 E:3948 ||| JJ
cDNA  ||| S:3948 E:3963 ||| JJ
microarrays  ||| S:3963 E:3985 ||| JJ
cDNA  ||| S:3985 E:3990 ||| JJ
microarray  ||| S:3990 E:4001 ||| JJ
analysis  ||| S:4001 E:4010 ||| NN
was  ||| S:4010 E:4014 ||| VBD
performed  ||| S:4014 E:4024 ||| VBN
using  ||| S:4024 E:4030 ||| VBG
the  ||| S:4030 E:4044 ||| DT
UniGEM-V  ||| S:4044 E:4053 ||| JJ
chip  ||| S:4053 E:4058 ||| NN
( ||| S:4058 E:4059 ||| -LRB-
IncyteGenomics ||| S:4059 E:4073 ||| NNP
,  ||| S:4073 E:4075 ||| ,
Palo  ||| S:4075 E:4080 ||| NNP
Alto ||| S:4080 E:4084 ||| NNP
,  ||| S:4084 E:4086 ||| ,
CA ||| S:4086 E:4088 ||| NNP
)  ||| S:4088 E:4090 ||| -RRB-
with  ||| S:4090 E:4095 ||| IN
mRNA  ||| S:4095 E:4110 ||| JJ
isolated  ||| S:4110 E:4119 ||| NN
from  ||| S:4119 E:4124 ||| IN
peripheral  ||| S:4124 E:4135 ||| JJ
blood  ||| S:4135 E:4141 ||| NN
mononuclear  ||| S:4141 E:4153 ||| NN
cells  ||| S:4153 E:4159 ||| NNS
( ||| S:4159 E:4160 ||| -LRB-
PBMC ||| S:4160 E:4164 ||| NNP
)  ||| S:4164 E:4176 ||| -RRB-
of  ||| S:4176 E:4179 ||| IN
a  ||| S:4179 E:4181 ||| DT
large  ||| S:4181 E:4187 ||| JJ
granular  ||| S:4187 E:4196 ||| JJ
lymphocyte  ||| S:4196 E:4207 ||| JJ
leukemia  ||| S:4207 E:4216 ||| NN
patient  ||| S:4216 E:4224 ||| NN
and  ||| S:4224 E:4228 ||| CC
a  ||| S:4228 E:4240 ||| DT
healthy  ||| S:4240 E:4248 ||| JJ
control ||| S:4248 E:4255 ||| NN
.  ||| S:4255 E:4257 ||| .
In  ||| S:4257 E:4260 ||| IN
this  ||| S:4260 E:4265 ||| DT
microarray ||| S:4265 E:4275 ||| NN
,  ||| S:4275 E:4277 ||| ,
7075  ||| S:4277 E:4282 ||| CD
immobilized  ||| S:4282 E:4304 ||| CD
cDNA  ||| S:4304 E:4309 ||| JJ
fragments  ||| S:4309 E:4319 ||| NNS
( ||| S:4319 E:4320 ||| -LRB-
4107  ||| S:4320 E:4325 ||| CD
from  ||| S:4325 E:4330 ||| IN
known  ||| S:4330 E:4336 ||| JJ
genes  ||| S:4336 E:4342 ||| NNS
and  ||| S:4342 E:4346 ||| CC
2968  ||| S:4346 E:4351 ||| CD
ESTs ||| S:4351 E:4355 ||| NN
)  ||| S:4355 E:4357 ||| -RRB-
were  ||| S:4357 E:4372 ||| VBD
immobilized  ||| S:4372 E:4384 ||| VBN
onto  ||| S:4384 E:4389 ||| IN
a  ||| S:4389 E:4391 ||| DT
glass  ||| S:4391 E:4397 ||| NN
slide ||| S:4397 E:4402 ||| NN
.  ||| S:4402 E:4404 ||| .
After  ||| S:4404 E:4410 ||| IN
careful  ||| S:4410 E:4418 ||| JJ
examination  ||| S:4418 E:4440 ||| NN
of  ||| S:4440 E:4443 ||| IN
the  ||| S:4443 E:4447 ||| DT
microarray  ||| S:4447 E:4458 ||| JJ
probes ||| S:4458 E:4464 ||| NNS
,  ||| S:4464 E:4466 ||| ,
it  ||| S:4466 E:4469 ||| PRP
was  ||| S:4469 E:4473 ||| VBD
determined  ||| S:4473 E:4484 ||| VBN
that  ||| S:4484 E:4489 ||| IN
the  ||| S:4489 E:4503 ||| DT
majority  ||| S:4503 E:4512 ||| NN
of  ||| S:4512 E:4515 ||| IN
the  ||| S:4515 E:4519 ||| DT
spotted  ||| S:4519 E:4527 ||| JJ
cDNA  ||| S:4527 E:4532 ||| JJ
fragments  ||| S:4532 E:4542 ||| NNS
were  ||| S:4542 E:4547 ||| VBD
from  ||| S:4547 E:4552 ||| IN
the  ||| S:4552 E:4556 ||| DT
3 ||| S:4556 E:4557 ||| CD
'  ||| S:4557 E:4569 ||| POS
end  ||| S:4569 E:4573 ||| NN
of  ||| S:4573 E:4576 ||| IN
the  ||| S:4576 E:4580 ||| DT
genes ||| S:4580 E:4585 ||| NNS
.  ||| S:4585 E:4587 ||| .
Approximately  ||| S:4587 E:4601 ||| RB
80  ||| S:4601 E:4604 ||| CD
up-regulated  ||| S:4604 E:4617 ||| JJ
and  ||| S:4617 E:4621 ||| CC
12  ||| S:4621 E:4634 ||| CD
down-regulated  ||| S:4634 E:4649 ||| JJ
genes  ||| S:4649 E:4655 ||| NNS
were  ||| S:4655 E:4660 ||| VBD
identified  ||| S:4660 E:4671 ||| VBN
in  ||| S:4671 E:4674 ||| IN
leukemic  ||| S:4674 E:4683 ||| JJ
LGL ||| S:4683 E:4686 ||| NNP
.  ||| S:4686 E:4688 ||| .
We  ||| S:4688 E:4701 ||| PRP
then  ||| S:4701 E:4706 ||| RB
purchased  ||| S:4706 E:4716 ||| VBN
seventeen  ||| S:4716 E:4726 ||| JJ
clones  ||| S:4726 E:4733 ||| NNS
from  ||| S:4733 E:4738 ||| IN
IncyteGenomics  ||| S:4738 E:4763 ||| JJ
containing  ||| S:4763 E:4774 ||| VBG
cDNA  ||| S:4774 E:4779 ||| JJ
fragments  ||| S:4779 E:4789 ||| NNS
that  ||| S:4789 E:4794 ||| WDT
represent  ||| S:4794 E:4804 ||| VBP
fourteen  ||| S:4804 E:4813 ||| VBN
of  ||| S:4813 E:4816 ||| IN
the  ||| S:4816 E:4830 ||| DT
up-regulated  ||| S:4830 E:4843 ||| JJ
and  ||| S:4843 E:4847 ||| CC
three  ||| S:4847 E:4853 ||| CD
of  ||| S:4853 E:4856 ||| IN
the  ||| S:4856 E:4860 ||| DT
down-regulated  ||| S:4860 E:4875 ||| JJ
genes ||| S:4875 E:4880 ||| NNS
.  ||| S:4880 E:4892 ||| .
Plasmid  ||| S:4892 E:4900 ||| NNP
DNA  ||| S:4900 E:4904 ||| NNP
was  ||| S:4904 E:4908 ||| VBD
isolated  ||| S:4908 E:4917 ||| VBN
from  ||| S:4917 E:4922 ||| IN
the  ||| S:4922 E:4926 ||| DT
clones  ||| S:4926 E:4933 ||| NNS
and  ||| S:4933 E:4937 ||| CC
the  ||| S:4937 E:4951 ||| DT
sequences  ||| S:4951 E:4961 ||| NN
were  ||| S:4961 E:4966 ||| VBD
verified ||| S:4966 E:4974 ||| VBN
.  ||| S:4974 E:4976 ||| .
Unfortunately ||| S:4976 E:4989 ||| RB
,  ||| S:4989 E:4991 ||| ,
we  ||| S:4991 E:4994 ||| PRP
found  ||| S:4994 E:5000 ||| VBD
several  ||| S:5000 E:5018 ||| JJ
problems  ||| S:5018 E:5027 ||| NNS
with  ||| S:5027 E:5032 ||| IN
the  ||| S:5032 E:5036 ||| DT
insert  ||| S:5036 E:5043 ||| JJ
DNA  ||| S:5043 E:5047 ||| NN
sequences  ||| S:5047 E:5057 ||| NN
in  ||| S:5057 E:5060 ||| IN
these  ||| S:5060 E:5066 ||| DT
clones ||| S:5066 E:5072 ||| NNS
.  ||| S:5072 E:5084 ||| .
Four  ||| S:5084 E:5089 ||| CD
of  ||| S:5089 E:5092 ||| IN
the  ||| S:5092 E:5096 ||| DT
seventeen  ||| S:5096 E:5106 ||| NN
c  ||| S:5106 E:5108 ||| SYM
DNA  ||| S:5108 E:5112 ||| NNP
fragments  ||| S:5112 E:5122 ||| VBZ
spotted  ||| S:5122 E:5130 ||| VBN
on  ||| S:5130 E:5133 ||| IN
the  ||| S:5133 E:5147 ||| DT
microarray  ||| S:5147 E:5158 ||| NN
contained  ||| S:5158 E:5168 ||| VBD
incorrect  ||| S:5168 E:5178 ||| JJ
sequences  ||| S:5178 E:5188 ||| NNS
( ||| S:5188 E:5189 ||| -LRB-
23.5 ||| S:5189 E:5193 ||| CD
% ||| S:5193 E:5194 ||| NN
)  ||| S:5194 E:5196 ||| -RRB-
( ||| S:5196 E:5197 ||| -LRB-
Table  ||| S:5197 E:5213 ||| NNP
1 ||| S:5213 E:5214 ||| CD
) ||| S:5214 E:5215 ||| -RRB-
.  ||| S:5215 E:5245 ||| .
Variable  ||| S:5245 E:5254 ||| JJ
reliability  ||| S:5254 E:5266 ||| NN
of  ||| S:5266 E:5269 ||| IN
differential  ||| S:5269 E:5282 ||| JJ
expression  ||| S:5282 E:5303 ||| NN
data  ||| S:5303 E:5318 ||| NNS
The  ||| S:5318 E:5322 ||| DT
cDNA  ||| S:5322 E:5327 ||| JJ
fragments  ||| S:5327 E:5337 ||| NNS
corresponding  ||| S:5337 E:5351 ||| JJ
to  ||| S:5351 E:5354 ||| TO
differentially  ||| S:5354 E:5379 ||| VB
expressed  ||| S:5379 E:5389 ||| VBN
genes  ||| S:5389 E:5395 ||| NNS
spotted  ||| S:5395 E:5403 ||| VBD
on  ||| S:5403 E:5406 ||| IN
the  ||| S:5406 E:5410 ||| DT
microarrays  ||| S:5410 E:5422 ||| NN
were  ||| S:5422 E:5427 ||| VBD
excised  ||| S:5427 E:5445 ||| VBN
from  ||| S:5445 E:5450 ||| IN
the  ||| S:5450 E:5454 ||| DT
plasmid  ||| S:5454 E:5462 ||| JJ
DNA  ||| S:5462 E:5466 ||| NN
and  ||| S:5466 E:5470 ||| CC
used  ||| S:5470 E:5475 ||| VBN
as  ||| S:5475 E:5478 ||| IN
probes  ||| S:5478 E:5485 ||| NNS
in  ||| S:5485 E:5488 ||| IN
Northern  ||| S:5488 E:5507 ||| JJ
blots ||| S:5507 E:5512 ||| NN
.  ||| S:5512 E:5514 ||| .
Out  ||| S:5514 E:5518 ||| RB
of  ||| S:5518 E:5521 ||| IN
the  ||| S:5521 E:5525 ||| DT
seventeen  ||| S:5525 E:5535 ||| NN
only  ||| S:5535 E:5540 ||| RB
eight  ||| S:5540 E:5546 ||| CD
provided  ||| S:5546 E:5555 ||| VBD
positive  ||| S:5555 E:5574 ||| JJ
results  ||| S:5574 E:5582 ||| NNS
as  ||| S:5582 E:5585 ||| RB
indicated  ||| S:5585 E:5595 ||| VBN
by  ||| S:5595 E:5598 ||| IN
microarray  ||| S:5598 E:5609 ||| NNS
( ||| S:5609 E:5610 ||| -LRB-
47 ||| S:5610 E:5612 ||| CD
% ||| S:5612 E:5613 ||| NN
) ||| S:5613 E:5614 ||| -RRB-
.  ||| S:5614 E:5616 ||| .
Although  ||| S:5616 E:5625 ||| IN
all  ||| S:5625 E:5639 ||| PDT
the  ||| S:5639 E:5643 ||| DT
sequences  ||| S:5643 E:5653 ||| NN
for  ||| S:5653 E:5657 ||| IN
the  ||| S:5657 E:5661 ||| DT
down-regulated  ||| S:5661 E:5676 ||| JJ
genes  ||| S:5676 E:5682 ||| NNS
were  ||| S:5682 E:5687 ||| VBD
correct ||| S:5687 E:5694 ||| JJ
,  ||| S:5694 E:5706 ||| ,
Northern  ||| S:5706 E:5715 ||| JJ
blot  ||| S:5715 E:5720 ||| JJ
analysis  ||| S:5720 E:5729 ||| NN
with  ||| S:5729 E:5734 ||| IN
these  ||| S:5734 E:5740 ||| DT
probes  ||| S:5740 E:5747 ||| NNS
did  ||| S:5747 E:5751 ||| VBD
not  ||| S:5751 E:5755 ||| RB
show  ||| S:5755 E:5760 ||| VB
any  ||| S:5760 E:5774 ||| DT
differential  ||| S:5774 E:5787 ||| JJ
expression  ||| S:5787 E:5798 ||| NN
of  ||| S:5798 E:5801 ||| IN
the  ||| S:5801 E:5805 ||| DT
genes ||| S:5805 E:5810 ||| NNS
.  ||| S:5810 E:5812 ||| .
This  ||| S:5812 E:5817 ||| DT
is  ||| S:5817 E:5820 ||| VBZ
in  ||| S:5820 E:5823 ||| IN
contrast  ||| S:5823 E:5842 ||| NN
to  ||| S:5842 E:5845 ||| TO
the  ||| S:5845 E:5849 ||| DT
microarray  ||| S:5849 E:5860 ||| JJ
data  ||| S:5860 E:5865 ||| NNS
that  ||| S:5865 E:5870 ||| WDT
suggested  ||| S:5870 E:5880 ||| VBD
they  ||| S:5880 E:5885 ||| PRP
were  ||| S:5885 E:5890 ||| VBD
down  ||| S:5890 E:5905 ||| RB
regulated  ||| S:5905 E:5915 ||| VBN
( ||| S:5915 E:5916 ||| -LRB-
Table  ||| S:5916 E:5922 ||| NNP
1 ||| S:5922 E:5923 ||| CD
) ||| S:5923 E:5924 ||| -RRB-
.  ||| S:5924 E:5954 ||| .
Low  ||| S:5954 E:5958 ||| JJ
specificity  ||| S:5958 E:5970 ||| NN
of  ||| S:5970 E:5973 ||| IN
cDNA  ||| S:5973 E:5978 ||| JJ
microarray  ||| S:5978 E:5989 ||| JJ
probes  ||| S:5989 E:6006 ||| NNS
By  ||| S:6006 E:6009 ||| IN
microarray  ||| S:6009 E:6020 ||| JJ
analysis ||| S:6020 E:6028 ||| NN
,  ||| S:6028 E:6030 ||| ,
it  ||| S:6030 E:6033 ||| PRP
is  ||| S:6033 E:6036 ||| VBZ
very  ||| S:6036 E:6041 ||| RB
difficult  ||| S:6041 E:6051 ||| JJ
to  ||| S:6051 E:6064 ||| TO
distinguish  ||| S:6064 E:6076 ||| VB
between  ||| S:6076 E:6084 ||| IN
two  ||| S:6084 E:6088 ||| CD
genes  ||| S:6088 E:6094 ||| NNS
that  ||| S:6094 E:6099 ||| IN
share  ||| S:6099 E:6105 ||| NN
a  ||| S:6105 E:6107 ||| DT
high  ||| S:6107 E:6112 ||| JJ
degree  ||| S:6112 E:6119 ||| NN
of  ||| S:6119 E:6132 ||| IN
sequence  ||| S:6132 E:6141 ||| JJ
similarity ||| S:6141 E:6151 ||| NN
.  ||| S:6151 E:6153 ||| .
Low  ||| S:6153 E:6157 ||| JJ
specificity  ||| S:6157 E:6169 ||| NN
of  ||| S:6169 E:6172 ||| IN
probes  ||| S:6172 E:6179 ||| NNS
is  ||| S:6179 E:6182 ||| VBZ
also  ||| S:6182 E:6187 ||| RB
a  ||| S:6187 E:6199 ||| DT
frequently  ||| S:6199 E:6210 ||| RB
encountered  ||| S:6210 E:6222 ||| JJ
problem  ||| S:6222 E:6230 ||| NN
in  ||| S:6230 E:6233 ||| IN
oligonucleotide  ||| S:6233 E:6249 ||| JJ
arrays ||| S:6249 E:6255 ||| NN
.  ||| S:6255 E:6267 ||| .
This  ||| S:6267 E:6272 ||| DT
problem  ||| S:6272 E:6280 ||| NN
is  ||| S:6280 E:6283 ||| VBZ
especially  ||| S:6283 E:6294 ||| RB
prevalent  ||| S:6294 E:6304 ||| JJ
in  ||| S:6304 E:6307 ||| IN
instances  ||| S:6307 E:6317 ||| NNS
where  ||| S:6317 E:6333 ||| WRB
DNA  ||| S:6333 E:6337 ||| NNP
sequences  ||| S:6337 E:6347 ||| NNS
are  ||| S:6347 E:6351 ||| VBP
nearly  ||| S:6351 E:6358 ||| RB
identical  ||| S:6358 E:6368 ||| JJ
between  ||| S:6368 E:6376 ||| IN
two  ||| S:6376 E:6380 ||| CD
genes  ||| S:6380 E:6386 ||| NNS
and  ||| S:6386 E:6400 ||| CC
the  ||| S:6400 E:6404 ||| DT
oligonucleotide  ||| S:6404 E:6420 ||| JJ
probes  ||| S:6420 E:6427 ||| NNS
are  ||| S:6427 E:6431 ||| VBP
generated  ||| S:6431 E:6441 ||| VBN
from  ||| S:6441 E:6446 ||| IN
the  ||| S:6446 E:6450 ||| DT
3 ||| S:6450 E:6451 ||| CD
'  ||| S:6451 E:6453 ||| POS
end  ||| S:6453 E:6467 ||| NN
of  ||| S:6467 E:6470 ||| IN
the  ||| S:6470 E:6474 ||| DT
genes ||| S:6474 E:6479 ||| NNS
.  ||| S:6479 E:6481 ||| .
For  ||| S:6481 E:6485 ||| IN
example ||| S:6485 E:6492 ||| NN
,  ||| S:6492 E:6494 ||| ,
the  ||| S:6494 E:6498 ||| DT
1.2  ||| S:6498 E:6502 ||| CD
kb  ||| S:6502 E:6505 ||| JJ
fragment  ||| S:6505 E:6514 ||| NN
( ||| S:6514 E:6515 ||| -LRB-
GB  ||| S:6515 E:6528 ||| UH
Accession  ||| S:6528 E:6538 ||| UH
No ||| S:6538 E:6540 ||| UH
.  ||| S:6540 E:6542 ||| .
M  ||| S:6542 E:6544 ||| NNP
57888 ||| S:6544 E:6549 ||| CD
)  ||| S:6549 E:6551 ||| -RRB-
spotted  ||| S:6551 E:6559 ||| VBD
on  ||| S:6559 E:6562 ||| IN
the  ||| S:6562 E:6566 ||| DT
cDNA  ||| S:6566 E:6571 ||| JJ
microarray  ||| S:6571 E:6582 ||| NN
as  ||| S:6582 E:6595 ||| IN
granzyme  ||| S:6595 E:6604 ||| JJ
B  ||| S:6604 E:6606 ||| NNP
was  ||| S:6606 E:6610 ||| VBD
not  ||| S:6610 E:6614 ||| RB
able  ||| S:6614 E:6619 ||| JJ
to  ||| S:6619 E:6622 ||| TO
distinguish  ||| S:6622 E:6634 ||| VB
between  ||| S:6634 E:6653 ||| IN
granzyme  ||| S:6653 E:6662 ||| JJ
B  ||| S:6662 E:6664 ||| NNP
and  ||| S:6664 E:6679 ||| CC
H  ||| S:6679 E:6681 ||| NNP
( ||| S:6681 E:6682 ||| -LRB-
Fig.  ||| S:6682 E:6687 ||| NNP
1a ||| S:6687 E:6689 ||| NNP
) ||| S:6689 E:6690 ||| -RRB-
.  ||| S:6690 E:6692 ||| .
The  ||| S:6692 E:6696 ||| DT
balanced  ||| S:6696 E:6715 ||| JJ
differential  ||| S:6715 E:6728 ||| NN
expression  ||| S:6728 E:6739 ||| NN
of  ||| S:6739 E:6742 ||| IN
6.3  ||| S:6742 E:6746 ||| CD
was  ||| S:6746 E:6750 ||| VBD
calculated ||| S:6750 E:6760 ||| VBN
.  ||| S:6760 E:6762 ||| .
A  ||| S:6762 E:6764 ||| DT
probe  ||| S:6764 E:6780 ||| NN
set  ||| S:6780 E:6784 ||| NN
was  ||| S:6784 E:6788 ||| VBD
generated  ||| S:6788 E:6798 ||| VBN
by  ||| S:6798 E:6801 ||| IN
Affymetrix  ||| S:6801 E:6812 ||| NNP
using  ||| S:6812 E:6818 ||| VBG
the  ||| S:6818 E:6822 ||| DT
similar  ||| S:6822 E:6840 ||| JJ
sequence  ||| S:6840 E:6849 ||| NN
information  ||| S:6849 E:6861 ||| NN
( ||| S:6861 E:6862 ||| -LRB-
GB  ||| S:6862 E:6865 ||| NNP
Accession  ||| S:6865 E:6875 ||| NNP
No.M28879 ||| S:6875 E:6884 ||| NNP
)  ||| S:6884 E:6886 ||| -RRB-
and  ||| S:6886 E:6900 ||| CC
according  ||| S:6900 E:6910 ||| VBG
to  ||| S:6910 E:6913 ||| TO
oligonucleotide  ||| S:6913 E:6929 ||| VB
array ||| S:6929 E:6934 ||| NN
,  ||| S:6934 E:6947 ||| ,
granzyme  ||| S:6947 E:6956 ||| VBG
B  ||| S:6956 E:6958 ||| NNP
was  ||| S:6958 E:6962 ||| VBD
shown  ||| S:6962 E:6968 ||| VBN
to  ||| S:6968 E:6971 ||| TO
be  ||| S:6971 E:6984 ||| VB
up-regulated  ||| S:6984 E:6997 ||| JJ
( ||| S:6997 E:6998 ||| -LRB-
fold  ||| S:6998 E:7003 ||| JJ
change  ||| S:7003 E:7010 ||| NN
21.5 ||| S:7010 E:7014 ||| CD
:  ||| S:7014 E:7016 ||| :
Fig.  ||| S:7016 E:7021 ||| CD
1b ||| S:7021 E:7023 ||| CD
) ||| S:7023 E:7024 ||| -RRB-
.  ||| S:7024 E:7026 ||| .
Northern  ||| S:7026 E:7035 ||| JJ
blot  ||| S:7035 E:7050 ||| JJ
analysis  ||| S:7050 E:7059 ||| NN
( ||| S:7059 E:7060 ||| -LRB-
using  ||| S:7060 E:7066 ||| VBG
the  ||| S:7066 E:7070 ||| DT
same  ||| S:7070 E:7075 ||| JJ
fragment  ||| S:7075 E:7084 ||| NN
as  ||| S:7084 E:7087 ||| IN
probe ||| S:7087 E:7092 ||| NN
)  ||| S:7092 E:7094 ||| -RRB-
did  ||| S:7094 E:7098 ||| VBD
not  ||| S:7098 E:7112 ||| RB
discriminate  ||| S:7112 E:7125 ||| VBN
between  ||| S:7125 E:7133 ||| IN
the  ||| S:7133 E:7137 ||| DT
genes  ||| S:7137 E:7143 ||| NNS
for  ||| S:7143 E:7158 ||| IN
granzyme  ||| S:7158 E:7167 ||| JJ
B  ||| S:7167 E:7169 ||| NNP
versus  ||| S:7169 E:7187 ||| FW
granzyme  ||| S:7187 E:7196 ||| FW
H  ||| S:7196 E:7198 ||| NNP
( ||| S:7198 E:7199 ||| -LRB-
Fig.  ||| S:7199 E:7204 ||| NNP
1c ||| S:7204 E:7206 ||| NNP
) ||| S:7206 E:7207 ||| -RRB-
.  ||| S:7207 E:7209 ||| .
However ||| S:7209 E:7216 ||| RB
,  ||| S:7216 E:7218 ||| ,
by  ||| S:7218 E:7231 ||| IN
using  ||| S:7231 E:7237 ||| VBG
gene-specific  ||| S:7237 E:7251 ||| JJ
probes  ||| S:7251 E:7258 ||| NNS
in  ||| S:7258 E:7261 ||| IN
an  ||| S:7261 E:7264 ||| DT
RNase  ||| S:7264 E:7270 ||| JJ
protection  ||| S:7270 E:7281 ||| NN
assay ||| S:7281 E:7286 ||| NN
,  ||| S:7286 E:7298 ||| ,
we  ||| S:7298 E:7301 ||| PRP
were  ||| S:7301 E:7306 ||| VBD
able  ||| S:7306 E:7311 ||| JJ
to  ||| S:7311 E:7314 ||| TO
demonstrate  ||| S:7314 E:7326 ||| VB
the  ||| S:7326 E:7330 ||| DT
over-expression  ||| S:7330 E:7346 ||| JJ
of  ||| S:7346 E:7360 ||| IN
granzyme  ||| S:7360 E:7369 ||| JJ
B  ||| S:7369 E:7371 ||| NNP
and  ||| S:7371 E:7386 ||| CC
granzyme  ||| S:7386 E:7395 ||| JJ
H  ||| S:7395 E:7397 ||| NNP
separately  ||| S:7397 E:7408 ||| RB
in  ||| S:7408 E:7411 ||| IN
leukemic  ||| S:7411 E:7430 ||| JJ
LGL  ||| S:7430 E:7434 ||| NN
cells  ||| S:7434 E:7440 ||| NNS
( ||| S:7440 E:7441 ||| -LRB-
Fig.  ||| S:7441 E:7446 ||| CD
1dand  ||| S:7446 E:7452 ||| CD
1e ||| S:7452 E:7454 ||| CD
) ||| S:7454 E:7455 ||| -RRB-
.  ||| S:7455 E:7485 ||| .
Discrepancy  ||| S:7485 E:7497 ||| NN
in  ||| S:7497 E:7500 ||| IN
fold  ||| S:7500 E:7505 ||| JJ
change  ||| S:7505 E:7512 ||| NN
calculation  ||| S:7512 E:7524 ||| NN
for  ||| S:7524 E:7528 ||| IN
a  ||| S:7528 E:7530 ||| DT
given  ||| S:7530 E:7546 ||| VBN
gene  ||| S:7546 E:7561 ||| NN
It  ||| S:7561 E:7564 ||| PRP
is  ||| S:7564 E:7567 ||| VBZ
very  ||| S:7567 E:7572 ||| RB
difficult  ||| S:7572 E:7582 ||| JJ
to  ||| S:7582 E:7585 ||| TO
compare  ||| S:7585 E:7593 ||| VB
the  ||| S:7593 E:7597 ||| DT
exact  ||| S:7597 E:7603 ||| JJ
fold  ||| S:7603 E:7608 ||| JJ
change  ||| S:7608 E:7625 ||| NN
between  ||| S:7625 E:7633 ||| IN
two  ||| S:7633 E:7637 ||| CD
microarray  ||| S:7637 E:7648 ||| CD
techniques ||| S:7648 E:7658 ||| NNS
,  ||| S:7658 E:7660 ||| ,
and  ||| S:7660 E:7664 ||| CC
no  ||| S:7664 E:7667 ||| DT
standard  ||| S:7667 E:7676 ||| JJ
value  ||| S:7676 E:7692 ||| NN
system  ||| S:7692 E:7699 ||| NN
is  ||| S:7699 E:7702 ||| VBZ
currently  ||| S:7702 E:7712 ||| RB
in  ||| S:7712 E:7715 ||| IN
place  ||| S:7715 E:7721 ||| NN
to  ||| S:7721 E:7724 ||| TO
compare  ||| S:7724 E:7732 ||| VB
the  ||| S:7732 E:7736 ||| DT
changes  ||| S:7736 E:7744 ||| NNS
found  ||| S:7744 E:7760 ||| VBD
in  ||| S:7760 E:7763 ||| IN
one  ||| S:7763 E:7767 ||| CD
microarray  ||| S:7767 E:7778 ||| NN
to  ||| S:7778 E:7781 ||| TO
the  ||| S:7781 E:7785 ||| DT
next ||| S:7785 E:7789 ||| JJ
.  ||| S:7789 E:7791 ||| .
This  ||| S:7791 E:7796 ||| DT
fact  ||| S:7796 E:7801 ||| NN
was  ||| S:7801 E:7805 ||| VBD
clearly  ||| S:7805 E:7823 ||| RB
demonstrated  ||| S:7823 E:7836 ||| VBN
by  ||| S:7836 E:7839 ||| IN
Kuo  ||| S:7839 E:7843 ||| NNP
et  ||| S:7843 E:7846 ||| FW
al  ||| S:7846 E:7849 ||| FW
( ||| S:7849 E:7850 ||| -LRB-
2002 ||| S:7850 E:7854 ||| CD
)  ||| S:7854 E:7856 ||| -RRB-
in  ||| S:7856 E:7859 ||| IN
their  ||| S:7859 E:7865 ||| PRP$
recent  ||| S:7865 E:7882 ||| JJ
publication  ||| S:7882 E:7894 ||| NN
[  ||| S:7894 E:7896 ||| -LRB-
6  ||| S:7896 E:7898 ||| CD
]  ||| S:7898 E:7900 ||| -RRB-
.  ||| S:7900 E:7902 ||| .
In  ||| S:7902 E:7905 ||| IN
this  ||| S:7905 E:7910 ||| DT
paper  ||| S:7910 E:7916 ||| NN
we  ||| S:7916 E:7919 ||| PRP
compared  ||| S:7919 E:7928 ||| VBD
the  ||| S:7928 E:7932 ||| DT
fold  ||| S:7932 E:7947 ||| JJ
change  ||| S:7947 E:7954 ||| NN
( ||| S:7954 E:7955 ||| -LRB-
Affymetrix ||| S:7955 E:7965 ||| NNP
)  ||| S:7965 E:7967 ||| -RRB-
and  ||| S:7967 E:7971 ||| CC
balanced  ||| S:7971 E:7980 ||| JJ
differential  ||| S:7980 E:7993 ||| NN
expression  ||| S:7993 E:8014 ||| NN
( ||| S:8014 E:8015 ||| -LRB-
cDNA ||| S:8015 E:8019 ||| NNP
)  ||| S:8019 E:8021 ||| -RRB-
with  ||| S:8021 E:8026 ||| IN
Northern  ||| S:8026 E:8035 ||| JJ
blot  ||| S:8035 E:8040 ||| JJ
expression ||| S:8040 E:8050 ||| NN
.  ||| S:8050 E:8052 ||| .
For  ||| S:8052 E:8056 ||| IN
example ||| S:8056 E:8063 ||| NN
,  ||| S:8063 E:8065 ||| ,
our  ||| S:8065 E:8079 ||| PRP$
IncyteGenomics  ||| S:8079 E:8094 ||| JJ
cDNA  ||| S:8094 E:8099 ||| JJ
microarray  ||| S:8099 E:8110 ||| JJ
data  ||| S:8110 E:8115 ||| NNS
demonstrated  ||| S:8115 E:8128 ||| VBD
only  ||| S:8128 E:8133 ||| RB
a  ||| S:8133 E:8145 ||| DT
3.8  ||| S:8145 E:8149 ||| CD
differential  ||| S:8149 E:8162 ||| NN
expression  ||| S:8162 E:8173 ||| NN
in  ||| S:8173 E:8176 ||| IN
the  ||| S:8176 E:8180 ||| DT
expression  ||| S:8180 E:8191 ||| NN
of  ||| S:8191 E:8205 ||| IN
perforin  ||| S:8205 E:8214 ||| NNS
( ||| S:8214 E:8215 ||| -LRB-
Fig.  ||| S:8215 E:8220 ||| NNP
2a ||| S:8220 E:8222 ||| NNP
) ||| S:8222 E:8223 ||| -RRB-
,  ||| S:8223 E:8225 ||| ,
a  ||| S:8225 E:8227 ||| DT
pore-forming  ||| S:8227 E:8250 ||| JJ
protein  ||| S:8250 E:8258 ||| NN
produced  ||| S:8258 E:8267 ||| VBN
by  ||| S:8267 E:8270 ||| IN
cytolytic  ||| S:8270 E:8280 ||| JJ
lymphocytes  ||| S:8280 E:8292 ||| NNS
[  ||| S:8292 E:8294 ||| -LRB-
8  ||| S:8294 E:8296 ||| CD
]  ||| S:8296 E:8298 ||| -RRB-
in  ||| S:8298 E:8311 ||| IN
leukemic  ||| S:8311 E:8320 ||| JJ
LGL  ||| S:8320 E:8324 ||| NN
cells ||| S:8324 E:8329 ||| NNS
,  ||| S:8329 E:8331 ||| ,
whereas  ||| S:8331 E:8339 ||| IN
the  ||| S:8339 E:8343 ||| DT
oligonucleotide  ||| S:8343 E:8369 ||| JJ
microarray  ||| S:8369 E:8380 ||| NN
indicated  ||| S:8380 E:8390 ||| VBD
a  ||| S:8390 E:8392 ||| DT
103  ||| S:8392 E:8396 ||| CD
fold  ||| S:8396 E:8401 ||| JJ
increase  ||| S:8401 E:8410 ||| NN
( ||| S:8410 E:8411 ||| -LRB-
Fig.  ||| S:8411 E:8416 ||| NNP
2b ||| S:8416 E:8418 ||| NNP
) ||| S:8418 E:8419 ||| -RRB-
.  ||| S:8419 E:8421 ||| .
Using  ||| S:8421 E:8437 ||| VBG
a  ||| S:8437 E:8439 ||| DT
probe  ||| S:8439 E:8445 ||| NN
identical  ||| S:8445 E:8455 ||| NN
to  ||| S:8455 E:8458 ||| TO
the  ||| S:8458 E:8462 ||| DT
one  ||| S:8462 E:8466 ||| NN
spotted  ||| S:8466 E:8474 ||| VBD
on  ||| S:8474 E:8477 ||| IN
the  ||| S:8477 E:8481 ||| DT
cDNA  ||| S:8481 E:8496 ||| JJ
microarray ||| S:8496 E:8506 ||| NN
,  ||| S:8506 E:8508 ||| ,
we  ||| S:8508 E:8511 ||| PRP
performed  ||| S:8511 E:8521 ||| VBD
a  ||| S:8521 E:8523 ||| DT
Northern  ||| S:8523 E:8532 ||| JJ
blot  ||| S:8532 E:8537 ||| JJ
analysis ||| S:8537 E:8545 ||| NN
.  ||| S:8545 E:8547 ||| .
The  ||| S:8547 E:8561 ||| DT
blot  ||| S:8561 E:8566 ||| NN
demonstrated  ||| S:8566 E:8579 ||| VBD
the  ||| S:8579 E:8583 ||| DT
up-regulation  ||| S:8583 E:8597 ||| JJ
of  ||| S:8597 E:8600 ||| IN
the  ||| S:8600 E:8615 ||| DT
perforin  ||| S:8615 E:8624 ||| JJ
transcript  ||| S:8624 E:8635 ||| NN
in  ||| S:8635 E:8638 ||| IN
leukemia  ||| S:8638 E:8647 ||| JJ
LGL  ||| S:8647 E:8661 ||| NN
cells  ||| S:8661 E:8667 ||| NNS
( ||| S:8667 E:8668 ||| -LRB-
Fig.  ||| S:8668 E:8673 ||| NNP
2c ||| S:8673 E:8675 ||| NNP
) ||| S:8675 E:8676 ||| -RRB-
,  ||| S:8676 E:8678 ||| ,
but  ||| S:8678 E:8682 ||| CC
the  ||| S:8682 E:8686 ||| DT
fold  ||| S:8686 E:8691 ||| JJ
increase  ||| S:8691 E:8700 ||| NN
was  ||| S:8700 E:8704 ||| VBD
neither  ||| S:8704 E:8712 ||| DT
103  ||| S:8712 E:8716 ||| CD
as  ||| S:8716 E:8729 ||| IN
indicated  ||| S:8729 E:8739 ||| VBN
by  ||| S:8739 E:8742 ||| IN
oligonucleotide  ||| S:8742 E:8758 ||| JJ
array  ||| S:8758 E:8764 ||| NN
nor  ||| S:8764 E:8768 ||| CC
3.8  ||| S:8768 E:8772 ||| CD
as  ||| S:8772 E:8775 ||| IN
determined  ||| S:8775 E:8796 ||| VBN
by  ||| S:8796 E:8799 ||| IN
the  ||| S:8799 E:8803 ||| DT
cDNA  ||| S:8803 E:8808 ||| JJ
microarray  ||| S:8808 E:8819 ||| JJ
data ||| S:8819 E:8823 ||| NNS
.  ||| S:8823 E:8825 ||| .
Instead ||| S:8825 E:8832 ||| RB
,  ||| S:8832 E:8834 ||| ,
the  ||| S:8834 E:8838 ||| DT
actual  ||| S:8838 E:8845 ||| JJ
value  ||| S:8845 E:8861 ||| NN
was  ||| S:8861 E:8865 ||| VBD
determined  ||| S:8865 E:8876 ||| VBN
to  ||| S:8876 E:8879 ||| TO
fall  ||| S:8879 E:8884 ||| VB
between  ||| S:8884 E:8892 ||| IN
these  ||| S:8892 E:8898 ||| DT
two  ||| S:8898 E:8902 ||| CD
extreme  ||| S:8902 E:8910 ||| JJ
values ||| S:8910 E:8916 ||| NNS
.  ||| S:8916 E:8928 ||| .
These  ||| S:8928 E:8934 ||| DT
observations  ||| S:8934 E:8947 ||| NNS
strongly  ||| S:8947 E:8956 ||| RB
suggest  ||| S:8956 E:8964 ||| VB
that  ||| S:8964 E:8969 ||| IN
results  ||| S:8969 E:8977 ||| NNS
for  ||| S:8977 E:8991 ||| IN
significantly  ||| S:8991 E:9005 ||| RB
altered  ||| S:9005 E:9013 ||| VBN
genes  ||| S:9013 E:9019 ||| NNS
should  ||| S:9019 E:9026 ||| MD
be  ||| S:9026 E:9029 ||| VB
confirmed  ||| S:9029 E:9039 ||| VBN
with  ||| S:9039 E:9054 ||| IN
other  ||| S:9054 E:9060 ||| JJ
traditional  ||| S:9060 E:9072 ||| JJ
techniques  ||| S:9072 E:9083 ||| NNS
such  ||| S:9083 E:9088 ||| JJ
as  ||| S:9088 E:9091 ||| IN
Northern  ||| S:9091 E:9100 ||| JJ
blots  ||| S:9100 E:9106 ||| NN
or  ||| S:9106 E:9119 ||| CC
RNase  ||| S:9119 E:9125 ||| JJ
protection  ||| S:9125 E:9136 ||| NN
assays  ||| S:9136 E:9143 ||| VBZ
prior  ||| S:9143 E:9149 ||| RB
to  ||| S:9149 E:9152 ||| TO
reporting  ||| S:9152 E:9162 ||| VBG
the  ||| S:9162 E:9166 ||| DT
fold  ||| S:9166 E:9181 ||| JJ
increase ||| S:9181 E:9189 ||| NN
.  ||| S:9189 E:9219 ||| .
Lack  ||| S:9219 E:9224 ||| NN
of  ||| S:9224 E:9227 ||| IN
probe  ||| S:9227 E:9233 ||| NN
specificity  ||| S:9233 E:9245 ||| NN
for  ||| S:9245 E:9249 ||| IN
gene  ||| S:9249 E:9254 ||| NN
isoforms  ||| S:9254 E:9273 ||| VBD
One  ||| S:9273 E:9277 ||| CD
of  ||| S:9277 E:9280 ||| IN
the  ||| S:9280 E:9284 ||| DT
genes  ||| S:9284 E:9290 ||| NNS
spotted  ||| S:9290 E:9298 ||| VBD
on  ||| S:9298 E:9301 ||| IN
the  ||| S:9301 E:9305 ||| DT
cDNA  ||| S:9305 E:9310 ||| JJ
microarray  ||| S:9310 E:9321 ||| NN
that  ||| S:9321 E:9336 ||| IN
we  ||| S:9336 E:9339 ||| PRP
are  ||| S:9339 E:9343 ||| VBP
interested  ||| S:9343 E:9354 ||| VBN
in  ||| S:9354 E:9357 ||| IN
is  ||| S:9357 E:9360 ||| VBZ
(  ||| S:9360 E:9373 ||| -LRB-
Phosphatase  ||| S:9373 E:9385 ||| NNP
in  ||| S:9385 E:9388 ||| IN
Activated  ||| S:9388 E:9398 ||| NNP
Cells  ||| S:9398 E:9404 ||| NNP
)  ||| S:9404 E:9417 ||| -RRB-
PAC-1  ||| S:9417 E:9423 ||| NNP
[  ||| S:9423 E:9425 ||| -LRB-
9  ||| S:9425 E:9427 ||| CD
]  ||| S:9427 E:9429 ||| -RRB-
.  ||| S:9429 E:9431 ||| .
The  ||| S:9431 E:9435 ||| DT
differential  ||| S:9435 E:9458 ||| JJ
expression  ||| S:9458 E:9469 ||| NN
of  ||| S:9469 E:9483 ||| IN
PAC-1  ||| S:9483 E:9489 ||| CD
by  ||| S:9489 E:9492 ||| IN
both  ||| S:9492 E:9497 ||| DT
cDNA  ||| S:9497 E:9502 ||| JJ
microarray  ||| S:9502 E:9523 ||| NNS
( ||| S:9523 E:9524 ||| -LRB-
differential  ||| S:9524 E:9537 ||| JJ
expression  ||| S:9537 E:9548 ||| NN
4.2 ||| S:9548 E:9551 ||| CD
)  ||| S:9551 E:9553 ||| -RRB-
and  ||| S:9553 E:9557 ||| CC
oligonucleotide  ||| S:9557 E:9573 ||| JJ
arrays  ||| S:9573 E:9590 ||| NNS
( ||| S:9590 E:9591 ||| -LRB-
fold  ||| S:9591 E:9596 ||| JJ
change  ||| S:9596 E:9603 ||| NN
1.6 ||| S:9603 E:9606 ||| CD
)  ||| S:9606 E:9608 ||| -RRB-
is  ||| S:9608 E:9611 ||| VBZ
shown  ||| S:9611 E:9617 ||| VBN
in  ||| S:9617 E:9620 ||| IN
Figures  ||| S:9620 E:9628 ||| NNP
3aand  ||| S:9628 E:9634 ||| NNP
3b ||| S:9634 E:9636 ||| NNP
.  ||| S:9636 E:9638 ||| .
Using  ||| S:9638 E:9644 ||| VBG
a  ||| S:9644 E:9656 ||| DT
cDNA  ||| S:9656 E:9661 ||| JJ
fragment  ||| S:9661 E:9670 ||| JJ
identical  ||| S:9670 E:9680 ||| JJ
to  ||| S:9680 E:9683 ||| TO
the  ||| S:9683 E:9698 ||| DT
PAC-1  ||| S:9698 E:9704 ||| JJ
probe  ||| S:9704 E:9710 ||| NN
on  ||| S:9710 E:9713 ||| IN
the  ||| S:9713 E:9717 ||| DT
cDNA  ||| S:9717 E:9722 ||| JJ
microarray ||| S:9722 E:9732 ||| NN
,  ||| S:9732 E:9744 ||| ,
we  ||| S:9744 E:9747 ||| PRP
performed  ||| S:9747 E:9757 ||| VBD
a  ||| S:9757 E:9759 ||| DT
Northern  ||| S:9759 E:9768 ||| JJ
blot  ||| S:9768 E:9773 ||| JJ
analysis  ||| S:9773 E:9782 ||| NN
and  ||| S:9782 E:9786 ||| CC
confirmed  ||| S:9786 E:9796 ||| VBD
the  ||| S:9796 E:9810 ||| DT
over-expression  ||| S:9810 E:9826 ||| JJ
of  ||| S:9826 E:9829 ||| IN
two  ||| S:9829 E:9833 ||| CD
transcripts  ||| S:9833 E:9845 ||| NNS
in  ||| S:9845 E:9848 ||| IN
leukemic  ||| S:9848 E:9857 ||| JJ
LGL  ||| S:9857 E:9861 ||| NN
cells  ||| S:9861 E:9877 ||| NNS
( ||| S:9877 E:9878 ||| -LRB-
Fig.  ||| S:9878 E:9883 ||| NNP
3c ||| S:9883 E:9885 ||| NNP
) ||| S:9885 E:9886 ||| -RRB-
.  ||| S:9886 E:9888 ||| .
RT-PCR  ||| S:9888 E:9895 ||| NNP
was  ||| S:9895 E:9899 ||| VBD
performed  ||| S:9899 E:9909 ||| VBN
using  ||| S:9909 E:9915 ||| VBG
total  ||| S:9915 E:9921 ||| JJ
RNA  ||| S:9921 E:9925 ||| NNP
from  ||| S:9925 E:9940 ||| IN
leukemic  ||| S:9940 E:9949 ||| JJ
LGL  ||| S:9949 E:9953 ||| NNP
and  ||| S:9953 E:9957 ||| CC
specific  ||| S:9957 E:9966 ||| JJ
probes  ||| S:9966 E:9973 ||| NNS
designed  ||| S:9973 E:9982 ||| VBN
to  ||| S:9982 E:9985 ||| TO
amplify  ||| S:9985 E:10003 ||| VB
full-length  ||| S:10003 E:10015 ||| JJ
PAC-1 ||| S:10015 E:10020 ||| NN
.  ||| S:10020 E:10022 ||| .
We  ||| S:10022 E:10025 ||| PRP
did  ||| S:10025 E:10029 ||| VBD
not  ||| S:10029 E:10033 ||| RB
see  ||| S:10033 E:10037 ||| VB
amplification  ||| S:10037 E:10051 ||| VBN
of  ||| S:10051 E:10054 ||| IN
any  ||| S:10054 E:10068 ||| DT
product ||| S:10068 E:10075 ||| NN
.  ||| S:10075 E:10077 ||| .
In  ||| S:10077 E:10080 ||| IN
addition ||| S:10080 E:10088 ||| NN
,  ||| S:10088 E:10090 ||| ,
we  ||| S:10090 E:10093 ||| PRP
found  ||| S:10093 E:10099 ||| VBD
no  ||| S:10099 E:10102 ||| DT
PAC-1  ||| S:10102 E:10108 ||| JJ
expression  ||| S:10108 E:10119 ||| NN
using  ||| S:10119 E:10135 ||| VBG
two  ||| S:10135 E:10139 ||| CD
different  ||| S:10139 E:10149 ||| JJ
monoclonal  ||| S:10149 E:10160 ||| NN
anti-PAC-1  ||| S:10160 E:10171 ||| CD
antibodies  ||| S:10171 E:10182 ||| NNS
in  ||| S:10182 E:10185 ||| IN
Western  ||| S:10185 E:10203 ||| JJ
blot  ||| S:10203 E:10208 ||| JJ
analysis  ||| S:10208 E:10217 ||| NN
( ||| S:10217 E:10218 ||| -LRB-
data  ||| S:10218 E:10223 ||| NNS
not  ||| S:10223 E:10227 ||| RB
shown ||| S:10227 E:10232 ||| VBN
) ||| S:10232 E:10233 ||| -RRB-
.  ||| S:10233 E:10235 ||| .
The  ||| S:10235 E:10239 ||| DT
monoclonal  ||| S:10239 E:10250 ||| JJ
antibodies  ||| S:10250 E:10271 ||| NNS
obtained  ||| S:10271 E:10280 ||| VBN
from  ||| S:10280 E:10285 ||| IN
Santa  ||| S:10285 E:10291 ||| NNP
Cruz  ||| S:10291 E:10296 ||| NNP
were  ||| S:10296 E:10301 ||| VBD
based  ||| S:10301 E:10307 ||| VBN
on  ||| S:10307 E:10310 ||| IN
the  ||| S:10310 E:10314 ||| DT
amino  ||| S:10314 E:10320 ||| JJ
acid  ||| S:10320 E:10335 ||| NN
sequence  ||| S:10335 E:10344 ||| NN
information  ||| S:10344 E:10356 ||| NN
obtained  ||| S:10356 E:10365 ||| VBN
from  ||| S:10365 E:10370 ||| IN
the  ||| S:10370 E:10374 ||| DT
N-terminus  ||| S:10374 E:10385 ||| JJ
and  ||| S:10385 E:10399 ||| CC
C-terminus  ||| S:10399 E:10410 ||| JJ
of  ||| S:10410 E:10413 ||| IN
the  ||| S:10413 E:10417 ||| DT
PAC-1 ||| S:10417 E:10422 ||| NN
.  ||| S:10422 E:10424 ||| .
The  ||| S:10424 E:10428 ||| DT
results  ||| S:10428 E:10436 ||| NNS
of  ||| S:10436 E:10439 ||| IN
all  ||| S:10439 E:10443 ||| PDT
the  ||| S:10443 E:10457 ||| DT
experiments  ||| S:10457 E:10469 ||| NNS
did  ||| S:10469 E:10473 ||| VBD
not  ||| S:10473 E:10477 ||| RB
confirm  ||| S:10477 E:10485 ||| VB
the  ||| S:10485 E:10489 ||| DT
over-expression  ||| S:10489 E:10505 ||| JJ
of  ||| S:10505 E:10519 ||| IN
PAC-1  ||| S:10519 E:10525 ||| CD
.  ||| S:10525 E:10527 ||| .
Therefore ||| S:10527 E:10536 ||| RB
,  ||| S:10536 E:10538 ||| ,
to  ||| S:10538 E:10541 ||| TO
obtain  ||| S:10541 E:10548 ||| VB
more  ||| S:10548 E:10563 ||| JJR
information  ||| S:10563 E:10575 ||| NN
about  ||| S:10575 E:10581 ||| IN
the  ||| S:10581 E:10585 ||| DT
structure  ||| S:10585 E:10595 ||| NN
of  ||| S:10595 E:10598 ||| IN
the  ||| S:10598 E:10613 ||| DT
PAC-1  ||| S:10613 E:10619 ||| JJ
related  ||| S:10619 E:10627 ||| JJ
genes  ||| S:10627 E:10633 ||| NNS
in  ||| S:10633 E:10636 ||| IN
leukemic  ||| S:10636 E:10655 ||| JJ
LGL ||| S:10655 E:10658 ||| NNP
,  ||| S:10658 E:10660 ||| ,
we  ||| S:10660 E:10663 ||| PRP
screened  ||| S:10663 E:10672 ||| VBD
an  ||| S:10672 E:10675 ||| DT
LGL  ||| S:10675 E:10679 ||| NNP
leukemia  ||| S:10679 E:10688 ||| VBD
cDNA  ||| S:10688 E:10693 ||| JJ
library  ||| S:10693 E:10701 ||| NN
using  ||| S:10701 E:10707 ||| VBG
a  ||| S:10707 E:10709 ||| DT
1.2  ||| S:10709 E:10723 ||| CD
kb  ||| S:10723 E:10737 ||| CD
PAC-1  ||| S:10737 E:10743 ||| CD
cDNA  ||| S:10743 E:10748 ||| JJ
fragment  ||| S:10748 E:10757 ||| NN
and  ||| S:10757 E:10761 ||| CC
identified  ||| S:10761 E:10782 ||| VBN
similar  ||| S:10782 E:10790 ||| JJ
genes  ||| S:10790 E:10796 ||| NNS
which  ||| S:10796 E:10802 ||| WDT
are  ||| S:10802 E:10806 ||| VBP
different  ||| S:10806 E:10816 ||| JJ
forms  ||| S:10816 E:10822 ||| NNS
of  ||| S:10822 E:10836 ||| IN
PAC-1  ||| S:10836 E:10842 ||| NNP
( ||| S:10842 E:10843 ||| -LRB-
GenBank  ||| S:10843 E:10851 ||| JJ
Accession  ||| S:10851 E:10861 ||| JJ
# ||| S:10861 E:10862 ||| #
AF331843 ||| S:10862 E:10870 ||| CD
,  ||| S:10870 E:10882 ||| ,
the  ||| S:10882 E:10886 ||| DT
other  ||| S:10886 E:10892 ||| JJ
sequence  ||| S:10892 E:10901 ||| NN
is  ||| S:10901 E:10904 ||| VBZ
not  ||| S:10904 E:10908 ||| RB
deposited ||| S:10908 E:10917 ||| CD
) ||| S:10917 E:10918 ||| -RRB-
.  ||| S:10918 E:10920 ||| .
Similarly  ||| S:10920 E:10930 ||| RB
an  ||| S:10930 E:10943 ||| DT
anti-apoptotic  ||| S:10943 E:10958 ||| JJ
gene  ||| S:10958 E:10974 ||| NN
A20  ||| S:10974 E:10978 ||| NN
is  ||| S:10978 E:10981 ||| VBZ
also  ||| S:10981 E:10986 ||| RB
over-expressed  ||| S:10986 E:11001 ||| JJ
in  ||| S:11001 E:11014 ||| IN
leukemic  ||| S:11014 E:11023 ||| JJ
LGL ||| S:11023 E:11026 ||| NNP
,  ||| S:11026 E:11028 ||| ,
but  ||| S:11028 E:11032 ||| CC
protein  ||| S:11032 E:11040 ||| NN
expression  ||| S:11040 E:11051 ||| NN
was  ||| S:11051 E:11055 ||| VBD
absent  ||| S:11055 E:11062 ||| VBN
when  ||| S:11062 E:11077 ||| WRB
Western  ||| S:11077 E:11085 ||| JJ
blots  ||| S:11085 E:11091 ||| NN
were  ||| S:11091 E:11096 ||| VBD
performed  ||| S:11096 E:11106 ||| VBN
with  ||| S:11106 E:11111 ||| IN
monoclonal  ||| S:11111 E:11122 ||| JJ
antibodies  ||| S:11122 E:11143 ||| NNS
raised  ||| S:11143 E:11150 ||| VBN
against  ||| S:11150 E:11158 ||| IN
the  ||| S:11158 E:11162 ||| DT
amino  ||| S:11162 E:11168 ||| JJ
acid  ||| S:11168 E:11173 ||| NN
sequence  ||| S:11173 E:11182 ||| VBZ
derived  ||| S:11182 E:11190 ||| VBN
from  ||| S:11190 E:11195 ||| IN
A20  ||| S:11195 E:11209 ||| NNP
( ||| S:11209 E:11210 ||| -LRB-
data  ||| S:11210 E:11215 ||| NNS
not  ||| S:11215 E:11219 ||| RB
shown ||| S:11219 E:11224 ||| VBN
) ||| S:11224 E:11225 ||| -RRB-
.  ||| S:11225 E:11237 ||| .
Likewise ||| S:11237 E:11245 ||| RB
,  ||| S:11245 E:11247 ||| ,
another  ||| S:11247 E:11255 ||| DT
gene  ||| S:11255 E:11260 ||| NN
of  ||| S:11260 E:11263 ||| IN
interest ||| S:11263 E:11271 ||| NN
,  ||| S:11271 E:11284 ||| ,
NKG2  ||| S:11284 E:11289 ||| NNP
C  ||| S:11289 E:11291 ||| NNP
,  ||| S:11291 E:11293 ||| ,
showed  ||| S:11293 E:11300 ||| VBD
a  ||| S:11300 E:11302 ||| DT
balanced  ||| S:11302 E:11321 ||| JJ
differential  ||| S:11321 E:11334 ||| NN
expression  ||| S:11334 E:11345 ||| NN
of  ||| S:11345 E:11348 ||| IN
5.5  ||| S:11348 E:11352 ||| CD
( ||| S:11352 E:11353 ||| -LRB-
Fig.  ||| S:11353 E:11358 ||| NNP
4a ||| S:11358 E:11360 ||| NNP
) ||| S:11360 E:11361 ||| -RRB-
.  ||| S:11361 E:11363 ||| .
By  ||| S:11363 E:11366 ||| IN
using  ||| S:11366 E:11372 ||| VBG
a  ||| S:11372 E:11384 ||| DT
probe  ||| S:11384 E:11390 ||| NN
derived  ||| S:11390 E:11398 ||| VBN
from  ||| S:11398 E:11403 ||| IN
an  ||| S:11403 E:11417 ||| DT
NKG2  ||| S:11417 E:11422 ||| NNP
C  ||| S:11422 E:11424 ||| NNP
clone ||| S:11424 E:11429 ||| NN
,  ||| S:11429 E:11431 ||| ,
we  ||| S:11431 E:11434 ||| PRP
identified  ||| S:11434 E:11445 ||| VBD
a  ||| S:11445 E:11457 ||| DT
number  ||| S:11457 E:11464 ||| NN
of  ||| S:11464 E:11467 ||| IN
transcripts  ||| S:11467 E:11479 ||| NNS
by  ||| S:11479 E:11482 ||| IN
Northern  ||| S:11482 E:11491 ||| JJ
blot  ||| S:11491 E:11496 ||| JJ
analysis  ||| S:11496 E:11505 ||| NN
( ||| S:11505 E:11506 ||| -LRB-
Fig.  ||| S:11506 E:11521 ||| NNP
4b ||| S:11521 E:11523 ||| NNP
) ||| S:11523 E:11524 ||| -RRB-
.  ||| S:11524 E:11526 ||| .
In  ||| S:11526 E:11529 ||| IN
order  ||| S:11529 E:11535 ||| NN
to  ||| S:11535 E:11538 ||| TO
ascertain  ||| S:11538 E:11548 ||| VB
more  ||| S:11548 E:11553 ||| RBR
structural  ||| S:11553 E:11564 ||| JJ
information ||| S:11564 E:11575 ||| NN
,  ||| S:11575 E:11587 ||| ,
we  ||| S:11587 E:11590 ||| PRP
again  ||| S:11590 E:11596 ||| RB
screened  ||| S:11596 E:11605 ||| VBD
the  ||| S:11605 E:11609 ||| DT
LGL  ||| S:11609 E:11613 ||| NNP
leukemia  ||| S:11613 E:11622 ||| NN
library  ||| S:11622 E:11630 ||| NN
and  ||| S:11630 E:11634 ||| CC
identified  ||| S:11634 E:11655 ||| VBN
the  ||| S:11655 E:11659 ||| DT
presence  ||| S:11659 E:11668 ||| NN
of  ||| S:11668 E:11671 ||| IN
several  ||| S:11671 E:11679 ||| JJ
members  ||| S:11679 E:11687 ||| NNS
of  ||| S:11687 E:11690 ||| IN
the  ||| S:11690 E:11705 ||| DT
NKG2  ||| S:11705 E:11710 ||| JJ
gene  ||| S:11710 E:11715 ||| NN
family  ||| S:11715 E:11722 ||| NN
including  ||| S:11722 E:11743 ||| VBG
NKG2  ||| S:11743 E:11748 ||| NNP
A ||| S:11748 E:11749 ||| NNP
,  ||| S:11749 E:11751 ||| ,
NKG2  ||| S:11751 E:11756 ||| NNP
D ||| S:11756 E:11757 ||| NNP
,  ||| S:11757 E:11759 ||| ,
NKG2  ||| S:11759 E:11764 ||| NNP
E  ||| S:11764 E:11766 ||| NNP
and  ||| S:11766 E:11781 ||| CC
NKG2  ||| S:11781 E:11786 ||| NNP
F  ||| S:11786 E:11788 ||| NNP
( ||| S:11788 E:11789 ||| -LRB-
GB  ||| S:11789 E:11792 ||| NNP
Accession  ||| S:11792 E:11802 ||| NNP
Nos ||| S:11802 E:11805 ||| NNP
.  ||| S:11805 E:11807 ||| .
AF461812 ||| S:11807 E:11815 ||| NNP
,  ||| S:11815 E:11827 ||| ,
AF461811 ||| S:11827 E:11835 ||| NNP
,  ||| S:11835 E:11837 ||| ,
AF461157 ||| S:11837 E:11845 ||| CD
)  ||| S:11845 E:11847 ||| -RRB-
[  ||| S:11847 E:11849 ||| -LRB-
10  ||| S:11849 E:11852 ||| CD
]  ||| S:11852 E:11854 ||| -RRB-
.  ||| S:11854 E:11856 ||| .
Therefore ||| S:11856 E:11865 ||| RB
,  ||| S:11865 E:11867 ||| ,
if  ||| S:11867 E:11870 ||| IN
genes  ||| S:11870 E:11876 ||| NNS
similar  ||| S:11876 E:11894 ||| JJ
to  ||| S:11894 E:11908 ||| TO
NKG2  ||| S:11908 E:11913 ||| CD
family  ||| S:11913 E:11920 ||| NN
members  ||| S:11920 E:11928 ||| NNS
are  ||| S:11928 E:11932 ||| VBP
spotted  ||| S:11932 E:11940 ||| VBN
on  ||| S:11940 E:11953 ||| IN
a  ||| S:11953 E:11955 ||| DT
microarray ||| S:11955 E:11965 ||| NN
,  ||| S:11965 E:11967 ||| ,
it  ||| S:11967 E:11970 ||| PRP
may  ||| S:11970 E:11974 ||| MD
be  ||| S:11974 E:11977 ||| VB
difficult  ||| S:11977 E:11987 ||| JJ
to  ||| S:11987 E:11990 ||| TO
confirm  ||| S:11990 E:11998 ||| VB
which  ||| S:11998 E:12004 ||| WDT
form  ||| S:12004 E:12019 ||| VBP
of  ||| S:12019 E:12022 ||| IN
the  ||| S:12022 E:12026 ||| DT
gene  ||| S:12026 E:12031 ||| NN
is  ||| S:12031 E:12034 ||| VBZ
differentially  ||| S:12034 E:12049 ||| VBN
expressed  ||| S:12049 E:12059 ||| VBN
in  ||| S:12059 E:12062 ||| IN
a  ||| S:12062 E:12064 ||| DT
given  ||| S:12064 E:12080 ||| VBN
sample ||| S:12080 E:12086 ||| NN
.  ||| S:12086 E:12116 ||| .
Mismatch  ||| S:12116 E:12125 ||| JJ
probe  ||| S:12125 E:12131 ||| NN
sets  ||| S:12131 E:12136 ||| VBZ
mask  ||| S:12136 E:12141 ||| VBG
the  ||| S:12141 E:12145 ||| DT
perfect  ||| S:12145 E:12153 ||| JJ
match  ||| S:12153 E:12159 ||| NN
signals  ||| S:12159 E:12177 ||| NNS
in  ||| S:12177 E:12180 ||| IN
oligonucleotide  ||| S:12180 E:12196 ||| JJ
array  ||| S:12196 E:12202 ||| NN
( ||| S:12202 E:12203 ||| -LRB-
Affymetrix ||| S:12203 E:12213 ||| NNP
)  ||| S:12213 E:12225 ||| -RRB-
In  ||| S:12225 E:12228 ||| IN
order  ||| S:12228 E:12234 ||| NN
to  ||| S:12234 E:12237 ||| TO
accomplish  ||| S:12237 E:12248 ||| VB
the  ||| S:12248 E:12252 ||| DT
highest  ||| S:12252 E:12260 ||| JJS
sensitivity  ||| S:12260 E:12272 ||| NN
and  ||| S:12272 E:12286 ||| CC
specificity  ||| S:12286 E:12298 ||| NN
in  ||| S:12298 E:12301 ||| IN
the  ||| S:12301 E:12305 ||| DT
presence  ||| S:12305 E:12314 ||| NN
of  ||| S:12314 E:12317 ||| IN
a  ||| S:12317 E:12319 ||| DT
complex  ||| S:12319 E:12327 ||| JJ
background ||| S:12327 E:12337 ||| NN
,  ||| S:12337 E:12349 ||| ,
Affymetrix  ||| S:12349 E:12360 ||| NNP
introduced  ||| S:12360 E:12371 ||| VBD
a  ||| S:12371 E:12373 ||| DT
system  ||| S:12373 E:12380 ||| NN
that  ||| S:12380 E:12385 ||| WDT
entails  ||| S:12385 E:12393 ||| VBZ
the  ||| S:12393 E:12397 ||| DT
use  ||| S:12397 E:12401 ||| NN
of  ||| S:12401 E:12404 ||| IN
a  ||| S:12404 E:12416 ||| DT
series  ||| S:12416 E:12423 ||| NN
of  ||| S:12423 E:12426 ||| IN
specific  ||| S:12426 E:12435 ||| JJ
and  ||| S:12435 E:12439 ||| CC
non-specific  ||| S:12439 E:12452 ||| JJ
gene  ||| S:12452 E:12457 ||| NN
probe  ||| S:12457 E:12463 ||| NN
sets  ||| S:12463 E:12468 ||| NNS
that  ||| S:12468 E:12483 ||| WDT
are  ||| S:12483 E:12487 ||| VBP
intended  ||| S:12487 E:12496 ||| VBN
to  ||| S:12496 E:12499 ||| TO
result  ||| S:12499 E:12506 ||| VB
in  ||| S:12506 E:12509 ||| IN
a  ||| S:12509 E:12511 ||| DT
more  ||| S:12511 E:12516 ||| RBR
accurate  ||| S:12516 E:12525 ||| JJ
discrimination  ||| S:12525 E:12550 ||| NN
between  ||| S:12550 E:12558 ||| IN
true  ||| S:12558 E:12563 ||| JJ
signal  ||| S:12563 E:12570 ||| NN
and  ||| S:12570 E:12574 ||| CC
random  ||| S:12574 E:12581 ||| JJ
hybridization ||| S:12581 E:12594 ||| NN
.  ||| S:12594 E:12596 ||| .
Each  ||| S:12596 E:12601 ||| DT
probe  ||| S:12601 E:12617 ||| NN
set  ||| S:12617 E:12621 ||| NN
consists  ||| S:12621 E:12630 ||| VBZ
of  ||| S:12630 E:12633 ||| IN
a  ||| S:12633 E:12635 ||| DT
pair  ||| S:12635 E:12640 ||| NN
of  ||| S:12640 E:12643 ||| IN
25-mer  ||| S:12643 E:12650 ||| CD
probes ||| S:12650 E:12656 ||| NNS
,  ||| S:12656 E:12658 ||| ,
one  ||| S:12658 E:12662 ||| CD
that  ||| S:12662 E:12677 ||| WDT
represents  ||| S:12677 E:12688 ||| VBZ
a  ||| S:12688 E:12690 ||| DT
perfect  ||| S:12690 E:12698 ||| JJ
match  ||| S:12698 E:12704 ||| NN
( ||| S:12704 E:12705 ||| -LRB-
PM ||| S:12705 E:12707 ||| NNP
) ||| S:12707 E:12708 ||| -RRB-
to  ||| S:12708 E:12711 ||| TO
the  ||| S:12711 E:12715 ||| DT
mRNA  ||| S:12715 E:12720 ||| JJ
of  ||| S:12720 E:12723 ||| IN
interest ||| S:12723 E:12731 ||| NN
,  ||| S:12731 E:12743 ||| ,
and  ||| S:12743 E:12747 ||| CC
a  ||| S:12747 E:12749 ||| DT
second  ||| S:12749 E:12756 ||| JJ
probe  ||| S:12756 E:12762 ||| NN
differing  ||| S:12762 E:12772 ||| VBG
by  ||| S:12772 E:12775 ||| IN
only  ||| S:12775 E:12780 ||| RB
one  ||| S:12780 E:12784 ||| CD
nucleotide ||| S:12784 E:12794 ||| NN
,  ||| S:12794 E:12796 ||| ,
the  ||| S:12796 E:12810 ||| DT
mismatch  ||| S:12810 E:12819 ||| NN
( ||| S:12819 E:12820 ||| -LRB-
MM ||| S:12820 E:12822 ||| NNP
) ||| S:12822 E:12823 ||| -RRB-
.  ||| S:12823 E:12825 ||| .
The  ||| S:12825 E:12829 ||| DT
mismatch  ||| S:12829 E:12838 ||| NN
in  ||| S:12838 E:12841 ||| IN
the  ||| S:12841 E:12845 ||| DT
middle  ||| S:12845 E:12852 ||| JJ
position  ||| S:12852 E:12871 ||| NN
theoretically  ||| S:12871 E:12885 ||| NN
provides  ||| S:12885 E:12894 ||| VBZ
maximal  ||| S:12894 E:12902 ||| JJ
disruption  ||| S:12902 E:12913 ||| NN
of  ||| S:12913 E:12926 ||| IN
hybridization ||| S:12926 E:12939 ||| NN
.  ||| S:12939 E:12941 ||| .
Unfortunately ||| S:12941 E:12954 ||| RB
,  ||| S:12954 E:12956 ||| ,
the  ||| S:12956 E:12960 ||| DT
use  ||| S:12960 E:12964 ||| NN
of  ||| S:12964 E:12967 ||| IN
the  ||| S:12967 E:12971 ||| DT
mismatch  ||| S:12971 E:12990 ||| JJ
probe  ||| S:12990 E:12996 ||| NN
information  ||| S:12996 E:13008 ||| NN
can  ||| S:13008 E:13012 ||| MD
interfere  ||| S:13012 E:13022 ||| VB
with  ||| S:13022 E:13027 ||| IN
fold  ||| S:13027 E:13032 ||| JJ
change  ||| S:13032 E:13049 ||| NN
calculations  ||| S:13049 E:13062 ||| NNS
of  ||| S:13062 E:13065 ||| IN
gene  ||| S:13065 E:13070 ||| NN
expression ||| S:13070 E:13080 ||| NN
.  ||| S:13080 E:13082 ||| .
For  ||| S:13082 E:13086 ||| IN
example ||| S:13086 E:13093 ||| NN
,  ||| S:13093 E:13106 ||| ,
perforin  ||| S:13106 E:13115 ||| JJ
transcripts  ||| S:13115 E:13127 ||| NNS
showed  ||| S:13127 E:13134 ||| VBD
strong  ||| S:13134 E:13151 ||| JJ
hybridization  ||| S:13151 E:13165 ||| NN
to  ||| S:13165 E:13168 ||| TO
both  ||| S:13168 E:13173 ||| DT
PM  ||| S:13173 E:13176 ||| NNP
and  ||| S:13176 E:13180 ||| CC
MM  ||| S:13180 E:13183 ||| NNP
probe  ||| S:13183 E:13189 ||| NN
sets ||| S:13189 E:13193 ||| NNS
.  ||| S:13193 E:13195 ||| .
As  ||| S:13195 E:13198 ||| IN
a  ||| S:13198 E:13210 ||| DT
consequence ||| S:13210 E:13221 ||| NN
,  ||| S:13221 E:13223 ||| ,
the  ||| S:13223 E:13227 ||| DT
strong  ||| S:13227 E:13234 ||| JJ
MM  ||| S:13234 E:13237 ||| NNP
signal  ||| S:13237 E:13244 ||| NN
masked  ||| S:13244 E:13251 ||| VBD
the  ||| S:13251 E:13255 ||| DT
PM  ||| S:13255 E:13258 ||| NNP
signal  ||| S:13258 E:13275 ||| NN
resulting  ||| S:13275 E:13285 ||| VBG
in  ||| S:13285 E:13288 ||| IN
a  ||| S:13288 E:13290 ||| DT
low  ||| S:13290 E:13294 ||| JJ
expression  ||| S:13294 E:13305 ||| NN
readout ||| S:13305 E:13312 ||| NN
,  ||| S:13312 E:13314 ||| ,
even  ||| S:13314 E:13319 ||| RB
though  ||| S:13319 E:13326 ||| IN
the  ||| S:13326 E:13340 ||| DT
gene  ||| S:13340 E:13345 ||| NN
was  ||| S:13345 E:13349 ||| VBD
present  ||| S:13349 E:13357 ||| JJ
in  ||| S:13357 E:13360 ||| IN
normal  ||| S:13360 E:13367 ||| JJ
PBMC  ||| S:13367 E:13372 ||| NNP
( ||| S:13372 E:13373 ||| -LRB-
Fig.  ||| S:13373 E:13378 ||| NNP
2b ||| S:13378 E:13380 ||| NNP
) ||| S:13380 E:13381 ||| -RRB-
.  ||| S:13381 E:13383 ||| .
Therefore ||| S:13383 E:13392 ||| RB
,  ||| S:13392 E:13394 ||| ,
the  ||| S:13394 E:13408 ||| DT
subsequently  ||| S:13408 E:13421 ||| RB
calculated  ||| S:13421 E:13432 ||| VBN
fold  ||| S:13432 E:13437 ||| JJ
increase  ||| S:13437 E:13446 ||| NN
from  ||| S:13446 E:13451 ||| IN
the  ||| S:13451 E:13455 ||| DT
test  ||| S:13455 E:13470 ||| NN
sample  ||| S:13470 E:13477 ||| NN
was  ||| S:13477 E:13481 ||| VBD
extraordinarily  ||| S:13481 E:13497 ||| RB
high  ||| S:13497 E:13502 ||| JJ
and  ||| S:13502 E:13506 ||| CC
deemed  ||| S:13506 E:13513 ||| JJ
unreliable ||| S:13513 E:13523 ||| NN
.  ||| S:13523 E:13535 ||| .
Similarly ||| S:13535 E:13544 ||| RB
,  ||| S:13544 E:13546 ||| ,
the  ||| S:13546 E:13550 ||| DT
fold  ||| S:13550 E:13555 ||| JJ
change  ||| S:13555 E:13562 ||| NN
calculation  ||| S:13562 E:13574 ||| NN
was  ||| S:13574 E:13578 ||| VBD
underestimated  ||| S:13578 E:13603 ||| VBN
for  ||| S:13603 E:13618 ||| IN
PAC-1  ||| S:13618 E:13624 ||| CD
due  ||| S:13624 E:13628 ||| JJ
to  ||| S:13628 E:13631 ||| TO
the  ||| S:13631 E:13635 ||| DT
strong  ||| S:13635 E:13642 ||| JJ
signal  ||| S:13642 E:13659 ||| NN
displayed  ||| S:13659 E:13669 ||| VBN
for  ||| S:13669 E:13673 ||| IN
MM  ||| S:13673 E:13676 ||| NNP
probe  ||| S:13676 E:13682 ||| NN
set  ||| S:13682 E:13686 ||| NN
( ||| S:13686 E:13687 ||| -LRB-
Fig.  ||| S:13687 E:13692 ||| NNP
3b ||| S:13692 E:13694 ||| NNP
) ||| S:13694 E:13695 ||| -RRB-
.  ||| S:13695 E:13697 ||| .
Genes  ||| S:13697 E:13703 ||| NNS
such  ||| S:13703 E:13719 ||| JJ
as  ||| S:13719 E:13722 ||| IN
human  ||| S:13722 E:13728 ||| JJ
auto-antigen  ||| S:13728 E:13741 ||| NN
( ||| S:13741 E:13742 ||| -LRB-
GenBank  ||| S:13742 E:13760 ||| JJ
Accession  ||| S:13760 E:13770 ||| JJ
# ||| S:13770 E:13771 ||| #
L26339 ||| S:13771 E:13777 ||| CD
)  ||| S:13777 E:13779 ||| -RRB-
and  ||| S:13779 E:13794 ||| CC
carboxyl  ||| S:13794 E:13803 ||| JJ
ester  ||| S:13803 E:13809 ||| JJ
lipase-like  ||| S:13809 E:13831 ||| JJ
protein  ||| S:13831 E:13839 ||| NN
( ||| S:13839 E:13840 ||| -LRB-
GenBank  ||| S:13840 E:13848 ||| JJ
Accession  ||| S:13848 E:13858 ||| JJ
# ||| S:13858 E:13859 ||| #
L14813 ||| S:13859 E:13865 ||| CD
) ||| S:13865 E:13866 ||| -RRB-
,  ||| S:13866 E:13868 ||| ,
are  ||| S:13868 E:13872 ||| VBP
additional  ||| S:13872 E:13893 ||| JJ
examples  ||| S:13893 E:13902 ||| NNS
where  ||| S:13902 E:13908 ||| WRB
these  ||| S:13908 E:13914 ||| DT
genes  ||| S:13914 E:13920 ||| NNS
are  ||| S:13920 E:13924 ||| VBP
present  ||| S:13924 E:13932 ||| JJ
in  ||| S:13932 E:13935 ||| IN
LGL  ||| S:13935 E:13939 ||| NNP
sample ||| S:13939 E:13945 ||| NN
,  ||| S:13945 E:13947 ||| ,
but  ||| S:13947 E:13961 ||| CC
because  ||| S:13961 E:13969 ||| RB
of  ||| S:13969 E:13972 ||| IN
the  ||| S:13972 E:13976 ||| DT
strong  ||| S:13976 E:13983 ||| JJ
signals  ||| S:13983 E:13991 ||| NNS
associated  ||| S:13991 E:14002 ||| VBN
with  ||| S:14002 E:14007 ||| IN
some  ||| S:14007 E:14012 ||| DT
of  ||| S:14012 E:14015 ||| IN
the  ||| S:14015 E:14029 ||| DT
MM  ||| S:14029 E:14032 ||| NNP
probes ||| S:14032 E:14038 ||| NNS
,  ||| S:14038 E:14040 ||| ,
they  ||| S:14040 E:14045 ||| PRP
are  ||| S:14045 E:14049 ||| VBP
considered  ||| S:14049 E:14060 ||| VBN
absent  ||| S:14060 E:14067 ||| VBN
in  ||| S:14067 E:14070 ||| IN
the  ||| S:14070 E:14074 ||| DT
samples  ||| S:14074 E:14092 ||| NNS
( ||| S:14092 E:14093 ||| -LRB-
Fig.  ||| S:14093 E:14098 ||| CD
5aand  ||| S:14098 E:14104 ||| CD
5b ||| S:14104 E:14106 ||| CD
) ||| S:14106 E:14107 ||| -RRB-
.  ||| S:14107 E:14140 ||| .
Discussion  ||| S:14140 E:14159 ||| NN
In  ||| S:14159 E:14162 ||| IN
order  ||| S:14162 E:14168 ||| NN
to  ||| S:14168 E:14171 ||| TO
identify  ||| S:14171 E:14180 ||| VB
the  ||| S:14180 E:14184 ||| DT
differentially  ||| S:14184 E:14199 ||| NN
expressed  ||| S:14199 E:14209 ||| VBD
genes  ||| S:14209 E:14223 ||| NNS
in  ||| S:14223 E:14226 ||| IN
large  ||| S:14226 E:14232 ||| JJ
granular  ||| S:14232 E:14241 ||| JJ
lymphocytic  ||| S:14241 E:14253 ||| NNS
( ||| S:14253 E:14254 ||| -LRB-
LGL ||| S:14254 E:14257 ||| NNP
)  ||| S:14257 E:14259 ||| -RRB-
leukemia ||| S:14259 E:14267 ||| NN
,  ||| S:14267 E:14269 ||| ,
we  ||| S:14269 E:14272 ||| PRP
performed  ||| S:14272 E:14290 ||| VBD
microarray  ||| S:14290 E:14301 ||| JJ
analysis  ||| S:14301 E:14310 ||| NN
using  ||| S:14310 E:14316 ||| VBG
the  ||| S:14316 E:14320 ||| DT
UniGEM-V  ||| S:14320 E:14329 ||| JJ
microarray  ||| S:14329 E:14340 ||| NN
from  ||| S:14340 E:14353 ||| IN
IncyteGenomics  ||| S:14353 E:14368 ||| JJ
and  ||| S:14368 E:14372 ||| CC
the  ||| S:14372 E:14376 ||| DT
HU6800  ||| S:14376 E:14383 ||| JJ
oligonucleotide  ||| S:14383 E:14399 ||| JJ
array  ||| S:14399 E:14405 ||| NN
from  ||| S:14405 E:14418 ||| IN
Affymetrix ||| S:14418 E:14428 ||| NNP
.  ||| S:14428 E:14430 ||| .
In  ||| S:14430 E:14433 ||| IN
the  ||| S:14433 E:14437 ||| DT
course  ||| S:14437 E:14444 ||| NN
of  ||| S:14444 E:14447 ||| IN
our  ||| S:14447 E:14451 ||| PRP$
analysis ||| S:14451 E:14459 ||| NN
,  ||| S:14459 E:14461 ||| ,
we  ||| S:14461 E:14464 ||| PRP
discovered  ||| S:14464 E:14483 ||| VBD
several  ||| S:14483 E:14491 ||| JJ
problems  ||| S:14491 E:14500 ||| NNS
that  ||| S:14500 E:14505 ||| IN
we  ||| S:14505 E:14508 ||| PRP
feel  ||| S:14508 E:14513 ||| VBP
could  ||| S:14513 E:14519 ||| MD
occur  ||| S:14519 E:14525 ||| VB
in  ||| S:14525 E:14528 ||| IN
other  ||| S:14528 E:14534 ||| JJ
studies  ||| S:14534 E:14550 ||| NNS
that  ||| S:14550 E:14555 ||| WDT
might  ||| S:14555 E:14561 ||| MD
lead  ||| S:14561 E:14566 ||| VB
to  ||| S:14566 E:14569 ||| TO
false  ||| S:14569 E:14575 ||| JJ
conclusions ||| S:14575 E:14586 ||| NNS
.  ||| S:14586 E:14596 ||| .
Approximately  ||| S:14596 E:14610 ||| RB
80  ||| S:14610 E:14613 ||| CD
up-regulated  ||| S:14613 E:14626 ||| JJ
genes  ||| S:14626 E:14632 ||| NNS
and  ||| S:14632 E:14636 ||| CC
12  ||| S:14636 E:14647 ||| CD
down-regulated  ||| S:14647 E:14662 ||| JJ
genes  ||| S:14662 E:14668 ||| NNS
were  ||| S:14668 E:14673 ||| VBD
identified  ||| S:14673 E:14684 ||| VBN
by  ||| S:14684 E:14687 ||| IN
cDNA  ||| S:14687 E:14692 ||| JJ
microarray  ||| S:14692 E:14711 ||| JJ
analysis  ||| S:14711 E:14720 ||| NN
in  ||| S:14720 E:14723 ||| IN
leukemic  ||| S:14723 E:14732 ||| JJ
LGL  ||| S:14732 E:14736 ||| NN
cells ||| S:14736 E:14741 ||| NNS
.  ||| S:14741 E:14743 ||| .
Since  ||| S:14743 E:14749 ||| IN
microarray  ||| S:14749 E:14760 ||| JJ
technology  ||| S:14760 E:14779 ||| NN
was  ||| S:14779 E:14783 ||| VBD
a  ||| S:14783 E:14785 ||| DT
new  ||| S:14785 E:14789 ||| JJ
tool  ||| S:14789 E:14794 ||| NN
at  ||| S:14794 E:14797 ||| IN
that  ||| S:14797 E:14802 ||| DT
time ||| S:14802 E:14806 ||| NN
,  ||| S:14806 E:14808 ||| ,
we  ||| S:14808 E:14811 ||| PRP
decided  ||| S:14811 E:14819 ||| VBD
to  ||| S:14819 E:14822 ||| TO
verify  ||| S:14822 E:14829 ||| VB
the  ||| S:14829 E:14841 ||| DT
sequences  ||| S:14841 E:14851 ||| NN
of  ||| S:14851 E:14854 ||| IN
all  ||| S:14854 E:14858 ||| PDT
the  ||| S:14858 E:14862 ||| DT
genes  ||| S:14862 E:14868 ||| NNS
that  ||| S:14868 E:14873 ||| WDT
were  ||| S:14873 E:14878 ||| VBD
differentially  ||| S:14878 E:14901 ||| VBN
expressed ||| S:14901 E:14910 ||| VBN
.  ||| S:14910 E:14912 ||| .
To  ||| S:14912 E:14915 ||| TO
that  ||| S:14915 E:14920 ||| DT
end ||| S:14920 E:14923 ||| NN
,  ||| S:14923 E:14925 ||| ,
we  ||| S:14925 E:14928 ||| PRP
purchased  ||| S:14928 E:14938 ||| VBD
approximately  ||| S:14938 E:14952 ||| RB
20  ||| S:14952 E:14963 ||| CD
clones  ||| S:14963 E:14970 ||| NNS
representing  ||| S:14970 E:14983 ||| VBG
the  ||| S:14983 E:14987 ||| DT
differentially  ||| S:14987 E:15002 ||| NN
expressed  ||| S:15002 E:15012 ||| VBD
genes  ||| S:15012 E:15018 ||| NNS
and  ||| S:15018 E:15030 ||| CC
verified  ||| S:15030 E:15039 ||| VBN
the  ||| S:15039 E:15043 ||| DT
sequences ||| S:15043 E:15052 ||| NN
.  ||| S:15052 E:15054 ||| .
We  ||| S:15054 E:15057 ||| PRP
found  ||| S:15057 E:15063 ||| VBD
that  ||| S:15063 E:15068 ||| IN
only  ||| S:15068 E:15073 ||| RB
approximately  ||| S:15073 E:15095 ||| RB
70 ||| S:15095 E:15097 ||| CD
%  ||| S:15097 E:15099 ||| NN
of  ||| S:15099 E:15102 ||| IN
the  ||| S:15102 E:15106 ||| DT
genes  ||| S:15106 E:15112 ||| NNS
spotted  ||| S:15112 E:15120 ||| VBD
on  ||| S:15120 E:15123 ||| IN
the  ||| S:15123 E:15127 ||| DT
microarray  ||| S:15127 E:15138 ||| NN
matched  ||| S:15138 E:15146 ||| VBD
the  ||| S:15146 E:15158 ||| DT
correct  ||| S:15158 E:15166 ||| JJ
sequence  ||| S:15166 E:15175 ||| NN
of  ||| S:15175 E:15178 ||| IN
the  ||| S:15178 E:15182 ||| DT
clones ||| S:15182 E:15188 ||| NNS
.  ||| S:15188 E:15190 ||| .
Other  ||| S:15190 E:15196 ||| JJ
groups  ||| S:15196 E:15203 ||| NNS
reported  ||| S:15203 E:15220 ||| VBD
similar  ||| S:15220 E:15228 ||| JJ
observations ||| S:15228 E:15240 ||| NNS
.  ||| S:15240 E:15242 ||| .
For  ||| S:15242 E:15246 ||| IN
example ||| S:15246 E:15253 ||| NN
,  ||| S:15253 E:15255 ||| ,
IMAGE  ||| S:15255 E:15261 ||| NNP
mouse  ||| S:15261 E:15267 ||| NN
cDNA  ||| S:15267 E:15272 ||| JJ
clones  ||| S:15272 E:15287 ||| NNS
( ||| S:15287 E:15288 ||| -LRB-
approximately  ||| S:15288 E:15302 ||| RB
1200 ||| S:15302 E:15306 ||| CD
)  ||| S:15306 E:15308 ||| -RRB-
were  ||| S:15308 E:15313 ||| VBD
purchased  ||| S:15313 E:15323 ||| VBN
from  ||| S:15323 E:15328 ||| IN
Research  ||| S:15328 E:15337 ||| NNP
Genetics  ||| S:15337 E:15354 ||| NNP
( ||| S:15354 E:15355 ||| -LRB-
Huntsville ||| S:15355 E:15365 ||| NNP
,  ||| S:15365 E:15367 ||| ,
Alabama ||| S:15367 E:15374 ||| NNP
)  ||| S:15374 E:15376 ||| -RRB-
and  ||| S:15376 E:15380 ||| CC
sequences  ||| S:15380 E:15390 ||| NNS
were  ||| S:15390 E:15395 ||| VBD
verified  ||| S:15395 E:15404 ||| VBN
by  ||| S:15404 E:15415 ||| IN
Halgren  ||| S:15415 E:15432 ||| NNP
et  ||| S:15432 E:15435 ||| FW
al  ||| S:15435 E:15438 ||| FW
[  ||| S:15438 E:15440 ||| -LRB-
11  ||| S:15440 E:15443 ||| CD
]  ||| S:15443 E:15445 ||| -RRB-
.  ||| S:15445 E:15447 ||| .
This  ||| S:15447 E:15452 ||| DT
group  ||| S:15452 E:15458 ||| NN
found  ||| S:15458 E:15464 ||| VBD
that  ||| S:15464 E:15477 ||| IN
only  ||| S:15477 E:15482 ||| RB
62 ||| S:15482 E:15484 ||| CD
%  ||| S:15484 E:15486 ||| NN
were  ||| S:15486 E:15491 ||| VBD
definitely  ||| S:15491 E:15502 ||| RB
identified  ||| S:15502 E:15513 ||| VBN
as  ||| S:15513 E:15516 ||| IN
a  ||| S:15516 E:15518 ||| DT
pure  ||| S:15518 E:15523 ||| JJ
sample  ||| S:15523 E:15530 ||| NN
of  ||| S:15530 E:15533 ||| IN
the  ||| S:15533 E:15545 ||| DT
correct  ||| S:15545 E:15553 ||| JJ
clones ||| S:15553 E:15559 ||| NNS
.  ||| S:15559 E:15561 ||| .
In  ||| S:15561 E:15564 ||| IN
another  ||| S:15564 E:15572 ||| DT
study ||| S:15572 E:15577 ||| NN
,  ||| S:15577 E:15579 ||| ,
PCR  ||| S:15579 E:15583 ||| NNP
amplification  ||| S:15583 E:15605 ||| NN
products  ||| S:15605 E:15614 ||| NNS
( ||| S:15614 E:15615 ||| -LRB-
previously  ||| S:15615 E:15626 ||| RB
sequence-verified  ||| S:15626 E:15644 ||| JJ
cDNA  ||| S:15644 E:15649 ||| JJ
clones ||| S:15649 E:15655 ||| NNS
)  ||| S:15655 E:15657 ||| -RRB-
were  ||| S:15657 E:15670 ||| VBD
re-sequenced  ||| S:15670 E:15683 ||| JJ
and  ||| S:15683 E:15687 ||| CC
only  ||| S:15687 E:15692 ||| RB
79 ||| S:15692 E:15694 ||| CD
%  ||| S:15694 E:15696 ||| NN
of  ||| S:15696 E:15699 ||| IN
the  ||| S:15699 E:15703 ||| DT
clones  ||| S:15703 E:15710 ||| NNS
matched  ||| S:15710 E:15718 ||| VBD
the  ||| S:15718 E:15730 ||| DT
original  ||| S:15730 E:15739 ||| JJ
database  ||| S:15739 E:15748 ||| NN
[  ||| S:15748 E:15750 ||| -LRB-
12  ||| S:15750 E:15753 ||| CD
]  ||| S:15753 E:15755 ||| -RRB-
.  ||| S:15755 E:15757 ||| .
In  ||| S:15757 E:15760 ||| IN
a  ||| S:15760 E:15762 ||| DT
different  ||| S:15762 E:15772 ||| JJ
study ||| S:15772 E:15777 ||| NN
,  ||| S:15777 E:15779 ||| ,
it  ||| S:15779 E:15782 ||| PRP
was  ||| S:15782 E:15794 ||| VBD
estimated  ||| S:15794 E:15804 ||| VBN
that  ||| S:15804 E:15809 ||| IN
only  ||| S:15809 E:15814 ||| RB
80 ||| S:15814 E:15816 ||| CD
%  ||| S:15816 E:15818 ||| NN
of  ||| S:15818 E:15821 ||| IN
the  ||| S:15821 E:15825 ||| DT
genes  ||| S:15825 E:15831 ||| NNS
in  ||| S:15831 E:15834 ||| IN
a  ||| S:15834 E:15836 ||| DT
set  ||| S:15836 E:15840 ||| NN
of  ||| S:15840 E:15843 ||| IN
microarray  ||| S:15843 E:15862 ||| JJ
experiments  ||| S:15862 E:15874 ||| NNS
were  ||| S:15874 E:15879 ||| VBD
correctly  ||| S:15879 E:15889 ||| RB
identified  ||| S:15889 E:15900 ||| VBN
[  ||| S:15900 E:15902 ||| -LRB-
5  ||| S:15902 E:15904 ||| LS
]  ||| S:15904 E:15906 ||| -RRB-
.  ||| S:15906 E:15908 ||| .
Therefore ||| S:15908 E:15917 ||| RB
,  ||| S:15917 E:15919 ||| ,
we  ||| S:15919 E:15930 ||| PRP
advise  ||| S:15930 E:15937 ||| VBP
that  ||| S:15937 E:15942 ||| IN
when  ||| S:15942 E:15947 ||| WRB
preparing  ||| S:15947 E:15957 ||| VBG
cDNA  ||| S:15957 E:15962 ||| JJ
microarrays  ||| S:15962 E:15974 ||| NNS
( ||| S:15974 E:15975 ||| -LRB-
commercial  ||| S:15975 E:15986 ||| JJ
or  ||| S:15986 E:15997 ||| CC
homemade ||| S:15997 E:16005 ||| CD
) ||| S:16005 E:16006 ||| -RRB-
,  ||| S:16006 E:16008 ||| ,
it  ||| S:16008 E:16011 ||| PRP
is  ||| S:16011 E:16014 ||| VBZ
necessary  ||| S:16014 E:16024 ||| JJ
to  ||| S:16024 E:16027 ||| TO
sequence  ||| S:16027 E:16036 ||| VB
verify  ||| S:16036 E:16043 ||| VB
each  ||| S:16043 E:16048 ||| DT
clone  ||| S:16048 E:16054 ||| NN
at  ||| S:16054 E:16065 ||| IN
the  ||| S:16065 E:16069 ||| DT
final  ||| S:16069 E:16075 ||| JJ
stage  ||| S:16075 E:16081 ||| NN
before  ||| S:16081 E:16088 ||| IN
printing  ||| S:16088 E:16097 ||| VBG
the  ||| S:16097 E:16101 ||| DT
microarray ||| S:16101 E:16111 ||| NN
.  ||| S:16111 E:16113 ||| .
If  ||| S:16113 E:16116 ||| IN
mistakes  ||| S:16116 E:16133 ||| NNS
are  ||| S:16133 E:16137 ||| VBP
made  ||| S:16137 E:16142 ||| VBN
at  ||| S:16142 E:16145 ||| IN
this  ||| S:16145 E:16150 ||| DT
stage ||| S:16150 E:16155 ||| NN
,  ||| S:16155 E:16157 ||| ,
it  ||| S:16157 E:16160 ||| PRP
is  ||| S:16160 E:16163 ||| VBZ
not  ||| S:16163 E:16167 ||| RB
possible  ||| S:16167 E:16176 ||| JJ
to  ||| S:16176 E:16179 ||| TO
correct  ||| S:16179 E:16187 ||| VB
them  ||| S:16187 E:16200 ||| PRP
later  ||| S:16200 E:16206 ||| RB
by  ||| S:16206 E:16209 ||| IN
using  ||| S:16209 E:16215 ||| VBG
the  ||| S:16215 E:16219 ||| DT
most  ||| S:16219 E:16224 ||| RBS
sophisticated  ||| S:16224 E:16238 ||| JJ
analytical  ||| S:16238 E:16249 ||| JJ
tools ||| S:16249 E:16254 ||| NNS
.  ||| S:16254 E:16264 ||| .
We  ||| S:16264 E:16267 ||| PRP
used  ||| S:16267 E:16272 ||| VBD
cDNA  ||| S:16272 E:16277 ||| JJ
microarray  ||| S:16277 E:16288 ||| JJ
analysis  ||| S:16288 E:16297 ||| NN
to  ||| S:16297 E:16300 ||| TO
compare  ||| S:16300 E:16308 ||| VB
the  ||| S:16308 E:16312 ||| DT
gene  ||| S:16312 E:16325 ||| NN
expression  ||| S:16325 E:16336 ||| NN
profile  ||| S:16336 E:16344 ||| NN
of  ||| S:16344 E:16347 ||| IN
leukemic  ||| S:16347 E:16356 ||| JJ
LGL  ||| S:16356 E:16360 ||| NN
cells  ||| S:16360 E:16366 ||| NNS
obtained  ||| S:16366 E:16375 ||| VBN
from  ||| S:16375 E:16380 ||| IN
a  ||| S:16380 E:16390 ||| DT
patient  ||| S:16390 E:16398 ||| NN
versus  ||| S:16398 E:16405 ||| IN
the  ||| S:16405 E:16409 ||| DT
expression  ||| S:16409 E:16420 ||| NN
profile  ||| S:16420 E:16428 ||| NN
of  ||| S:16428 E:16431 ||| IN
PBMC  ||| S:16431 E:16436 ||| NNP
obtained  ||| S:16436 E:16445 ||| VBD
from  ||| S:16445 E:16458 ||| IN
a  ||| S:16458 E:16460 ||| DT
normal  ||| S:16460 E:16467 ||| JJ
healthy  ||| S:16467 E:16475 ||| JJ
individual  ||| S:16475 E:16486 ||| NN
as  ||| S:16486 E:16489 ||| IN
a  ||| S:16489 E:16491 ||| DT
control ||| S:16491 E:16498 ||| NN
.  ||| S:16498 E:16500 ||| .
We  ||| S:16500 E:16503 ||| PRP
decided  ||| S:16503 E:16511 ||| VBD
to  ||| S:16511 E:16522 ||| TO
verify  ||| S:16522 E:16529 ||| VB
the  ||| S:16529 E:16533 ||| DT
microarray  ||| S:16533 E:16544 ||| JJ
results  ||| S:16544 E:16552 ||| NNS
using  ||| S:16552 E:16558 ||| VBG
samples  ||| S:16558 E:16566 ||| NNS
from  ||| S:16566 E:16571 ||| IN
more  ||| S:16571 E:16584 ||| JJR
patients  ||| S:16584 E:16593 ||| NNS
by  ||| S:16593 E:16596 ||| IN
employing  ||| S:16596 E:16606 ||| VBG
the  ||| S:16606 E:16610 ||| DT
use  ||| S:16610 E:16614 ||| NN
of  ||| S:16614 E:16617 ||| IN
other  ||| S:16617 E:16623 ||| JJ
methods  ||| S:16623 E:16631 ||| NNS
such  ||| S:16631 E:16636 ||| JJ
as  ||| S:16636 E:16639 ||| IN
PCR ||| S:16639 E:16642 ||| NNP
,  ||| S:16642 E:16652 ||| ,
Northern  ||| S:16652 E:16661 ||| JJ
blot  ||| S:16661 E:16666 ||| NN
and  ||| S:16666 E:16670 ||| CC
RNase  ||| S:16670 E:16676 ||| JJ
protection  ||| S:16676 E:16687 ||| NN
assay ||| S:16687 E:16692 ||| NN
.  ||| S:16692 E:16694 ||| .
To  ||| S:16694 E:16697 ||| TO
our  ||| S:16697 E:16701 ||| PRP$
surprise ||| S:16701 E:16709 ||| NN
,  ||| S:16709 E:16719 ||| ,
none  ||| S:16719 E:16724 ||| NN
of  ||| S:16724 E:16727 ||| IN
the  ||| S:16727 E:16731 ||| DT
three  ||| S:16731 E:16737 ||| CD
down-regulated  ||| S:16737 E:16752 ||| JJ
genes  ||| S:16752 E:16758 ||| NNS
studied  ||| S:16758 E:16766 ||| VBD
exhibited  ||| S:16766 E:16784 ||| VBN
differential  ||| S:16784 E:16797 ||| JJ
expression  ||| S:16797 E:16808 ||| NN
in  ||| S:16808 E:16811 ||| IN
Northern  ||| S:16811 E:16820 ||| JJ
blots  ||| S:16820 E:16826 ||| NN
when  ||| S:16826 E:16831 ||| WRB
the  ||| S:16831 E:16835 ||| DT
cDNA  ||| S:16835 E:16848 ||| JJ
fragments  ||| S:16848 E:16858 ||| NNS
of  ||| S:16858 E:16861 ||| IN
these  ||| S:16861 E:16867 ||| DT
genes  ||| S:16867 E:16873 ||| NNS
were  ||| S:16873 E:16878 ||| VBD
used  ||| S:16878 E:16883 ||| VBN
as  ||| S:16883 E:16886 ||| IN
probes ||| S:16886 E:16892 ||| NNS
.  ||| S:16892 E:16894 ||| .
In  ||| S:16894 E:16897 ||| IN
the  ||| S:16897 E:16909 ||| DT
up-regulated  ||| S:16909 E:16922 ||| JJ
genes ||| S:16922 E:16927 ||| NNS
,  ||| S:16927 E:16929 ||| ,
only  ||| S:16929 E:16934 ||| RB
47  ||| S:16934 E:16937 ||| CD
%  ||| S:16937 E:16939 ||| NN
proved  ||| S:16939 E:16946 ||| VBD
to  ||| S:16946 E:16949 ||| TO
support  ||| S:16949 E:16957 ||| VB
the  ||| S:16957 E:16961 ||| DT
results  ||| S:16961 E:16977 ||| NNS
from  ||| S:16977 E:16982 ||| IN
the  ||| S:16982 E:16986 ||| DT
microarray  ||| S:16986 E:16997 ||| JJ
data ||| S:16997 E:17001 ||| NNS
.  ||| S:17001 E:17003 ||| .
The  ||| S:17003 E:17007 ||| DT
rest  ||| S:17007 E:17012 ||| NN
either  ||| S:17012 E:17019 ||| CC
displayed  ||| S:17019 E:17029 ||| VBD
no  ||| S:17029 E:17040 ||| DT
signal ||| S:17040 E:17046 ||| NN
,  ||| S:17046 E:17048 ||| ,
were  ||| S:17048 E:17053 ||| VBD
not  ||| S:17053 E:17057 ||| RB
detectable  ||| S:17057 E:17068 ||| VBN
in  ||| S:17068 E:17071 ||| IN
any  ||| S:17071 E:17075 ||| DT
sample  ||| S:17075 E:17082 ||| NN
or  ||| S:17082 E:17085 ||| CC
failed  ||| S:17085 E:17092 ||| VBD
to  ||| S:17092 E:17103 ||| TO
reveal  ||| S:17103 E:17110 ||| VB
any  ||| S:17110 E:17114 ||| DT
differential  ||| S:17114 E:17127 ||| JJ
expression  ||| S:17127 E:17138 ||| NN
whatsoever ||| S:17138 E:17148 ||| RB
.  ||| S:17148 E:17150 ||| .
Although  ||| S:17150 E:17167 ||| IN
some  ||| S:17167 E:17172 ||| DT
genes  ||| S:17172 E:17178 ||| NNS
such  ||| S:17178 E:17183 ||| JJ
as  ||| S:17183 E:17195 ||| IN
PAC-1  ||| S:17195 E:17201 ||| NNP
and  ||| S:17201 E:17214 ||| CC
A20  ||| S:17214 E:17218 ||| NNP
showed  ||| S:17218 E:17225 ||| VBD
differential  ||| S:17225 E:17238 ||| JJ
expression  ||| S:17238 E:17249 ||| NN
in  ||| S:17249 E:17260 ||| IN
LGL  ||| S:17260 E:17264 ||| NNP
leukemia  ||| S:17264 E:17273 ||| NN
patients ||| S:17273 E:17281 ||| NNS
,  ||| S:17281 E:17283 ||| ,
no  ||| S:17283 E:17286 ||| DT
product  ||| S:17286 E:17294 ||| NN
amplification  ||| S:17294 E:17308 ||| NNS
was  ||| S:17308 E:17320 ||| VBD
obtained  ||| S:17320 E:17329 ||| VBN
using  ||| S:17329 E:17335 ||| VBG
RT-PCR  ||| S:17335 E:17342 ||| JJ
with  ||| S:17342 E:17347 ||| IN
gene-specific  ||| S:17347 E:17361 ||| JJ
primers ||| S:17361 E:17368 ||| NN
.  ||| S:17368 E:17378 ||| .
By  ||| S:17378 E:17381 ||| IN
microarray  ||| S:17381 E:17392 ||| JJ
analysis ||| S:17392 E:17400 ||| NN
,  ||| S:17400 E:17402 ||| ,
it  ||| S:17402 E:17405 ||| PRP
is  ||| S:17405 E:17408 ||| VBZ
very  ||| S:17408 E:17413 ||| RB
difficult  ||| S:17413 E:17423 ||| JJ
to  ||| S:17423 E:17434 ||| TO
distinguish  ||| S:17434 E:17446 ||| VB
between  ||| S:17446 E:17454 ||| IN
two  ||| S:17454 E:17458 ||| CD
similar  ||| S:17458 E:17466 ||| JJ
genes ||| S:17466 E:17471 ||| NNS
.  ||| S:17471 E:17473 ||| .
The  ||| S:17473 E:17477 ||| DT
best  ||| S:17477 E:17482 ||| JJS
example  ||| S:17482 E:17490 ||| NN
in  ||| S:17490 E:17501 ||| IN
our  ||| S:17501 E:17505 ||| PRP$
case  ||| S:17505 E:17510 ||| NN
is  ||| S:17510 E:17513 ||| VBZ
when  ||| S:17513 E:17527 ||| WRB
granzyme  ||| S:17527 E:17536 ||| JJ
B  ||| S:17536 E:17538 ||| NNP
and  ||| S:17538 E:17551 ||| CC
granzyme  ||| S:17551 E:17560 ||| JJ
H  ||| S:17560 E:17562 ||| NNP
are  ||| S:17562 E:17566 ||| VBP
compared ||| S:17566 E:17574 ||| VBN
.  ||| S:17574 E:17576 ||| .
These  ||| S:17576 E:17582 ||| DT
two  ||| S:17582 E:17594 ||| CD
genes  ||| S:17594 E:17600 ||| NNS
share  ||| S:17600 E:17606 ||| VBP
approximately  ||| S:17606 E:17620 ||| RB
80 ||| S:17620 E:17622 ||| CD
%  ||| S:17622 E:17624 ||| NN
similarity  ||| S:17624 E:17635 ||| NN
at  ||| S:17635 E:17638 ||| IN
the  ||| S:17638 E:17642 ||| DT
DNA  ||| S:17642 E:17646 ||| NN
level  ||| S:17646 E:17660 ||| NN
but  ||| S:17660 E:17664 ||| CC
have  ||| S:17664 E:17669 ||| VBP
different  ||| S:17669 E:17679 ||| JJ
enzymatic  ||| S:17679 E:17689 ||| JJ
activities  ||| S:17689 E:17700 ||| NNS
[  ||| S:17700 E:17702 ||| -LRB-
13  ||| S:17702 E:17705 ||| CD
14  ||| S:17705 E:17708 ||| CD
]  ||| S:17708 E:17710 ||| -RRB-
.  ||| S:17710 E:17712 ||| .
Using  ||| S:17712 E:17726 ||| VBG
either  ||| S:17726 E:17733 ||| DT
one  ||| S:17733 E:17737 ||| NN
of  ||| S:17737 E:17740 ||| IN
the  ||| S:17740 E:17744 ||| DT
genes  ||| S:17744 E:17750 ||| NNS
as  ||| S:17750 E:17753 ||| IN
a  ||| S:17753 E:17755 ||| DT
probe ||| S:17755 E:17760 ||| NN
,  ||| S:17760 E:17762 ||| ,
both  ||| S:17762 E:17767 ||| DT
cDNA  ||| S:17767 E:17772 ||| JJ
microarray  ||| S:17772 E:17791 ||| NN
and  ||| S:17791 E:17795 ||| CC
northern  ||| S:17795 E:17804 ||| JJ
blot  ||| S:17804 E:17809 ||| JJ
analysis  ||| S:17809 E:17818 ||| NN
indicated  ||| S:17818 E:17828 ||| VBD
over-expression  ||| S:17828 E:17844 ||| JJ
of  ||| S:17844 E:17855 ||| IN
both  ||| S:17855 E:17860 ||| DT
genes  ||| S:17860 E:17866 ||| NNS
indiscriminately  ||| S:17866 E:17883 ||| VBP
( ||| S:17883 E:17884 ||| -LRB-
Fig.  ||| S:17884 E:17889 ||| CD
1 ||| S:17889 E:17890 ||| CD
) ||| S:17890 E:17891 ||| -RRB-
.  ||| S:17891 E:17893 ||| .
However ||| S:17893 E:17900 ||| RB
,  ||| S:17900 E:17902 ||| ,
using  ||| S:17902 E:17916 ||| VBG
gene-specific  ||| S:17916 E:17930 ||| JJ
probes  ||| S:17930 E:17937 ||| NNS
in  ||| S:17937 E:17940 ||| IN
an  ||| S:17940 E:17943 ||| DT
RNase  ||| S:17943 E:17949 ||| JJ
protection  ||| S:17949 E:17960 ||| NN
assay ||| S:17960 E:17965 ||| NN
,  ||| S:17965 E:17967 ||| ,
we  ||| S:17967 E:17970 ||| PRP
were  ||| S:17970 E:17983 ||| VBD
able  ||| S:17983 E:17988 ||| JJ
to  ||| S:17988 E:17991 ||| TO
distinctly  ||| S:17991 E:18002 ||| RB
identify  ||| S:18002 E:18011 ||| VB
the  ||| S:18011 E:18015 ||| DT
over-expression  ||| S:18015 E:18031 ||| JJ
of  ||| S:18031 E:18034 ||| IN
both  ||| S:18034 E:18048 ||| DT
granzyme  ||| S:18048 E:18057 ||| JJ
B  ||| S:18057 E:18059 ||| NNP
and  ||| S:18059 E:18072 ||| CC
H  ||| S:18072 E:18074 ||| NNP
in  ||| S:18074 E:18077 ||| IN
leukemic  ||| S:18077 E:18086 ||| JJ
LGL  ||| S:18086 E:18090 ||| NN
cells  ||| S:18090 E:18096 ||| NNS
( ||| S:18096 E:18097 ||| -LRB-
Fig.  ||| S:18097 E:18102 ||| CD
1dand  ||| S:18102 E:18116 ||| CD
1e ||| S:18116 E:18118 ||| CD
) ||| S:18118 E:18119 ||| -RRB-
.  ||| S:18119 E:18121 ||| .
In  ||| S:18121 E:18124 ||| IN
normal  ||| S:18124 E:18131 ||| JJ
PBMC  ||| S:18131 E:18136 ||| NNP
only  ||| S:18136 E:18141 ||| RB
trace  ||| S:18141 E:18147 ||| JJ
amounts  ||| S:18147 E:18155 ||| NNS
of  ||| S:18155 E:18158 ||| IN
both  ||| S:18158 E:18163 ||| DT
genes  ||| S:18163 E:18169 ||| NNS
were  ||| S:18169 E:18182 ||| VBD
identified ||| S:18182 E:18192 ||| VBN
,  ||| S:18192 E:18194 ||| ,
but  ||| S:18194 E:18198 ||| CC
after  ||| S:18198 E:18204 ||| IN
activation  ||| S:18204 E:18215 ||| NN
by  ||| S:18215 E:18218 ||| IN
PHA  ||| S:18218 E:18222 ||| NNP
and  ||| S:18222 E:18226 ||| CC
IL2  ||| S:18226 E:18230 ||| NNP
only  ||| S:18230 E:18244 ||| RB
granzyme  ||| S:18244 E:18253 ||| JJ
B  ||| S:18253 E:18255 ||| NNP
was  ||| S:18255 E:18259 ||| VBD
up-regulated ||| S:18259 E:18271 ||| JJ
.  ||| S:18271 E:18273 ||| .
It  ||| S:18273 E:18276 ||| PRP
is  ||| S:18276 E:18287 ||| VBZ
very  ||| S:18287 E:18292 ||| RB
difficult  ||| S:18292 E:18302 ||| JJ
to  ||| S:18302 E:18305 ||| TO
get  ||| S:18305 E:18309 ||| VB
this  ||| S:18309 E:18314 ||| DT
information  ||| S:18314 E:18326 ||| NN
by  ||| S:18326 E:18329 ||| IN
microarray  ||| S:18329 E:18348 ||| JJ
analysis  ||| S:18348 E:18357 ||| NN
alone ||| S:18357 E:18362 ||| RB
.  ||| S:18362 E:18364 ||| .
Therefore ||| S:18364 E:18373 ||| RB
,  ||| S:18373 E:18375 ||| ,
caution  ||| S:18375 E:18383 ||| NN
in  ||| S:18383 E:18386 ||| IN
presenting  ||| S:18386 E:18397 ||| VBG
microarray  ||| S:18397 E:18416 ||| JJ
data  ||| S:18416 E:18421 ||| NNS
without  ||| S:18421 E:18429 ||| IN
verification  ||| S:18429 E:18442 ||| NN
and  ||| S:18442 E:18446 ||| CC
confirmation  ||| S:18446 E:18459 ||| NN
is  ||| S:18459 E:18462 ||| VBZ
advised ||| S:18462 E:18469 ||| VBN
.  ||| S:18469 E:18479 ||| .
When  ||| S:18479 E:18484 ||| WRB
the  ||| S:18484 E:18488 ||| DT
results  ||| S:18488 E:18496 ||| NNS
from  ||| S:18496 E:18501 ||| IN
two  ||| S:18501 E:18505 ||| CD
different  ||| S:18505 E:18515 ||| JJ
microarray  ||| S:18515 E:18534 ||| JJ
technologies  ||| S:18534 E:18547 ||| NNS
( ||| S:18547 E:18548 ||| -LRB-
cDNA  ||| S:18548 E:18553 ||| NNP
and  ||| S:18553 E:18557 ||| CC
oligonucleotide  ||| S:18557 E:18573 ||| JJ
arrays ||| S:18573 E:18579 ||| NN
)  ||| S:18579 E:18581 ||| -RRB-
were  ||| S:18581 E:18594 ||| VBD
compared ||| S:18594 E:18602 ||| VBN
,  ||| S:18602 E:18604 ||| ,
the  ||| S:18604 E:18608 ||| DT
differential  ||| S:18608 E:18621 ||| JJ
expression  ||| S:18621 E:18632 ||| NN
in  ||| S:18632 E:18635 ||| IN
some  ||| S:18635 E:18640 ||| DT
of  ||| S:18640 E:18643 ||| IN
the  ||| S:18643 E:18647 ||| DT
genes  ||| S:18647 E:18661 ||| NNS
appeared  ||| S:18661 E:18670 ||| VBD
to  ||| S:18670 E:18673 ||| TO
agree  ||| S:18673 E:18679 ||| VB
in  ||| S:18679 E:18682 ||| IN
both  ||| S:18682 E:18687 ||| DT
cases  ||| S:18687 E:18693 ||| NNS
but  ||| S:18693 E:18697 ||| CC
a  ||| S:18697 E:18699 ||| DT
large  ||| S:18699 E:18705 ||| JJ
variation  ||| S:18705 E:18715 ||| NN
in  ||| S:18715 E:18726 ||| IN
expression  ||| S:18726 E:18737 ||| NN
profiles  ||| S:18737 E:18746 ||| NNS
between  ||| S:18746 E:18754 ||| IN
the  ||| S:18754 E:18758 ||| DT
two  ||| S:18758 E:18762 ||| CD
microarrays  ||| S:18762 E:18774 ||| NNS
was  ||| S:18774 E:18778 ||| VBD
clearly  ||| S:18778 E:18794 ||| RB
evident ||| S:18794 E:18801 ||| JJ
.  ||| S:18801 E:18803 ||| .
Previously ||| S:18803 E:18813 ||| RB
,  ||| S:18813 E:18815 ||| ,
such  ||| S:18815 E:18820 ||| JJ
systematic  ||| S:18820 E:18831 ||| JJ
differences  ||| S:18831 E:18843 ||| NNS
in  ||| S:18843 E:18846 ||| IN
the  ||| S:18846 E:18850 ||| DT
two  ||| S:18850 E:18862 ||| CD
technologies  ||| S:18862 E:18875 ||| NNS
were  ||| S:18875 E:18880 ||| VBD
reported  ||| S:18880 E:18889 ||| VBN
[  ||| S:18889 E:18891 ||| -LRB-
6  ||| S:18891 E:18893 ||| CD
]  ||| S:18893 E:18895 ||| -RRB-
.  ||| S:18895 E:18897 ||| .
For  ||| S:18897 E:18901 ||| IN
example ||| S:18901 E:18908 ||| NN
,  ||| S:18908 E:18919 ||| ,
perforin  ||| S:18919 E:18928 ||| NN
showed  ||| S:18928 E:18935 ||| VBD
a  ||| S:18935 E:18937 ||| DT
103-fold  ||| S:18937 E:18946 ||| JJ
change  ||| S:18946 E:18953 ||| NN
in  ||| S:18953 E:18964 ||| IN
the  ||| S:18964 E:18968 ||| DT
Affymetrix  ||| S:18968 E:18979 ||| JJ
array ||| S:18979 E:18984 ||| NN
,  ||| S:18984 E:18986 ||| ,
whereas  ||| S:18986 E:18994 ||| IN
the  ||| S:18994 E:18998 ||| DT
cDNA  ||| S:18998 E:19003 ||| JJ
microarray  ||| S:19003 E:19014 ||| NN
showed  ||| S:19014 E:19029 ||| VBD
only  ||| S:19029 E:19034 ||| RB
a  ||| S:19034 E:19036 ||| DT
balanced  ||| S:19036 E:19045 ||| JJ
differential  ||| S:19045 E:19058 ||| NN
expression  ||| S:19058 E:19069 ||| NN
of  ||| S:19069 E:19072 ||| IN
3.8-fold ||| S:19072 E:19080 ||| CD
.  ||| S:19080 E:19090 ||| .
Northern  ||| S:19090 E:19099 ||| JJ
blot  ||| S:19099 E:19104 ||| JJ
results  ||| S:19104 E:19112 ||| NNS
indicate  ||| S:19112 E:19121 ||| VBP
that  ||| S:19121 E:19126 ||| IN
the  ||| S:19126 E:19130 ||| DT
genes  ||| S:19130 E:19136 ||| NNS
were  ||| S:19136 E:19149 ||| VBD
over-expressed ||| S:19149 E:19163 ||| JJ
,  ||| S:19163 E:19165 ||| ,
but  ||| S:19165 E:19169 ||| CC
the  ||| S:19169 E:19173 ||| DT
actual  ||| S:19173 E:19180 ||| JJ
value  ||| S:19180 E:19186 ||| NN
is  ||| S:19186 E:19189 ||| VBZ
in  ||| S:19189 E:19192 ||| IN
between  ||| S:19192 E:19200 ||| IN
the  ||| S:19200 E:19212 ||| DT
values  ||| S:19212 E:19219 ||| NNS
from  ||| S:19219 E:19224 ||| IN
the  ||| S:19224 E:19228 ||| DT
two  ||| S:19228 E:19232 ||| CD
microarrays ||| S:19232 E:19243 ||| NNS
.  ||| S:19243 E:19245 ||| .
This  ||| S:19245 E:19250 ||| DT
problem  ||| S:19250 E:19258 ||| NN
may  ||| S:19258 E:19262 ||| MD
be  ||| S:19262 E:19265 ||| VB
due  ||| S:19265 E:19269 ||| JJ
to  ||| S:19269 E:19280 ||| TO
an  ||| S:19280 E:19283 ||| DT
inaccurate  ||| S:19283 E:19294 ||| JJ
fold  ||| S:19294 E:19299 ||| JJ
change  ||| S:19299 E:19306 ||| NN
calculation  ||| S:19306 E:19318 ||| NN
due  ||| S:19318 E:19322 ||| JJ
to  ||| S:19322 E:19325 ||| TO
the  ||| S:19325 E:19329 ||| DT
inclusion  ||| S:19329 E:19347 ||| NN
of  ||| S:19347 E:19350 ||| IN
mismatch  ||| S:19350 E:19359 ||| JJ
values  ||| S:19359 E:19366 ||| NNS
in  ||| S:19366 E:19369 ||| IN
the  ||| S:19369 E:19373 ||| DT
formula ||| S:19373 E:19380 ||| NN
.  ||| S:19380 E:19382 ||| .
We  ||| S:19382 E:19385 ||| PRP
observed  ||| S:19385 E:19394 ||| VBD
that  ||| S:19394 E:19399 ||| DT
many  ||| S:19399 E:19412 ||| JJ
over-expressed  ||| S:19412 E:19427 ||| JJ
genes  ||| S:19427 E:19433 ||| NNS
were  ||| S:19433 E:19438 ||| VBD
not  ||| S:19438 E:19442 ||| RB
properly  ||| S:19442 E:19451 ||| RB
identified  ||| S:19451 E:19462 ||| VBN
at  ||| S:19462 E:19465 ||| IN
times ||| S:19465 E:19470 ||| NNS
.  ||| S:19470 E:19480 ||| .
This  ||| S:19480 E:19485 ||| DT
may  ||| S:19485 E:19489 ||| MD
be  ||| S:19489 E:19492 ||| VB
the  ||| S:19492 E:19496 ||| DT
result  ||| S:19496 E:19503 ||| NN
of  ||| S:19503 E:19506 ||| IN
the  ||| S:19506 E:19510 ||| DT
introduction  ||| S:19510 E:19523 ||| NN
of  ||| S:19523 E:19526 ||| IN
mismatch  ||| S:19526 E:19543 ||| JJ
values  ||| S:19543 E:19550 ||| NNS
in  ||| S:19550 E:19553 ||| IN
the  ||| S:19553 E:19557 ||| DT
Affymetrix  ||| S:19557 E:19568 ||| JJ
system ||| S:19568 E:19574 ||| NN
.  ||| S:19574 E:19576 ||| .
For  ||| S:19576 E:19580 ||| IN
example ||| S:19580 E:19587 ||| NN
,  ||| S:19587 E:19589 ||| ,
genes  ||| S:19589 E:19595 ||| NNS
for  ||| S:19595 E:19608 ||| IN
human  ||| S:19608 E:19614 ||| JJ
autoantigen  ||| S:19614 E:19626 ||| NN
and  ||| S:19626 E:19639 ||| CC
human  ||| S:19639 E:19645 ||| JJ
carboxyl  ||| S:19645 E:19654 ||| NNS
ester  ||| S:19654 E:19660 ||| VBP
lipase-like  ||| S:19660 E:19680 ||| JJ
protein  ||| S:19680 E:19688 ||| NN
would  ||| S:19688 E:19694 ||| MD
be  ||| S:19694 E:19697 ||| VB
considered  ||| S:19697 E:19708 ||| VBN
up-regulated  ||| S:19708 E:19721 ||| JJ
in  ||| S:19721 E:19724 ||| IN
the  ||| S:19724 E:19736 ||| DT
microarray  ||| S:19736 E:19747 ||| NN
( ||| S:19747 E:19748 ||| -LRB-
according  ||| S:19748 E:19758 ||| VBG
to  ||| S:19758 E:19761 ||| TO
PM  ||| S:19761 E:19764 ||| NNP
match  ||| S:19764 E:19770 ||| NN
hybridization ||| S:19770 E:19783 ||| NN
)  ||| S:19783 E:19785 ||| -RRB-
if  ||| S:19785 E:19788 ||| IN
the  ||| S:19788 E:19792 ||| DT
MM  ||| S:19792 E:19803 ||| NNP
hybridization  ||| S:19803 E:19817 ||| NN
values  ||| S:19817 E:19824 ||| NNS
were  ||| S:19824 E:19829 ||| VBD
ignored  ||| S:19829 E:19837 ||| VBN
in  ||| S:19837 E:19840 ||| IN
the  ||| S:19840 E:19844 ||| DT
fold  ||| S:19844 E:19849 ||| JJ
change  ||| S:19849 E:19864 ||| NN
calculation ||| S:19864 E:19875 ||| NN
.  ||| S:19875 E:19885 ||| .
DNA  ||| S:19885 E:19889 ||| NNP
microarray  ||| S:19889 E:19900 ||| NN
anlysis  ||| S:19900 E:19908 ||| NNS
can  ||| S:19908 E:19912 ||| MD
be  ||| S:19912 E:19915 ||| VB
a  ||| S:19915 E:19917 ||| DT
powerful  ||| S:19917 E:19926 ||| JJ
technique  ||| S:19926 E:19936 ||| NN
to  ||| S:19936 E:19947 ||| TO
identify  ||| S:19947 E:19956 ||| VB
differentially  ||| S:19956 E:19971 ||| VBN
expressed  ||| S:19971 E:19981 ||| VBN
genes  ||| S:19981 E:19987 ||| NNS
but  ||| S:19987 E:19991 ||| CC
differentiating  ||| S:19991 E:20015 ||| VBG
between  ||| S:20015 E:20023 ||| IN
splice  ||| S:20023 E:20030 ||| JJ
variants  ||| S:20030 E:20039 ||| NN
can  ||| S:20039 E:20043 ||| MD
be  ||| S:20043 E:20046 ||| VB
problematic ||| S:20046 E:20057 ||| JJ
.  ||| S:20057 E:20059 ||| .
For  ||| S:20059 E:20063 ||| IN
example ||| S:20063 E:20070 ||| NN
,  ||| S:20070 E:20080 ||| ,
although  ||| S:20080 E:20089 ||| IN
the  ||| S:20089 E:20093 ||| DT
differential  ||| S:20093 E:20106 ||| JJ
expression  ||| S:20106 E:20117 ||| NN
of  ||| S:20117 E:20120 ||| IN
the  ||| S:20120 E:20124 ||| DT
several  ||| S:20124 E:20132 ||| JJ
genes  ||| S:20132 E:20146 ||| NNS
such  ||| S:20146 E:20151 ||| JJ
as  ||| S:20151 E:20163 ||| IN
PAC-1  ||| S:20163 E:20169 ||| NNP
and  ||| S:20169 E:20182 ||| CC
A20  ||| S:20182 E:20186 ||| NNP
were  ||| S:20186 E:20191 ||| VBD
confirmed  ||| S:20191 E:20201 ||| VBN
by  ||| S:20201 E:20204 ||| IN
northern  ||| S:20204 E:20213 ||| JJ
blot  ||| S:20213 E:20226 ||| JJ
analysis ||| S:20226 E:20234 ||| NN
,  ||| S:20234 E:20236 ||| ,
we  ||| S:20236 E:20239 ||| PRP
were  ||| S:20239 E:20244 ||| VBD
unable  ||| S:20244 E:20251 ||| JJ
to  ||| S:20251 E:20254 ||| TO
see  ||| S:20254 E:20258 ||| VB
any  ||| S:20258 E:20262 ||| DT
expression  ||| S:20262 E:20273 ||| NN
of  ||| S:20273 E:20276 ||| IN
protein  ||| S:20276 E:20292 ||| JJ
corresponding  ||| S:20292 E:20306 ||| JJ
to  ||| S:20306 E:20309 ||| TO
these  ||| S:20309 E:20315 ||| DT
genes  ||| S:20315 E:20321 ||| NNS
by  ||| S:20321 E:20324 ||| IN
Western  ||| S:20324 E:20332 ||| JJ
blot  ||| S:20332 E:20337 ||| JJ
analysis ||| S:20337 E:20345 ||| NN
.  ||| S:20345 E:20347 ||| .
We  ||| S:20347 E:20358 ||| PRP
were  ||| S:20358 E:20363 ||| VBD
also  ||| S:20363 E:20368 ||| RB
unable  ||| S:20368 E:20375 ||| JJ
to  ||| S:20375 E:20378 ||| TO
amplify  ||| S:20378 E:20386 ||| VB
those  ||| S:20386 E:20392 ||| DT
genes  ||| S:20392 E:20398 ||| NNS
using  ||| S:20398 E:20404 ||| VBG
gene-specific  ||| S:20404 E:20426 ||| JJ
primers  ||| S:20426 E:20434 ||| NN
by  ||| S:20434 E:20437 ||| IN
RT-PCR ||| S:20437 E:20443 ||| JJ
.  ||| S:20443 E:20445 ||| .
After  ||| S:20445 E:20451 ||| IN
screening  ||| S:20451 E:20461 ||| VBG
the  ||| S:20461 E:20465 ||| DT
LGL  ||| S:20465 E:20469 ||| NNP
library ||| S:20469 E:20476 ||| NN
,  ||| S:20476 E:20478 ||| ,
we  ||| S:20478 E:20489 ||| PRP
obtained  ||| S:20489 E:20498 ||| VBD
several  ||| S:20498 E:20506 ||| JJ
full-length  ||| S:20506 E:20518 ||| JJ
genes  ||| S:20518 E:20524 ||| NNS
that  ||| S:20524 E:20529 ||| WDT
were  ||| S:20529 E:20534 ||| VBD
different  ||| S:20534 E:20544 ||| JJ
from  ||| S:20544 E:20557 ||| IN
both  ||| S:20557 E:20562 ||| PDT
the  ||| S:20562 E:20566 ||| DT
5 ||| S:20566 E:20567 ||| CD
'  ||| S:20567 E:20569 ||| ''
and  ||| S:20569 E:20573 ||| CC
3 ||| S:20573 E:20574 ||| CD
'  ||| S:20574 E:20576 ||| POS
ends  ||| S:20576 E:20581 ||| NNS
of  ||| S:20581 E:20593 ||| IN
PAC1  ||| S:20593 E:20598 ||| CD
.  ||| S:20598 E:20600 ||| .
Similarly ||| S:20600 E:20609 ||| RB
,  ||| S:20609 E:20611 ||| ,
we  ||| S:20611 E:20614 ||| PRP
screened  ||| S:20614 E:20623 ||| VBD
an  ||| S:20623 E:20626 ||| DT
LGL  ||| S:20626 E:20638 ||| NNP
leukemia  ||| S:20638 E:20647 ||| NN
library  ||| S:20647 E:20655 ||| NN
and  ||| S:20655 E:20659 ||| CC
obtained  ||| S:20659 E:20668 ||| VBD
several  ||| S:20668 E:20676 ||| JJ
1.5  ||| S:20676 E:20680 ||| CD
kb  ||| S:20680 E:20683 ||| CD
cDNA  ||| S:20683 E:20688 ||| JJ
fragments  ||| S:20688 E:20706 ||| NNS
using  ||| S:20706 E:20712 ||| VBG
the  ||| S:20712 E:20725 ||| DT
A20  ||| S:20725 E:20729 ||| JJ
cDNA  ||| S:20729 E:20734 ||| NN
as  ||| S:20734 E:20737 ||| IN
a  ||| S:20737 E:20739 ||| DT
probe ||| S:20739 E:20744 ||| NN
.  ||| S:20744 E:20746 ||| .
The  ||| S:20746 E:20750 ||| DT
deduced  ||| S:20750 E:20766 ||| JJ
amino  ||| S:20766 E:20772 ||| JJ
acid  ||| S:20772 E:20777 ||| NN
sequences  ||| S:20777 E:20787 ||| NN
of  ||| S:20787 E:20790 ||| IN
these  ||| S:20790 E:20796 ||| DT
genes  ||| S:20796 E:20802 ||| NNS
revealed  ||| S:20802 E:20811 ||| VBD
different  ||| S:20811 E:20829 ||| JJ
proteins ||| S:20829 E:20837 ||| NNS
.  ||| S:20837 E:20847 ||| .
We  ||| S:20847 E:20850 ||| PRP
found  ||| S:20850 E:20856 ||| VBD
an  ||| S:20856 E:20859 ||| DT
up-regulation  ||| S:20859 E:20873 ||| JJ
of  ||| S:20873 E:20885 ||| IN
NKG2C  ||| S:20885 E:20891 ||| CD
with  ||| S:20891 E:20896 ||| IN
a  ||| S:20896 E:20898 ||| DT
balanced  ||| S:20898 E:20907 ||| JJ
differential  ||| S:20907 E:20928 ||| NN
expression  ||| S:20928 E:20939 ||| NN
of  ||| S:20939 E:20942 ||| IN
5.8  ||| S:20942 E:20946 ||| CD
in  ||| S:20946 E:20949 ||| IN
cDNA  ||| S:20949 E:20954 ||| JJ
microarray  ||| S:20954 E:20965 ||| NNS
( ||| S:20965 E:20966 ||| -LRB-
Fig.  ||| S:20966 E:20971 ||| NNP
4a ||| S:20971 E:20973 ||| NNP
) ||| S:20973 E:20974 ||| -RRB-
.  ||| S:20974 E:20976 ||| .
When  ||| S:20976 E:20989 ||| WRB
Northern  ||| S:20989 E:20998 ||| NNP
Blot  ||| S:20998 E:21003 ||| NNP
analysis  ||| S:21003 E:21012 ||| NN
was  ||| S:21012 E:21016 ||| VBD
performed  ||| S:21016 E:21026 ||| VBN
using  ||| S:21026 E:21041 ||| VBG
NKG2  ||| S:21041 E:21046 ||| NNP
C  ||| S:21046 E:21048 ||| NNP
cDNA  ||| S:21048 E:21053 ||| NNP
as  ||| S:21053 E:21056 ||| IN
a  ||| S:21056 E:21058 ||| DT
probe ||| S:21058 E:21063 ||| NN
,  ||| S:21063 E:21065 ||| ,
we  ||| S:21065 E:21068 ||| PRP
identified  ||| S:21068 E:21087 ||| VBD
multiple  ||| S:21087 E:21096 ||| JJ
transcripts ||| S:21096 E:21107 ||| NNS
.  ||| S:21107 E:21109 ||| .
Screening  ||| S:21109 E:21119 ||| VBG
the  ||| S:21119 E:21123 ||| DT
LGL  ||| S:21123 E:21127 ||| NNP
leukemia  ||| S:21127 E:21136 ||| NN
library  ||| S:21136 E:21152 ||| NN
resulted  ||| S:21152 E:21161 ||| VBD
in  ||| S:21161 E:21164 ||| IN
the  ||| S:21164 E:21168 ||| DT
identification  ||| S:21168 E:21183 ||| NN
of  ||| S:21183 E:21186 ||| IN
several  ||| S:21186 E:21194 ||| JJ
other  ||| S:21194 E:21200 ||| JJ
members  ||| S:21200 E:21208 ||| NNS
of  ||| S:21208 E:21219 ||| IN
the  ||| S:21219 E:21232 ||| DT
NKG2  ||| S:21232 E:21237 ||| JJ
family  ||| S:21237 E:21244 ||| NN
such  ||| S:21244 E:21249 ||| JJ
as  ||| S:21249 E:21261 ||| IN
NKG2  ||| S:21261 E:21266 ||| NNP
A ||| S:21266 E:21267 ||| NNP
,  ||| S:21267 E:21269 ||| ,
D ||| S:21269 E:21270 ||| NNP
,  ||| S:21270 E:21272 ||| ,
E  ||| S:21272 E:21274 ||| NNP
,  ||| S:21274 E:21276 ||| ,
and  ||| S:21276 E:21289 ||| CC
F  ||| S:21289 E:21291 ||| NNP
[  ||| S:21291 E:21293 ||| -LRB-
10  ||| S:21293 E:21296 ||| CD
]  ||| S:21296 E:21298 ||| -RRB-
.  ||| S:21298 E:21300 ||| .
Therefore ||| S:21300 E:21309 ||| RB
,  ||| S:21309 E:21311 ||| ,
it  ||| S:21311 E:21314 ||| PRP
can  ||| S:21314 E:21318 ||| MD
be  ||| S:21318 E:21321 ||| VB
very  ||| S:21321 E:21334 ||| RB
difficult  ||| S:21334 E:21344 ||| JJ
to  ||| S:21344 E:21347 ||| TO
distinguish  ||| S:21347 E:21359 ||| VB
different  ||| S:21359 E:21369 ||| JJ
forms  ||| S:21369 E:21375 ||| NNS
of  ||| S:21375 E:21378 ||| IN
genes  ||| S:21378 E:21384 ||| NNS
if  ||| S:21384 E:21387 ||| IN
they  ||| S:21387 E:21400 ||| PRP
are  ||| S:21400 E:21404 ||| VBP
similar  ||| S:21404 E:21412 ||| JJ
in  ||| S:21412 E:21415 ||| IN
certain  ||| S:21415 E:21423 ||| JJ
sequence  ||| S:21423 E:21432 ||| NN
regions ||| S:21432 E:21439 ||| NNS
.  ||| S:21439 E:21463 ||| .
Conclusions  ||| S:21463 E:21483 ||| NNS
At  ||| S:21483 E:21486 ||| IN
the  ||| S:21486 E:21490 ||| DT
time  ||| S:21490 E:21495 ||| NN
of  ||| S:21495 E:21498 ||| IN
writing  ||| S:21498 E:21506 ||| VBG
this  ||| S:21506 E:21511 ||| DT
report  ||| S:21511 E:21518 ||| NN
there  ||| S:21518 E:21524 ||| EX
were  ||| S:21524 E:21537 ||| VBD
approximately  ||| S:21537 E:21551 ||| RB
1150  ||| S:21551 E:21556 ||| CD
articles  ||| S:21556 E:21565 ||| NNS
published  ||| S:21565 E:21575 ||| VBN
describing  ||| S:21575 E:21586 ||| VBG
microarray  ||| S:21586 E:21605 ||| JJ
results  ||| S:21605 E:21613 ||| NNS
( ||| S:21613 E:21614 ||| -LRB-
PubMed ||| S:21614 E:21620 ||| NNP
) ||| S:21620 E:21621 ||| -RRB-
.  ||| S:21621 E:21623 ||| .
There  ||| S:21623 E:21629 ||| EX
is  ||| S:21629 E:21632 ||| VBZ
no  ||| S:21632 E:21635 ||| DT
doubt  ||| S:21635 E:21641 ||| NN
that  ||| S:21641 E:21646 ||| IN
these  ||| S:21646 E:21652 ||| DT
results  ||| S:21652 E:21660 ||| NNS
will  ||| S:21660 E:21673 ||| MD
provide  ||| S:21673 E:21681 ||| VB
an  ||| S:21681 E:21684 ||| DT
overall  ||| S:21684 E:21692 ||| JJ
idea  ||| S:21692 E:21697 ||| NN
of  ||| S:21697 E:21700 ||| IN
gene  ||| S:21700 E:21705 ||| NN
expression  ||| S:21705 E:21716 ||| NN
and  ||| S:21716 E:21720 ||| CC
contribute  ||| S:21720 E:21739 ||| VB
to  ||| S:21739 E:21742 ||| TO
understanding  ||| S:21742 E:21756 ||| VB
the  ||| S:21756 E:21760 ||| DT
molecular  ||| S:21760 E:21770 ||| JJ
mechanisms  ||| S:21770 E:21781 ||| NNS
involved  ||| S:21781 E:21790 ||| VBN
in  ||| S:21790 E:21801 ||| IN
various  ||| S:21801 E:21809 ||| JJ
processes ||| S:21809 E:21818 ||| NNS
.  ||| S:21818 E:21820 ||| .
However ||| S:21820 E:21827 ||| RB
,  ||| S:21827 E:21829 ||| ,
as  ||| S:21829 E:21832 ||| RB
demonstrated  ||| S:21832 E:21845 ||| VBN
by  ||| S:21845 E:21848 ||| IN
our  ||| S:21848 E:21860 ||| PRP$
findings ||| S:21860 E:21868 ||| NNS
,  ||| S:21868 E:21870 ||| ,
the  ||| S:21870 E:21874 ||| DT
development  ||| S:21874 E:21886 ||| NN
of  ||| S:21886 E:21889 ||| IN
a  ||| S:21889 E:21891 ||| DT
standardized  ||| S:21891 E:21904 ||| JJ
microarray  ||| S:21904 E:21923 ||| JJ
system  ||| S:21923 E:21930 ||| NN
is  ||| S:21930 E:21933 ||| VBZ
needed  ||| S:21933 E:21940 ||| VBN
to  ||| S:21940 E:21943 ||| TO
obtain  ||| S:21943 E:21950 ||| VB
more  ||| S:21950 E:21955 ||| RBR
meaningful  ||| S:21955 E:21966 ||| JJ
data  ||| S:21966 E:21971 ||| NNS
from  ||| S:21971 E:21976 ||| IN
these  ||| S:21976 E:21990 ||| DT
experiments ||| S:21990 E:22001 ||| NNS
.  ||| S:22001 E:22003 ||| .
The  ||| S:22003 E:22007 ||| DT
introduction  ||| S:22007 E:22020 ||| NN
of  ||| S:22020 E:22023 ||| IN
more  ||| S:22023 E:22028 ||| RBR
uniform  ||| S:22028 E:22036 ||| JJ
systems  ||| S:22036 E:22052 ||| NNS
combined  ||| S:22052 E:22061 ||| VBN
with  ||| S:22061 E:22066 ||| IN
the  ||| S:22066 E:22070 ||| DT
consideration  ||| S:22070 E:22084 ||| NN
of  ||| S:22084 E:22087 ||| IN
the  ||| S:22087 E:22091 ||| DT
above  ||| S:22091 E:22097 ||| JJ
described  ||| S:22097 E:22115 ||| JJ
pitfalls  ||| S:22115 E:22124 ||| NNS
and  ||| S:22124 E:22128 ||| CC
alternatives  ||| S:22128 E:22141 ||| NNS
will  ||| S:22141 E:22146 ||| MD
allow  ||| S:22146 E:22152 ||| VB
better  ||| S:22152 E:22159 ||| JJR
utilization  ||| S:22159 E:22171 ||| NN
of  ||| S:22171 E:22182 ||| IN
this  ||| S:22182 E:22187 ||| DT
powerful  ||| S:22187 E:22196 ||| JJ
technique  ||| S:22196 E:22206 ||| NN
in  ||| S:22206 E:22209 ||| IN
an  ||| S:22209 E:22212 ||| DT
expanding  ||| S:22212 E:22222 ||| VBG
collection  ||| S:22222 E:22233 ||| NN
of  ||| S:22233 E:22244 ||| IN
scientific  ||| S:22244 E:22255 ||| JJ
endeavors ||| S:22255 E:22264 ||| NNS
.  ||| S:22264 E:22266 ||| .
It  ||| S:22266 E:22269 ||| PRP
will  ||| S:22269 E:22274 ||| MD
be  ||| S:22274 E:22277 ||| VB
very  ||| S:22277 E:22282 ||| RB
helpful  ||| S:22282 E:22290 ||| JJ
for  ||| S:22290 E:22294 ||| IN
the  ||| S:22294 E:22306 ||| DT
scientific  ||| S:22306 E:22317 ||| JJ
community  ||| S:22317 E:22327 ||| NN
if  ||| S:22327 E:22330 ||| IN
the  ||| S:22330 E:22334 ||| DT
verified  ||| S:22334 E:22343 ||| JJ
data  ||| S:22343 E:22348 ||| NN
is  ||| S:22348 E:22351 ||| VBZ
deposited  ||| S:22351 E:22361 ||| VBN
in  ||| S:22361 E:22364 ||| IN
a  ||| S:22364 E:22374 ||| DT
public  ||| S:22374 E:22381 ||| JJ
data  ||| S:22381 E:22386 ||| NN
base ||| S:22386 E:22390 ||| NN
.  ||| S:22390 E:22414 ||| .
Methods  ||| S:22414 E:22441 ||| NNP
Isolation  ||| S:22441 E:22451 ||| NNP
of  ||| S:22451 E:22454 ||| IN
PBMC  ||| S:22454 E:22459 ||| NNP
and  ||| S:22459 E:22463 ||| CC
RNA  ||| S:22463 E:22477 ||| NNP
PBMC  ||| S:22477 E:22482 ||| NNP
were  ||| S:22482 E:22487 ||| VBD
isolated  ||| S:22487 E:22496 ||| VBN
from  ||| S:22496 E:22501 ||| IN
whole  ||| S:22501 E:22507 ||| JJ
blood  ||| S:22507 E:22513 ||| NN
using  ||| S:22513 E:22529 ||| VBG
Ficoll-Hypaque  ||| S:22529 E:22544 ||| JJ
density  ||| S:22544 E:22552 ||| JJ
gradient  ||| S:22552 E:22561 ||| JJ
centrifugation ||| S:22561 E:22575 ||| NN
.  ||| S:22575 E:22577 ||| .
These  ||| S:22577 E:22593 ||| DT
cells  ||| S:22593 E:22599 ||| NNS
were  ||| S:22599 E:22604 ||| VBD
suspended  ||| S:22604 E:22614 ||| VBN
in  ||| S:22614 E:22617 ||| IN
Trizol  ||| S:22617 E:22624 ||| NNP
reagent  ||| S:22624 E:22632 ||| NNS
( ||| S:22632 E:22633 ||| -LRB-
GIBCO-BRL ||| S:22633 E:22642 ||| NNP
,  ||| S:22642 E:22654 ||| ,
Rockville ||| S:22654 E:22663 ||| NNP
,  ||| S:22663 E:22665 ||| ,
MD ||| S:22665 E:22667 ||| NNP
)  ||| S:22667 E:22669 ||| -RRB-
and  ||| S:22669 E:22673 ||| CC
total  ||| S:22673 E:22679 ||| JJ
RNA  ||| S:22679 E:22683 ||| NNP
was  ||| S:22683 E:22687 ||| VBD
isolated  ||| S:22687 E:22696 ||| VBN
immediately  ||| S:22696 E:22718 ||| RB
according  ||| S:22718 E:22728 ||| VBG
to  ||| S:22728 E:22731 ||| TO
the  ||| S:22731 E:22735 ||| DT
manufacturer ||| S:22735 E:22747 ||| NN
's  ||| S:22747 E:22750 ||| POS
instructions ||| S:22750 E:22762 ||| NNS
.  ||| S:22762 E:22764 ||| .
Poly  ||| S:22764 E:22769 ||| NNP
A+  ||| S:22769 E:22772 ||| NNP
RNA  ||| S:22772 E:22786 ||| NNP
was  ||| S:22786 E:22790 ||| VBD
isolated  ||| S:22790 E:22799 ||| VBN
from  ||| S:22799 E:22804 ||| IN
total  ||| S:22804 E:22810 ||| JJ
RNA  ||| S:22810 E:22814 ||| NNP
by  ||| S:22814 E:22817 ||| IN
using  ||| S:22817 E:22823 ||| VBG
Oligo-Tex  ||| S:22823 E:22833 ||| JJ
mini  ||| S:22833 E:22838 ||| JJ
mRNA  ||| S:22838 E:22853 ||| JJ
kit  ||| S:22853 E:22857 ||| NN
( ||| S:22857 E:22858 ||| -LRB-
Qiagen ||| S:22858 E:22864 ||| NNP
,  ||| S:22864 E:22866 ||| ,
Valencia ||| S:22866 E:22874 ||| NNP
,  ||| S:22874 E:22876 ||| ,
CA ||| S:22876 E:22878 ||| NNP
)  ||| S:22878 E:22880 ||| -RRB-
according  ||| S:22880 E:22890 ||| VBG
to  ||| S:22890 E:22893 ||| TO
the  ||| S:22893 E:22907 ||| DT
manufacturer ||| S:22907 E:22919 ||| NN
's  ||| S:22919 E:22922 ||| POS
recommendations ||| S:22922 E:22937 ||| NNS
.  ||| S:22937 E:22967 ||| .
Activation  ||| S:22967 E:22978 ||| NNP
of  ||| S:22978 E:22981 ||| IN
PBMC  ||| S:22981 E:22996 ||| NNP
Normal  ||| S:22996 E:23003 ||| NNP
PBMC  ||| S:23003 E:23008 ||| NNP
were  ||| S:23008 E:23013 ||| VBD
cultured  ||| S:23013 E:23033 ||| VBN
in  ||| S:23033 E:23036 ||| IN
vitro  ||| S:23036 E:23042 ||| NN
and  ||| S:23042 E:23046 ||| CC
activated  ||| S:23046 E:23056 ||| VBN
by  ||| S:23056 E:23059 ||| IN
PHA ||| S:23059 E:23062 ||| NNP
,  ||| S:23062 E:23074 ||| ,
( ||| S:23074 E:23075 ||| -LRB-
Sigma  ||| S:23075 E:23081 ||| NNP
Chemical  ||| S:23081 E:23090 ||| NNP
Co ||| S:23090 E:23092 ||| NNP
.  ||| S:23092 E:23094 ||| .
St.  ||| S:23094 E:23098 ||| NNP
Louis ||| S:23098 E:23103 ||| NNP
,  ||| S:23103 E:23105 ||| ,
MO ||| S:23105 E:23107 ||| NNP
)  ||| S:23107 E:23109 ||| -RRB-
( ||| S:23109 E:23110 ||| -LRB-
1  ||| S:23110 E:23112 ||| CD
μg ||| S:23112 E:23114 ||| CD
/ ||| S:23114 E:23115 ||| CD
ml ||| S:23115 E:23117 ||| NN
,  ||| S:23117 E:23119 ||| ,
2  ||| S:23119 E:23121 ||| CD
days ||| S:23121 E:23125 ||| NNS
)  ||| S:23125 E:23127 ||| -RRB-
and  ||| S:23127 E:23141 ||| CC
Interleukin-2  ||| S:23141 E:23155 ||| NNP
( ||| S:23155 E:23156 ||| -LRB-
IL-2 ||| S:23156 E:23160 ||| NNP
)  ||| S:23160 E:23162 ||| -RRB-
( ||| S:23162 E:23163 ||| -LRB-
100  ||| S:23163 E:23167 ||| CD
U ||| S:23167 E:23168 ||| NNP
/ ||| S:23168 E:23169 ||| NNP
ml ||| S:23169 E:23171 ||| NN
,  ||| S:23171 E:23173 ||| ,
10  ||| S:23173 E:23176 ||| CD
days ||| S:23176 E:23180 ||| NNS
) ||| S:23180 E:23181 ||| -RRB-
,  ||| S:23181 E:23183 ||| ,
then  ||| S:23183 E:23188 ||| RB
total  ||| S:23188 E:23194 ||| JJ
RNA  ||| S:23194 E:23208 ||| NNP
was  ||| S:23208 E:23212 ||| VBD
isolated.  ||| S:23212 E:23250 ||| CD
cDNA  ||| S:23250 E:23255 ||| JJ
microarray  ||| S:23255 E:23266 ||| JJ
analysis  ||| S:23266 E:23285 ||| NN
Microarray  ||| S:23285 E:23296 ||| NNP
probing  ||| S:23296 E:23304 ||| NN
and  ||| S:23304 E:23308 ||| CC
analysis  ||| S:23308 E:23317 ||| NN
was  ||| S:23317 E:23321 ||| VBD
performed  ||| S:23321 E:23331 ||| VBN
by  ||| S:23331 E:23344 ||| IN
IncyteGenomics ||| S:23344 E:23358 ||| JJ
.  ||| S:23358 E:23360 ||| .
Briefly ||| S:23360 E:23367 ||| RB
,  ||| S:23367 E:23369 ||| ,
one  ||| S:23369 E:23373 ||| CD
μg  ||| S:23373 E:23376 ||| NN
of  ||| S:23376 E:23379 ||| IN
Poly  ||| S:23379 E:23384 ||| NNP
( ||| S:23384 E:23385 ||| -LRB-
A ||| S:23385 E:23386 ||| NNP
)  ||| S:23386 E:23388 ||| -RRB-
+  ||| S:23388 E:23390 ||| NNP
RNA  ||| S:23390 E:23404 ||| NNP
isolated  ||| S:23404 E:23413 ||| VBD
from  ||| S:23413 E:23418 ||| IN
PBMC  ||| S:23418 E:23423 ||| NNP
of  ||| S:23423 E:23426 ||| IN
an  ||| S:23426 E:23429 ||| DT
LGL  ||| S:23429 E:23433 ||| NNP
leukemia  ||| S:23433 E:23442 ||| NN
patient  ||| S:23442 E:23450 ||| NN
and  ||| S:23450 E:23454 ||| CC
healthy  ||| S:23454 E:23472 ||| JJ
individual  ||| S:23472 E:23483 ||| NN
was  ||| S:23483 E:23487 ||| VBD
reverse  ||| S:23487 E:23495 ||| JJ
transcribed  ||| S:23495 E:23507 ||| NN
to  ||| S:23507 E:23510 ||| TO
generate  ||| S:23510 E:23519 ||| VB
Cy3  ||| S:23519 E:23523 ||| NNP
and  ||| S:23523 E:23537 ||| CC
Cy5  ||| S:23537 E:23541 ||| NNP
fluorescent  ||| S:23541 E:23553 ||| VBD
labeled  ||| S:23553 E:23561 ||| VBN
cDNA  ||| S:23561 E:23566 ||| JJ
probes.  ||| S:23566 E:23574 ||| CD
cDNA  ||| S:23574 E:23579 ||| JJ
probes  ||| S:23579 E:23586 ||| NNS
were  ||| S:23586 E:23601 ||| VBD
competitively  ||| S:23601 E:23615 ||| RB
hybridized  ||| S:23615 E:23626 ||| VBN
to  ||| S:23626 E:23629 ||| TO
a  ||| S:23629 E:23631 ||| DT
human  ||| S:23631 E:23637 ||| JJ
UniGEM-V  ||| S:23637 E:23646 ||| JJ
cDNA  ||| S:23646 E:23661 ||| JJ
microarray  ||| S:23661 E:23672 ||| NNS
containing  ||| S:23672 E:23683 ||| VBG
approximately  ||| S:23683 E:23697 ||| RB
7075  ||| S:23697 E:23702 ||| CD
immobilized  ||| S:23702 E:23714 ||| CD
cDNA  ||| S:23714 E:23729 ||| JJ
fragments  ||| S:23729 E:23739 ||| NNS
( ||| S:23739 E:23740 ||| -LRB-
4107  ||| S:23740 E:23745 ||| CD
for  ||| S:23745 E:23749 ||| IN
known  ||| S:23749 E:23755 ||| JJ
genes  ||| S:23755 E:23761 ||| NNS
and  ||| S:23761 E:23765 ||| CC
2968  ||| S:23765 E:23770 ||| CD
for  ||| S:23770 E:23774 ||| IN
ESTs ||| S:23774 E:23778 ||| NNP
) ||| S:23778 E:23779 ||| -RRB-
.  ||| S:23779 E:23791 ||| .
Microarrays  ||| S:23791 E:23803 ||| NNP
were  ||| S:23803 E:23808 ||| VBD
scanned  ||| S:23808 E:23816 ||| VBN
in  ||| S:23816 E:23819 ||| IN
both  ||| S:23819 E:23824 ||| DT
Cy3  ||| S:23824 E:23828 ||| NNP
and  ||| S:23828 E:23832 ||| CC
Cy5  ||| S:23832 E:23836 ||| CD
channels  ||| S:23836 E:23855 ||| NNS
with  ||| S:23855 E:23860 ||| IN
an  ||| S:23860 E:23863 ||| DT
Axon  ||| S:23863 E:23868 ||| JJ
GenePix  ||| S:23868 E:23876 ||| JJ
scanner  ||| S:23876 E:23884 ||| NNS
( ||| S:23884 E:23885 ||| -LRB-
Foster  ||| S:23885 E:23892 ||| NNP
City ||| S:23892 E:23896 ||| NNP
,  ||| S:23896 E:23898 ||| ,
CA ||| S:23898 E:23900 ||| NNP
)  ||| S:23900 E:23902 ||| -RRB-
with  ||| S:23902 E:23907 ||| IN
a  ||| S:23907 E:23909 ||| DT
10  ||| S:23909 E:23922 ||| CD
μm  ||| S:23922 E:23925 ||| JJ
resolution ||| S:23925 E:23935 ||| NN
.  ||| S:23935 E:23937 ||| .
P1  ||| S:23937 E:23940 ||| NNP
and  ||| S:23940 E:23944 ||| CC
P2  ||| S:23944 E:23947 ||| CD
signals  ||| S:23947 E:23955 ||| NNS
are  ||| S:23955 E:23959 ||| VBP
the  ||| S:23959 E:23963 ||| DT
intensity  ||| S:23963 E:23983 ||| NN
reading  ||| S:23983 E:23991 ||| NN
obtained  ||| S:23991 E:24000 ||| VBN
by  ||| S:24000 E:24003 ||| IN
the  ||| S:24003 E:24007 ||| DT
scanner  ||| S:24007 E:24015 ||| NN
for  ||| S:24015 E:24019 ||| IN
Cy3  ||| S:24019 E:24023 ||| NNP
and  ||| S:24023 E:24027 ||| CC
Cy5  ||| S:24027 E:24031 ||| CD
channels ||| S:24031 E:24039 ||| NNS
.  ||| S:24039 E:24051 ||| .
The  ||| S:24051 E:24055 ||| DT
balanced  ||| S:24055 E:24064 ||| JJ
differential  ||| S:24064 E:24077 ||| NN
expression  ||| S:24077 E:24088 ||| NN
was  ||| S:24088 E:24092 ||| VBD
calculated  ||| S:24092 E:24103 ||| VBN
using  ||| S:24103 E:24119 ||| VBG
the  ||| S:24119 E:24123 ||| DT
ratio  ||| S:24123 E:24129 ||| NN
between  ||| S:24129 E:24137 ||| IN
the  ||| S:24137 E:24141 ||| DT
P1  ||| S:24141 E:24144 ||| JJ
signal  ||| S:24144 E:24151 ||| NN
( ||| S:24151 E:24152 ||| -LRB-
intensity  ||| S:24152 E:24162 ||| NN
reading  ||| S:24162 E:24170 ||| NN
for  ||| S:24170 E:24184 ||| IN
probe  ||| S:24184 E:24190 ||| NN
1 ||| S:24190 E:24191 ||| CD
)  ||| S:24191 E:24193 ||| -RRB-
and  ||| S:24193 E:24197 ||| CC
the  ||| S:24197 E:24201 ||| DT
balanced  ||| S:24201 E:24210 ||| JJ
P2  ||| S:24210 E:24213 ||| CD
signal  ||| S:24213 E:24220 ||| NN
( ||| S:24220 E:24221 ||| -LRB-
intensity  ||| S:24221 E:24231 ||| NN
reading  ||| S:24231 E:24249 ||| NN
for  ||| S:24249 E:24253 ||| IN
probe  ||| S:24253 E:24259 ||| NN
2  ||| S:24259 E:24261 ||| CD
adjusted  ||| S:24261 E:24270 ||| VBN
using  ||| S:24270 E:24276 ||| VBG
the  ||| S:24276 E:24280 ||| DT
balanced  ||| S:24280 E:24289 ||| JJ
coefficient ||| S:24289 E:24300 ||| NN
)  ||| S:24300 E:24312 ||| -RRB-
Incyte  ||| S:24312 E:24319 ||| NNP
GEMtools  ||| S:24319 E:24328 ||| JJ
software  ||| S:24328 E:24337 ||| NN
( ||| S:24337 E:24338 ||| -LRB-
Incyte  ||| S:24338 E:24345 ||| NNP
Pharmaceuticals ||| S:24345 E:24360 ||| NNP
,  ||| S:24360 E:24372 ||| ,
Inc. ||| S:24372 E:24376 ||| NNP
,  ||| S:24376 E:24378 ||| ,
Palo  ||| S:24378 E:24383 ||| NNP
Alto ||| S:24383 E:24387 ||| NNP
,  ||| S:24387 E:24389 ||| ,
CA ||| S:24389 E:24391 ||| NNP
)  ||| S:24391 E:24393 ||| -RRB-
was  ||| S:24393 E:24397 ||| VBD
used  ||| S:24397 E:24402 ||| VBN
for  ||| S:24402 E:24406 ||| IN
image  ||| S:24406 E:24412 ||| NN
analysis ||| S:24412 E:24420 ||| NN
.  ||| S:24420 E:24422 ||| .
A  ||| S:24422 E:24434 ||| DT
gridding  ||| S:24434 E:24443 ||| NN
and  ||| S:24443 E:24447 ||| CC
region  ||| S:24447 E:24454 ||| NN
detection  ||| S:24454 E:24464 ||| NNS
algorithm  ||| S:24464 E:24474 ||| VBP
determined  ||| S:24474 E:24485 ||| VBN
the  ||| S:24485 E:24499 ||| DT
elements ||| S:24499 E:24507 ||| NNS
.  ||| S:24507 E:24509 ||| .
The  ||| S:24509 E:24513 ||| DT
area  ||| S:24513 E:24518 ||| NN
surrounding  ||| S:24518 E:24530 ||| VBG
each  ||| S:24530 E:24535 ||| DT
element  ||| S:24535 E:24543 ||| NN
image  ||| S:24543 E:24549 ||| NN
was  ||| S:24549 E:24563 ||| VBD
used  ||| S:24563 E:24568 ||| VBN
to  ||| S:24568 E:24571 ||| TO
calculate  ||| S:24571 E:24581 ||| VB
a  ||| S:24581 E:24583 ||| DT
local  ||| S:24583 E:24589 ||| JJ
background  ||| S:24589 E:24600 ||| NN
and  ||| S:24600 E:24604 ||| CC
was  ||| S:24604 E:24608 ||| VBD
subtracted  ||| S:24608 E:24629 ||| VBN
from  ||| S:24629 E:24634 ||| IN
the  ||| S:24634 E:24638 ||| DT
total  ||| S:24638 E:24644 ||| JJ
element  ||| S:24644 E:24652 ||| NN
signal ||| S:24652 E:24658 ||| NN
.  ||| S:24658 E:24660 ||| .
Background  ||| S:24660 E:24671 ||| NN
subtracted  ||| S:24671 E:24692 ||| NN
element  ||| S:24692 E:24700 ||| NN
signals  ||| S:24700 E:24708 ||| NNS
were  ||| S:24708 E:24713 ||| VBD
used  ||| S:24713 E:24718 ||| VBN
to  ||| S:24718 E:24721 ||| TO
calculate  ||| S:24721 E:24731 ||| VB
Cy3 ||| S:24731 E:24734 ||| CD
: ||| S:24734 E:24735 ||| :
Cy5  ||| S:24735 E:24739 ||| CD
ratio ||| S:24739 E:24744 ||| NN
.  ||| S:24744 E:24746 ||| .
The  ||| S:24746 E:24760 ||| DT
average  ||| S:24760 E:24768 ||| NN
of  ||| S:24768 E:24771 ||| IN
the  ||| S:24771 E:24775 ||| DT
resulting  ||| S:24775 E:24785 ||| VBG
total  ||| S:24785 E:24791 ||| JJ
Cy3  ||| S:24791 E:24795 ||| NN
and  ||| S:24795 E:24799 ||| CC
Cy5  ||| S:24799 E:24803 ||| CD
signal  ||| S:24803 E:24810 ||| NN
gave  ||| S:24810 E:24815 ||| VBD
a  ||| S:24815 E:24827 ||| DT
ratio  ||| S:24827 E:24833 ||| NN
that  ||| S:24833 E:24838 ||| WDT
was  ||| S:24838 E:24842 ||| VBD
used  ||| S:24842 E:24847 ||| VBN
to  ||| S:24847 E:24850 ||| TO
balance  ||| S:24850 E:24858 ||| VB
or  ||| S:24858 E:24861 ||| CC
normalize  ||| S:24861 E:24871 ||| VB
the  ||| S:24871 E:24885 ||| DT
signals ||| S:24885 E:24892 ||| NNS
.  ||| S:24892 E:24922 ||| .
Oligonucleotide  ||| S:24922 E:24938 ||| JJ
microarray  ||| S:24938 E:24949 ||| JJ
analysis  ||| S:24949 E:24968 ||| NN
The  ||| S:24968 E:24972 ||| DT
HU  ||| S:24972 E:24975 ||| NNP
6800  ||| S:24975 E:24980 ||| CD
microarray  ||| S:24980 E:24991 ||| NNS
was  ||| S:24991 E:24995 ||| VBD
obtained  ||| S:24995 E:25004 ||| VBN
from  ||| S:25004 E:25009 ||| IN
Affymetrix  ||| S:25009 E:25030 ||| NNP
( ||| S:25030 E:25031 ||| -LRB-
Santa  ||| S:25031 E:25037 ||| NNP
Clara ||| S:25037 E:25042 ||| NNP
,  ||| S:25042 E:25044 ||| ,
CA ||| S:25044 E:25046 ||| NNP
) ||| S:25046 E:25047 ||| -RRB-
.  ||| S:25047 E:25049 ||| .
Briefly ||| S:25049 E:25056 ||| RB
,  ||| S:25056 E:25058 ||| ,
total  ||| S:25058 E:25064 ||| JJ
RNA  ||| S:25064 E:25068 ||| NNP
isolated  ||| S:25068 E:25077 ||| VBD
from  ||| S:25077 E:25092 ||| IN
normal  ||| S:25092 E:25099 ||| JJ
PBMC  ||| S:25099 E:25104 ||| NNP
and  ||| S:25104 E:25108 ||| CC
leukemic  ||| S:25108 E:25117 ||| JJ
LGL  ||| S:25117 E:25121 ||| NNP
were  ||| S:25121 E:25126 ||| VBD
DNase-treated  ||| S:25126 E:25140 ||| JJ
and  ||| S:25140 E:25154 ||| CC
purified  ||| S:25154 E:25163 ||| NN
with  ||| S:25163 E:25168 ||| IN
a  ||| S:25168 E:25170 ||| DT
Qiagen  ||| S:25170 E:25177 ||| JJ
kit  ||| S:25177 E:25181 ||| NN
( ||| S:25181 E:25182 ||| -LRB-
Valencia ||| S:25182 E:25190 ||| NNP
,  ||| S:25190 E:25192 ||| ,
CA ||| S:25192 E:25194 ||| NNP
) ||| S:25194 E:25195 ||| -RRB-
.  ||| S:25195 E:25197 ||| .
Approximately  ||| S:25197 E:25221 ||| RB
10  ||| S:25221 E:25224 ||| CD
μg  ||| S:25224 E:25227 ||| NN
of  ||| S:25227 E:25230 ||| IN
purified  ||| S:25230 E:25239 ||| JJ
RNA  ||| S:25239 E:25243 ||| NNP
was  ||| S:25243 E:25247 ||| VBD
used  ||| S:25247 E:25252 ||| VBN
to  ||| S:25252 E:25255 ||| TO
prepare  ||| S:25255 E:25263 ||| VB
double-stranded  ||| S:25263 E:25289 ||| JJ
cDNA  ||| S:25289 E:25294 ||| NN
( ||| S:25294 E:25295 ||| -LRB-
Supercript  ||| S:25295 E:25306 ||| NNP
GIBCO ||| S:25306 E:25311 ||| NNP
/ ||| S:25311 E:25312 ||| NNP
BRL ||| S:25312 E:25315 ||| NNP
,  ||| S:25315 E:25317 ||| ,
Rockville ||| S:25317 E:25326 ||| NNP
,  ||| S:25326 E:25328 ||| ,
MD ||| S:25328 E:25330 ||| NNP
)  ||| S:25330 E:25332 ||| -RRB-
using  ||| S:25332 E:25338 ||| VBG
a  ||| S:25338 E:25340 ||| DT
T7  ||| S:25340 E:25353 ||| NNP
( ||| S:25353 E:25354 ||| -LRB-
dT ||| S:25354 E:25356 ||| NNP
) ||| S:25356 E:25357 ||| -RRB-
24  ||| S:25357 E:25360 ||| CD
primer  ||| S:25360 E:25367 ||| NNS
containing  ||| S:25367 E:25378 ||| VBG
a  ||| S:25378 E:25380 ||| DT
T7  ||| S:25380 E:25383 ||| NNP
RNA  ||| S:25383 E:25387 ||| NNP
polymerase  ||| S:25387 E:25398 ||| FW
promoter  ||| S:25398 E:25417 ||| FW
binding  ||| S:25417 E:25425 ||| FW
site ||| S:25425 E:25429 ||| NN
.  ||| S:25429 E:25431 ||| .
Biotinylated  ||| S:25431 E:25444 ||| JJ
complementary  ||| S:25444 E:25458 ||| JJ
RNA  ||| S:25458 E:25462 ||| NNP
was  ||| S:25462 E:25466 ||| VBD
prepared  ||| S:25466 E:25485 ||| VBN
from  ||| S:25485 E:25490 ||| IN
10  ||| S:25490 E:25493 ||| CD
μg  ||| S:25493 E:25496 ||| NN
of  ||| S:25496 E:25499 ||| IN
cDNA  ||| S:25499 E:25504 ||| JJ
and  ||| S:25504 E:25508 ||| CC
then  ||| S:25508 E:25513 ||| RB
fragmented  ||| S:25513 E:25524 ||| VBN
to  ||| S:25524 E:25527 ||| TO
approximately  ||| S:25527 E:25551 ||| RB
50  ||| S:25551 E:25554 ||| CD
to  ||| S:25554 E:25557 ||| TO
100  ||| S:25557 E:25561 ||| CD
nucleotides ||| S:25561 E:25572 ||| NNS
.  ||| S:25572 E:25585 ||| .
In  ||| S:25585 E:25588 ||| IN
vitro  ||| S:25588 E:25594 ||| JJ
transcribed  ||| S:25594 E:25606 ||| JJ
transcripts  ||| S:25606 E:25628 ||| NNS
were  ||| S:25628 E:25633 ||| VBD
hybridized  ||| S:25633 E:25644 ||| VBN
to  ||| S:25644 E:25647 ||| TO
the  ||| S:25647 E:25651 ||| DT
HU  ||| S:25651 E:25654 ||| NNP
6800  ||| S:25654 E:25659 ||| CD
microarray  ||| S:25659 E:25670 ||| NN
for  ||| S:25670 E:25674 ||| IN
16  ||| S:25674 E:25677 ||| CD
h  ||| S:25677 E:25679 ||| NN
at  ||| S:25679 E:25692 ||| IN
45°C  ||| S:25692 E:25697 ||| CD
with  ||| S:25697 E:25702 ||| IN
constant  ||| S:25702 E:25711 ||| JJ
rotation  ||| S:25711 E:25720 ||| NN
at  ||| S:25720 E:25723 ||| IN
60  ||| S:25723 E:25726 ||| CD
rpm ||| S:25726 E:25729 ||| NNS
.  ||| S:25729 E:25731 ||| .
Chips  ||| S:25731 E:25737 ||| NNS
were  ||| S:25737 E:25742 ||| VBD
washed  ||| S:25742 E:25759 ||| VBN
and  ||| S:25759 E:25763 ||| CC
stained  ||| S:25763 E:25771 ||| NN
by  ||| S:25771 E:25774 ||| IN
using  ||| S:25774 E:25780 ||| VBG
the  ||| S:25780 E:25784 ||| DT
Affymetrix  ||| S:25784 E:25795 ||| JJ
fluidics  ||| S:25795 E:25804 ||| JJ
station ||| S:25804 E:25811 ||| NN
.  ||| S:25811 E:25823 ||| .
Fluorescence  ||| S:25823 E:25836 ||| JJ
intensity  ||| S:25836 E:25846 ||| NN
was  ||| S:25846 E:25850 ||| VBD
measured  ||| S:25850 E:25859 ||| VBN
for  ||| S:25859 E:25863 ||| IN
each  ||| S:25863 E:25868 ||| DT
chip  ||| S:25868 E:25873 ||| NN
and  ||| S:25873 E:25887 ||| CC
normalized  ||| S:25887 E:25898 ||| JJ
to  ||| S:25898 E:25901 ||| TO
the  ||| S:25901 E:25905 ||| DT
fluorescence  ||| S:25905 E:25918 ||| JJ
intensity  ||| S:25918 E:25928 ||| NN
for  ||| S:25928 E:25932 ||| IN
the  ||| S:25932 E:25936 ||| DT
entire  ||| S:25936 E:25953 ||| JJ
chip ||| S:25953 E:25957 ||| NN
.  ||| S:25957 E:25987 ||| .
Verification  ||| S:25987 E:26000 ||| NN
of  ||| S:26000 E:26003 ||| IN
the  ||| S:26003 E:26007 ||| DT
clones  ||| S:26007 E:26024 ||| FW
GEM  ||| S:26024 E:26028 ||| FW
cDNA  ||| S:26028 E:26033 ||| FW
clones  ||| S:26033 E:26040 ||| FW
( ||| S:26040 E:26041 ||| -LRB-
supplied  ||| S:26041 E:26050 ||| VBN
as  ||| S:26050 E:26053 ||| IN
a  ||| S:26053 E:26055 ||| DT
bacterial  ||| S:26055 E:26065 ||| JJ
stab ||| S:26065 E:26069 ||| NN
)  ||| S:26069 E:26071 ||| -RRB-
were  ||| S:26071 E:26086 ||| VBD
purchased  ||| S:26086 E:26096 ||| VBN
from  ||| S:26096 E:26101 ||| IN
IncyteGenomics  ||| S:26101 E:26116 ||| JJ
and  ||| S:26116 E:26120 ||| CC
streaked  ||| S:26120 E:26129 ||| NN
on  ||| S:26129 E:26132 ||| IN
LB  ||| S:26132 E:26135 ||| NNP
agar  ||| S:26135 E:26150 ||| NNS
plates  ||| S:26150 E:26157 ||| VBP
containing  ||| S:26157 E:26168 ||| VBG
the  ||| S:26168 E:26172 ||| DT
appropriate  ||| S:26172 E:26184 ||| JJ
antibiotic ||| S:26184 E:26194 ||| NN
.  ||| S:26194 E:26196 ||| .
Individual  ||| S:26196 E:26217 ||| JJ
colonies  ||| S:26217 E:26226 ||| NNS
were  ||| S:26226 E:26231 ||| VBD
picked  ||| S:26231 E:26238 ||| VBN
and  ||| S:26238 E:26242 ||| CC
grown  ||| S:26242 E:26248 ||| VBN
in  ||| S:26248 E:26251 ||| IN
LB  ||| S:26251 E:26254 ||| NNP
medium ||| S:26254 E:26260 ||| NN
.  ||| S:26260 E:26262 ||| .
Plasmid  ||| S:26262 E:26270 ||| NNP
DNA  ||| S:26270 E:26284 ||| NNP
was  ||| S:26284 E:26288 ||| VBD
isolated  ||| S:26288 E:26297 ||| VBN
and  ||| S:26297 E:26301 ||| CC
sequenced  ||| S:26301 E:26311 ||| NN
in  ||| S:26311 E:26314 ||| IN
order  ||| S:26314 E:26320 ||| NN
to  ||| S:26320 E:26323 ||| TO
verify  ||| S:26323 E:26330 ||| VB
the  ||| S:26330 E:26344 ||| DT
sequence  ||| S:26344 E:26353 ||| JJ
identity ||| S:26353 E:26361 ||| NN
.  ||| S:26361 E:26391 ||| .
Northern  ||| S:26391 E:26400 ||| JJ
blot  ||| S:26400 E:26405 ||| JJ
analysis  ||| S:26405 E:26424 ||| NN
Northern  ||| S:26424 E:26433 ||| NNP
Blotting  ||| S:26433 E:26442 ||| NNP
was  ||| S:26442 E:26446 ||| VBD
performed  ||| S:26446 E:26456 ||| VBN
as  ||| S:26456 E:26459 ||| RB
described ||| S:26459 E:26468 ||| VBN
.  ||| S:26468 E:26470 ||| .
Briefly  ||| S:26470 E:26488 ||| RB
10  ||| S:26488 E:26491 ||| CD
μg  ||| S:26491 E:26494 ||| NN
of  ||| S:26494 E:26497 ||| IN
total  ||| S:26497 E:26503 ||| JJ
RNA  ||| S:26503 E:26507 ||| NNP
from  ||| S:26507 E:26512 ||| IN
each  ||| S:26512 E:26517 ||| DT
sample  ||| S:26517 E:26524 ||| NN
was  ||| S:26524 E:26528 ||| VBD
denatured  ||| S:26528 E:26538 ||| VBN
at  ||| S:26538 E:26541 ||| IN
65°C  ||| S:26541 E:26556 ||| CD
in  ||| S:26556 E:26559 ||| IN
RNA  ||| S:26559 E:26563 ||| NNP
loading  ||| S:26563 E:26571 ||| NN
buffer ||| S:26571 E:26577 ||| NN
,  ||| S:26577 E:26579 ||| ,
electrophoresed  ||| S:26579 E:26595 ||| VBG
in  ||| S:26595 E:26598 ||| IN
a  ||| S:26598 E:26600 ||| DT
1 ||| S:26600 E:26601 ||| CD
%  ||| S:26601 E:26603 ||| NN
agarose  ||| S:26603 E:26621 ||| NNS
gel  ||| S:26621 E:26625 ||| VBP
containing  ||| S:26625 E:26636 ||| VBG
2.2  ||| S:26636 E:26640 ||| CD
M  ||| S:26640 E:26642 ||| NNP
formaldehyde ||| S:26642 E:26654 ||| NN
,  ||| S:26654 E:26656 ||| ,
then  ||| S:26656 E:26661 ||| RB
blotted  ||| S:26661 E:26669 ||| VBN
onto  ||| S:26669 E:26674 ||| IN
a  ||| S:26674 E:26686 ||| DT
Nytran  ||| S:26686 E:26693 ||| JJ
membrane  ||| S:26693 E:26702 ||| NNS
( ||| S:26702 E:26703 ||| -LRB-
Schleicher  ||| S:26703 E:26714 ||| NNP
&  ||| S:26714 E:26716 ||| CC
Schuell ||| S:26716 E:26723 ||| NNP
,  ||| S:26723 E:26725 ||| ,
Inc ||| S:26725 E:26728 ||| NNP
,  ||| S:26728 E:26730 ||| ,
Keene ||| S:26730 E:26735 ||| NNP
,  ||| S:26735 E:26747 ||| ,
N.H ||| S:26747 E:26750 ||| NNP
) ||| S:26750 E:26751 ||| -RRB-
.  ||| S:26751 E:26753 ||| .
The  ||| S:26753 E:26757 ||| DT
RNA  ||| S:26757 E:26761 ||| NNP
was  ||| S:26761 E:26765 ||| VBD
fixed  ||| S:26765 E:26771 ||| VBN
to  ||| S:26771 E:26774 ||| TO
the  ||| S:26774 E:26778 ||| DT
membrane  ||| S:26778 E:26787 ||| NN
by  ||| S:26787 E:26790 ||| IN
UV  ||| S:26790 E:26803 ||| NNP
cross-linking.  ||| S:26803 E:26818 ||| NNP
cDNA  ||| S:26818 E:26823 ||| NNP
was  ||| S:26823 E:26827 ||| VBD
labeled  ||| S:26827 E:26835 ||| VBN
with  ||| S:26835 E:26840 ||| IN
[  ||| S:26840 E:26842 ||| -LRB-
32P ||| S:26842 E:26845 ||| NNP
]  ||| S:26845 E:26847 ||| -RRB-
and  ||| S:26847 E:26851 ||| CC
purified  ||| S:26851 E:26870 ||| VBP
using  ||| S:26870 E:26876 ||| VBG
Nick  ||| S:26876 E:26881 ||| NNP
columns  ||| S:26881 E:26889 ||| NNS
( ||| S:26889 E:26890 ||| -LRB-
Amersham  ||| S:26890 E:26899 ||| NNP
Pharmacia  ||| S:26899 E:26909 ||| NNP
Biotech  ||| S:26909 E:26917 ||| NNP
AB ||| S:26917 E:26919 ||| NNP
,  ||| S:26919 E:26931 ||| ,
Piscataway ||| S:26931 E:26941 ||| NNP
,  ||| S:26941 E:26943 ||| ,
NJ ||| S:26943 E:26945 ||| NNP
) ||| S:26945 E:26946 ||| -RRB-
.  ||| S:26946 E:26948 ||| .
Hybridization  ||| S:26948 E:26962 ||| NNP
and  ||| S:26962 E:26966 ||| CC
washing  ||| S:26966 E:26974 ||| VBG
of  ||| S:26974 E:26977 ||| IN
the  ||| S:26977 E:26981 ||| DT
blots  ||| S:26981 E:26997 ||| NN
were  ||| S:26997 E:27002 ||| VBD
performed  ||| S:27002 E:27012 ||| VBN
as  ||| S:27012 E:27015 ||| RB
described  ||| S:27015 E:27025 ||| VBN
by  ||| S:27025 E:27028 ||| IN
Engler-Blum  ||| S:27028 E:27040 ||| FW
et  ||| S:27040 E:27043 ||| FW
al  ||| S:27043 E:27046 ||| FW
[  ||| S:27046 E:27048 ||| -LRB-
15  ||| S:27048 E:27051 ||| CD
]  ||| S:27051 E:27063 ||| -RRB-
.  ||| S:27063 E:27093 ||| .
RNase  ||| S:27093 E:27099 ||| JJ
protection  ||| S:27099 E:27110 ||| NN
assay  ||| S:27110 E:27116 ||| NNS
( ||| S:27116 E:27117 ||| -LRB-
RPA ||| S:27117 E:27120 ||| NNP
)  ||| S:27120 E:27132 ||| -RRB-
RPAs  ||| S:27132 E:27137 ||| NNP
were  ||| S:27137 E:27142 ||| VBD
performed  ||| S:27142 E:27152 ||| VBN
using  ||| S:27152 E:27158 ||| VBG
the  ||| S:27158 E:27162 ||| DT
RNA  ||| S:27162 E:27166 ||| NNP
isolated  ||| S:27166 E:27175 ||| VBD
from  ||| S:27175 E:27190 ||| IN
leukemic  ||| S:27190 E:27199 ||| JJ
LGL ||| S:27199 E:27202 ||| NNP
,  ||| S:27202 E:27204 ||| ,
normal  ||| S:27204 E:27211 ||| JJ
PBMC  ||| S:27211 E:27216 ||| NNP
and  ||| S:27216 E:27220 ||| CC
normal  ||| S:27220 E:27227 ||| JJ
PBMC  ||| S:27227 E:27232 ||| NNS
activated  ||| S:27232 E:27242 ||| VBN
by  ||| S:27242 E:27255 ||| IN
IL-2  ||| S:27255 E:27260 ||| NNP
and  ||| S:27260 E:27264 ||| CC
PHA ||| S:27264 E:27267 ||| NNP
.  ||| S:27267 E:27269 ||| .
Five  ||| S:27269 E:27274 ||| CD
μg  ||| S:27274 E:27277 ||| NN
of  ||| S:27277 E:27280 ||| IN
total  ||| S:27280 E:27286 ||| JJ
RNA  ||| S:27286 E:27290 ||| NNP
was  ||| S:27290 E:27294 ||| VBD
hybridized  ||| S:27294 E:27305 ||| VBN
to  ||| S:27305 E:27308 ||| TO
the  ||| S:27308 E:27323 ||| DT
in  ||| S:27323 E:27326 ||| FW
vitro  ||| S:27326 E:27332 ||| FW
transcribed  ||| S:27332 E:27344 ||| FW
hAPO-4  ||| S:27344 E:27351 ||| FW
probe  ||| S:27351 E:27367 ||| FW
set  ||| S:27367 E:27371 ||| FW
( ||| S:27371 E:27372 ||| -LRB-
PharMingen ||| S:27372 E:27382 ||| NNP
,  ||| S:27382 E:27384 ||| ,
SanDiego ||| S:27384 E:27392 ||| NNP
,  ||| S:27392 E:27394 ||| ,
CA ||| S:27394 E:27396 ||| NNP
) ||| S:27396 E:27397 ||| -RRB-
,  ||| S:27397 E:27399 ||| ,
and  ||| S:27399 E:27403 ||| CC
the  ||| S:27403 E:27407 ||| DT
RPA  ||| S:27407 E:27411 ||| NNP
assay  ||| S:27411 E:27417 ||| NN
was  ||| S:27417 E:27431 ||| VBD
performed  ||| S:27431 E:27441 ||| VBN
according  ||| S:27441 E:27451 ||| VBG
to  ||| S:27451 E:27454 ||| TO
the  ||| S:27454 E:27458 ||| DT
manufacturer ||| S:27458 E:27470 ||| NN
's  ||| S:27470 E:27473 ||| POS
protocol ||| S:27473 E:27481 ||| NN
.  ||| S:27481 E:27483 ||| .
After  ||| S:27483 E:27499 ||| IN
the  ||| S:27499 E:27503 ||| DT
assay ||| S:27503 E:27508 ||| NN
,  ||| S:27508 E:27510 ||| ,
the  ||| S:27510 E:27514 ||| DT
samples  ||| S:27514 E:27522 ||| NNS
were  ||| S:27522 E:27527 ||| VBD
resolved  ||| S:27527 E:27536 ||| VBN
on  ||| S:27536 E:27539 ||| IN
a  ||| S:27539 E:27541 ||| DT
5 ||| S:27541 E:27542 ||| CD
%  ||| S:27542 E:27554 ||| NN
polyacrylamide  ||| S:27554 E:27569 ||| NN
gel ||| S:27569 E:27572 ||| NN
.  ||| S:27572 E:27574 ||| .
The  ||| S:27574 E:27578 ||| DT
gel  ||| S:27578 E:27582 ||| NN
was  ||| S:27582 E:27586 ||| VBD
dried  ||| S:27586 E:27592 ||| VBN
and  ||| S:27592 E:27596 ||| CC
exposed  ||| S:27596 E:27604 ||| VBN
to  ||| S:27604 E:27617 ||| TO
X-ray  ||| S:27617 E:27623 ||| NN
film ||| S:27623 E:27627 ||| NN
.  ||| S:27627 E:27629 ||| .
After  ||| S:27629 E:27635 ||| IN
developing  ||| S:27635 E:27646 ||| VBG
the  ||| S:27646 E:27650 ||| DT
film ||| S:27650 E:27654 ||| NN
,  ||| S:27654 E:27656 ||| ,
the  ||| S:27656 E:27660 ||| DT
bands  ||| S:27660 E:27666 ||| NNS
were  ||| S:27666 E:27681 ||| VBD
quantitated  ||| S:27681 E:27693 ||| VBN
by  ||| S:27693 E:27696 ||| IN
using  ||| S:27696 E:27702 ||| VBG
the  ||| S:27702 E:27706 ||| DT
ImageQuant  ||| S:27706 E:27717 ||| JJ
program  ||| S:27717 E:27725 ||| NN
and  ||| S:27725 E:27739 ||| CC
normalized  ||| S:27739 E:27750 ||| NN
with  ||| S:27750 E:27755 ||| IN
the  ||| S:27755 E:27759 ||| DT
housekeeping  ||| S:27759 E:27772 ||| JJ
gene ||| S:27772 E:27776 ||| NN
,  ||| S:27776 E:27778 ||| ,
L32 ||| S:27778 E:27781 ||| NNP
.  ||| S:27781 E:27811 ||| .
Western  ||| S:27811 E:27819 ||| JJ
immunoblot  ||| S:27819 E:27830 ||| JJ
analysis  ||| S:27830 E:27849 ||| NN
Cells  ||| S:27849 E:27855 ||| NNP
were  ||| S:27855 E:27860 ||| VBD
lysed  ||| S:27860 E:27866 ||| VBN
in  ||| S:27866 E:27869 ||| IN
a  ||| S:27869 E:27871 ||| DT
buffer  ||| S:27871 E:27878 ||| NN
containing  ||| S:27878 E:27889 ||| VBG
50  ||| S:27889 E:27892 ||| CD
mM  ||| S:27892 E:27895 ||| JJ
Tris-HCl  ||| S:27895 E:27914 ||| NN
( ||| S:27914 E:27915 ||| -LRB-
pH  ||| S:27915 E:27918 ||| NNP
7.6 ||| S:27918 E:27921 ||| CD
) ||| S:27921 E:27922 ||| -RRB-
,  ||| S:27922 E:27924 ||| ,
5  ||| S:27924 E:27926 ||| CD
mM  ||| S:27926 E:27929 ||| JJ
EDTA ||| S:27929 E:27933 ||| NNP
,  ||| S:27933 E:27935 ||| ,
150  ||| S:27935 E:27939 ||| CD
mM  ||| S:27939 E:27942 ||| JJ
NaCl ||| S:27942 E:27946 ||| NN
,  ||| S:27946 E:27948 ||| ,
0.5  ||| S:27948 E:27952 ||| CD
%  ||| S:27952 E:27954 ||| NN
NP-40 ||| S:27954 E:27959 ||| NN
,  ||| S:27959 E:27961 ||| ,
and  ||| S:27961 E:27965 ||| CC
0.5 ||| S:27965 E:27968 ||| CD
%  ||| S:27968 E:27980 ||| NN
Triton  ||| S:27980 E:27987 ||| NNP
X-100  ||| S:27987 E:27993 ||| NNP
containing  ||| S:27993 E:28004 ||| VBG
1  ||| S:28004 E:28006 ||| CD
μg ||| S:28006 E:28008 ||| CD
/ ||| S:28008 E:28009 ||| CD
ml  ||| S:28009 E:28012 ||| JJ
leupeptin ||| S:28012 E:28021 ||| NN
,  ||| S:28021 E:28023 ||| ,
aprotinin  ||| S:28023 E:28033 ||| NN
and  ||| S:28033 E:28047 ||| CC
antipain ||| S:28047 E:28055 ||| NNS
;  ||| S:28055 E:28057 ||| :
1  ||| S:28057 E:28059 ||| CD
mM  ||| S:28059 E:28062 ||| JJ
sodiumorthovanadate ||| S:28062 E:28081 ||| NN
;  ||| S:28081 E:28083 ||| :
and  ||| S:28083 E:28087 ||| CC
0.5  ||| S:28087 E:28091 ||| CD
mM  ||| S:28091 E:28094 ||| JJ
PMSF  ||| S:28094 E:28099 ||| NNP
( ||| S:28099 E:28100 ||| -LRB-
all  ||| S:28100 E:28114 ||| DT
reagents  ||| S:28114 E:28123 ||| NN
were  ||| S:28123 E:28128 ||| VBD
obtained  ||| S:28128 E:28137 ||| VBN
from  ||| S:28137 E:28142 ||| IN
Sigma  ||| S:28142 E:28148 ||| NNP
Chemical  ||| S:28148 E:28157 ||| NNP
Co. ||| S:28157 E:28160 ||| NNP
) ||| S:28160 E:28161 ||| -RRB-
.  ||| S:28161 E:28173 ||| .
Twenty-five  ||| S:28173 E:28185 ||| CD
μg  ||| S:28185 E:28188 ||| NN
of  ||| S:28188 E:28191 ||| IN
total  ||| S:28191 E:28197 ||| JJ
protein  ||| S:28197 E:28205 ||| NN
from  ||| S:28205 E:28210 ||| IN
each  ||| S:28210 E:28215 ||| DT
sample  ||| S:28215 E:28222 ||| NN
was  ||| S:28222 E:28236 ||| VBD
subjected  ||| S:28236 E:28246 ||| VBN
to  ||| S:28246 E:28249 ||| TO
10 ||| S:28249 E:28251 ||| CD
%  ||| S:28251 E:28253 ||| NN
SDS-PAGE ||| S:28253 E:28261 ||| NN
.  ||| S:28261 E:28263 ||| .
Then  ||| S:28263 E:28268 ||| RB
the  ||| S:28268 E:28272 ||| DT
proteins  ||| S:28272 E:28281 ||| NNS
were  ||| S:28281 E:28296 ||| VBD
transferred  ||| S:28296 E:28308 ||| VBN
to  ||| S:28308 E:28311 ||| TO
a  ||| S:28311 E:28313 ||| DT
membrane  ||| S:28313 E:28322 ||| NN
and  ||| S:28322 E:28326 ||| CC
Western  ||| S:28326 E:28334 ||| JJ
blotting  ||| S:28334 E:28343 ||| NN
was  ||| S:28343 E:28357 ||| VBD
performed  ||| S:28357 E:28367 ||| VBN
using  ||| S:28367 E:28373 ||| VBG
the  ||| S:28373 E:28377 ||| DT
monoclonal  ||| S:28377 E:28388 ||| JJ
antibody  ||| S:28388 E:28397 ||| NN
for  ||| S:28397 E:28401 ||| IN
PAC-1  ||| S:28401 E:28407 ||| NNP
and  ||| S:28407 E:28421 ||| CC
A20 ||| S:28421 E:28424 ||| NNP
,  ||| S:28424 E:28426 ||| ,
followed  ||| S:28426 E:28435 ||| VBN
by  ||| S:28435 E:28438 ||| IN
the  ||| S:28438 E:28442 ||| DT
ECL  ||| S:28442 E:28446 ||| NNP
technique  ||| S:28446 E:28456 ||| NN
as  ||| S:28456 E:28459 ||| IN
recommended  ||| S:28459 E:28471 ||| VBN
by  ||| S:28471 E:28474 ||| IN
the  ||| S:28474 E:28488 ||| DT
manufacturer  ||| S:28488 E:28501 ||| NN
( ||| S:28501 E:28502 ||| -LRB-
Amersham  ||| S:28502 E:28511 ||| NNP
Biosciences ||| S:28511 E:28522 ||| NNP
,  ||| S:28522 E:28524 ||| ,
Piscataway ||| S:28524 E:28534 ||| NNP
,  ||| S:28534 E:28536 ||| ,
NJ ||| S:28536 E:28538 ||| NNP
) ||| S:28538 E:28539 ||| -RRB-
.  ||| S:28539 E:28572 ||| .
Authors ||| S:28572 E:28579 ||| NNP
'  ||| S:28579 E:28581 ||| POS
contributions  ||| S:28581 E:28603 ||| NNS
RK  ||| S:28603 E:28606 ||| VBP
conceived  ||| S:28606 E:28616 ||| VBN
of  ||| S:28616 E:28619 ||| IN
the  ||| S:28619 E:28623 ||| DT
study  ||| S:28623 E:28629 ||| NN
along  ||| S:28629 E:28635 ||| IN
with  ||| S:28635 E:28640 ||| IN
TPL ||| S:28640 E:28643 ||| NNP
,  ||| S:28643 E:28645 ||| ,
isolated ||| S:28645 E:28653 ||| VBN
,  ||| S:28653 E:28663 ||| ,
purified  ||| S:28663 E:28672 ||| VBG
RNA  ||| S:28672 E:28676 ||| NNP
from  ||| S:28676 E:28681 ||| IN
the  ||| S:28681 E:28685 ||| DT
samples  ||| S:28685 E:28693 ||| NNS
for  ||| S:28693 E:28697 ||| IN
microarray  ||| S:28697 E:28708 ||| NN
and  ||| S:28708 E:28712 ||| CC
performed  ||| S:28712 E:28730 ||| VBN
all  ||| S:28730 E:28734 ||| PDT
the  ||| S:28734 E:28738 ||| DT
experiments  ||| S:28738 E:28750 ||| NNS
to  ||| S:28750 E:28753 ||| TO
validate  ||| S:28753 E:28762 ||| VB
the  ||| S:28762 E:28766 ||| DT
microarray  ||| S:28766 E:28777 ||| JJ
data  ||| S:28777 E:28782 ||| NNS
and  ||| S:28782 E:28794 ||| CC
analysed  ||| S:28794 E:28803 ||| VBG
the  ||| S:28803 E:28807 ||| DT
data  ||| S:28807 E:28812 ||| NNS
and  ||| S:28812 E:28816 ||| CC
drafted  ||| S:28816 E:28824 ||| VBD
the  ||| S:28824 E:28828 ||| DT
manuscript ||| S:28828 E:28838 ||| NN
.  ||| S:28838 E:28840 ||| .
SJY  ||| S:28840 E:28844 ||| NNP
verified  ||| S:28844 E:28861 ||| VBD
the  ||| S:28861 E:28865 ||| DT
microarray  ||| S:28865 E:28876 ||| JJ
data  ||| S:28876 E:28881 ||| NNS
and  ||| S:28881 E:28885 ||| CC
participated  ||| S:28885 E:28898 ||| VBD
in  ||| S:28898 E:28901 ||| IN
validation  ||| S:28901 E:28912 ||| NN
of  ||| S:28912 E:28915 ||| IN
the  ||| S:28915 E:28927 ||| DT
microarray ||| S:28927 E:28937 ||| NN
.  ||| S:28937 E:28939 ||| .
SM  ||| S:28939 E:28942 ||| NNP
performed  ||| S:28942 E:28952 ||| VBD
microarray  ||| S:28952 E:28963 ||| JJ
analysis  ||| S:28963 E:28972 ||| NN
and  ||| S:28972 E:28976 ||| CC
analyzed  ||| S:28976 E:28993 ||| VBD
the  ||| S:28993 E:28997 ||| DT
data  ||| S:28997 E:29002 ||| NNS
and  ||| S:29002 E:29006 ||| CC
TPL  ||| S:29006 E:29010 ||| NNP
conceived  ||| S:29010 E:29020 ||| VBD
of  ||| S:29020 E:29023 ||| IN
the  ||| S:29023 E:29027 ||| DT
study ||| S:29027 E:29032 ||| NN
,  ||| S:29032 E:29034 ||| ,
and  ||| S:29034 E:29038 ||| CC
participated  ||| S:29038 E:29059 ||| VBD
in  ||| S:29059 E:29062 ||| IN
its  ||| S:29062 E:29066 ||| PRP$
design  ||| S:29066 E:29073 ||| NN
and  ||| S:29073 E:29077 ||| CC
coordination ||| S:29077 E:29089 ||| NN
.  ||| S:29089 E:29106 ||| .
